
<html lang="en"     class="pb-page"  data-request-id="116e7b98-3079-4ed1-9a50-590ddaa6e96f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.5b00774;requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2015.58.issue-22;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of a Novel, Potent Spirocyclic Series of γ-Secretase Inhibitors" /></meta><meta name="dc.Creator" content="Zhiqiang  Zhao" /></meta><meta name="dc.Creator" content="Dmitri A.  Pissarnitski" /></meta><meta name="dc.Creator" content="Hubert B.  Josien" /></meta><meta name="dc.Creator" content="Wen-Lian  Wu" /></meta><meta name="dc.Creator" content="Ruo  Xu" /></meta><meta name="dc.Creator" content="Hongmei  Li" /></meta><meta name="dc.Creator" content="John W.  Clader" /></meta><meta name="dc.Creator" content="Duane A.  Burnett" /></meta><meta name="dc.Creator" content="Giuseppe  Terracina" /></meta><meta name="dc.Creator" content="Lynn  Hyde" /></meta><meta name="dc.Creator" content="Julie  Lee" /></meta><meta name="dc.Creator" content="Lixin  Song" /></meta><meta name="dc.Creator" content="Lili  Zhang" /></meta><meta name="dc.Creator" content="Eric M.  Parker" /></meta><meta name="dc.Description" content="In the present paper, we described the design, synthesis, SAR, and biological profile of a novel spirocyclic sulfone series of γ-secretase inhibitors (GSIs) related to MRK-560. We utilized an addit..." /></meta><meta name="Description" content="In the present paper, we described the design, synthesis, SAR, and biological profile of a novel spirocyclic sulfone series of γ-secretase inhibitors (GSIs) related to MRK-560. We utilized an addit..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 6, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00774" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00774" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00774" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00774" /></link>
        
    
    

<title>Discovery of a Novel, Potent Spirocyclic Series of γ-Secretase Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00774" /></meta><meta property="og:title" content="Discovery of a Novel, Potent Spirocyclic Series of γ-Secretase Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0009.jpeg" /></meta><meta property="og:description" content="In the present paper, we described the design, synthesis, SAR, and biological profile of a novel spirocyclic sulfone series of γ-secretase inhibitors (GSIs) related to MRK-560. We utilized an additional spirocyclic ring system to stabilize the active chair conformation of the parent γ-secretase inhibitors. The resulting series is devoid of the CYP2C9 inhibition liability of MRK-560. A few representative analogs were assessed in a nontransgenic animal model of Alzheimer’s disease (AD), demonstrating reduction of amyloid-β (Aβ) in the CNS after acute oral dosing. A spirocyclic phosphonate was identified as the optimal ring system for both potency and pharmacokinetics. Compared to GSIs studied in the clinic, representative spirocyclic phosphonate 18a(−) features improved selectivity for the inhibition of the PS-1 isoform of γ-secretase (33-fold vs PS-2), which may alleviate the adverse effect profile of the clinical GSIs." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00774"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00774">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00774&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00774&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00774&amp;href=/doi/10.1021/acs.jmedchem.5b00774" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 8806-8817</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b00272" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b00857" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Novel, Potent Spirocyclic Series of γ-Secretase Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhiqiang++Zhao">Zhiqiang Zhao</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dmitri+A.++Pissarnitski">Dmitri A. Pissarnitski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hubert+B.++Josien">Hubert B. Josien</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wen-Lian++Wu">Wen-Lian Wu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ruo++Xu">Ruo Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hongmei++Li">Hongmei Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+W.++Clader">John W. Clader</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Duane+A.++Burnett">Duane A. Burnett</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giuseppe++Terracina">Giuseppe Terracina</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lynn++Hyde">Lynn Hyde</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julie++Lee">Julie Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lixin++Song">Lixin Song</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lili++Zhang">Lili Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+M.++Parker">Eric M. Parker</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Medicinal Chemistry, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Neurobiology, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 908-740-2383. E-mail: <a href="/cdn-cgi/l/email-protection#7f0517160e161e11185105171e103f121a0d1c14511c1012"><span class="__cf_email__" data-cfemail="42382a2b332b232c256c382a232d022f273021296c212d2f">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00774&amp;href=/doi/10.1021%2Facs.jmedchem.5b00774" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 8806–8817</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 23, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 June 2015</li><li><span class="item_label"><b>Published</b> online</span>6 November 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 November 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00774" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00774</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8806%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DZhiqiang%2BZhao%252C%2BDmitri%2BA.%2BPissarnitski%252C%2BHubert%2BB.%2BJosien%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D22%26contentID%3Dacs.jmedchem.5b00774%26title%3DDiscovery%2Bof%2Ba%2BNovel%252C%2BPotent%2BSpirocyclic%2BSeries%2Bof%2B%25CE%25B3-Secretase%2BInhibitors%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8817%26publicationDate%3DNovember%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00774"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2212</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00774" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Novel, Potent Spirocyclic Series of γ-Secretase Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zhiqiang&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Dmitri&quot;,&quot;last_name&quot;:&quot;A. Pissarnitski&quot;},{&quot;first_name&quot;:&quot;Hubert&quot;,&quot;last_name&quot;:&quot;B. Josien&quot;},{&quot;first_name&quot;:&quot;Wen-Lian&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Ruo&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Hongmei&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;W. Clader&quot;},{&quot;first_name&quot;:&quot;Duane&quot;,&quot;last_name&quot;:&quot;A. Burnett&quot;},{&quot;first_name&quot;:&quot;Giuseppe&quot;,&quot;last_name&quot;:&quot;Terracina&quot;},{&quot;first_name&quot;:&quot;Lynn&quot;,&quot;last_name&quot;:&quot;Hyde&quot;},{&quot;first_name&quot;:&quot;Julie&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Lixin&quot;,&quot;last_name&quot;:&quot;Song&quot;},{&quot;first_name&quot;:&quot;Lili&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;M. Parker&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;8806-8817&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00774&quot;},&quot;abstract&quot;:&quot;In the present paper, we described the design, synthesis, SAR, and biological profile of a novel spirocyclic sulfone series of γ-secretase inhibitors (GSIs) related to MRK-560. We utilized an additional spirocyclic ring system to stabilize the active chair conformation of the parent γ-secretase inhibitors. The resulting series is devoid of the CYP2C9 inhibition liability of MRK-560. A few representative analogs were assessed in a nontransgenic animal model of Alzheimer’s disease (AD), demonstrating reduction of amyloid-β (Aβ) in the CNS after acute oral dosing. A spirocyclic phosphonate was identified as the optimal ring system for both potency and pharmacokinetics. Compared to GSIs studied in the clinic, representative spirocyclic phosphonate 18a(−) features improved selectivity for the inhibition of the PS-1 isoform of γ-secretase (33-fold vs PS-2), which may alleviate the adverse effect profile of the clinical GSIs.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00774&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00774" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00774&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00774" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00774&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00774" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00774&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00774&amp;href=/doi/10.1021/acs.jmedchem.5b00774" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00774" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00774" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (959 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00774%26sid%3Dliteratum%253Aachs%26pmid%3D26496070%26genre%3Darticle%26aulast%3DZhao%26date%3D2015%26atitle%3DDiscovery%2Bof%2Ba%2BNovel%252C%2BPotent%2BSpirocyclic%2BSeries%2Bof%2B%25CE%25B3-Secretase%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D22%26spage%3D8806%26epage%3D8817%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292020" title="Diols">Diols</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=290723" title="Solutions">Solutions</a>,</li><li><a href="/action/doSearch?ConceptID=291304" title="Organic reactions">Organic reactions</a>,</li><li><a href="/action/doSearch?ConceptID=291291" title="Water">Water</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/jmcmar.2015.58.issue-22/20151125/jmcmar.2015.58.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/medium/jm-2015-00774k_0009.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00774&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In the present paper, we described the design, synthesis, SAR, and biological profile of a novel spirocyclic sulfone series of γ-secretase inhibitors (GSIs) related to MRK-560. We utilized an additional spirocyclic ring system to stabilize the active chair conformation of the parent γ-secretase inhibitors. The resulting series is devoid of the CYP2C9 inhibition liability of MRK-560. A few representative analogs were assessed in a nontransgenic animal model of Alzheimer’s disease (AD), demonstrating reduction of amyloid-β (Aβ) in the CNS after acute oral dosing. A spirocyclic phosphonate was identified as the optimal ring system for both potency and pharmacokinetics. Compared to GSIs studied in the clinic, representative spirocyclic phosphonate <b>18a(−)</b> features improved selectivity for the inhibition of the PS-1 isoform of γ-secretase (33-fold vs PS-2), which may alleviate the adverse effect profile of the clinical GSIs.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11100" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11100" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is the most common form of dementia in the elderly. It causes problems with memory, thinking and behavior. These problems get worse with increasing age. AD is the sixth leading cause of death across all ages in the United States.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> As the elderly population continues to grow, the prevalence of AD will increasingly be a major burden to the nation’s health care system.</div><div class="NLM_p">It is known that accumulation and deposition of Aβ plaques leads to the damage and death of neurons, which is correlated with severity of AD.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> An important step in the formation of Aβ peptides is the secondary processing of amyloid precursor protein (APP) fragments by γ-secretase, which is a multiprotein enzymatic complex containing presenilin (PS), aph-1, nicastrin, and pen-2.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Thus, γ-secretase is one of the critical enzymes required for the generation of Aβ peptides, which play a key role in AD. Inhibition of γ-secretase is considered to be a disease-modifying approach for this disorder<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> because small-molecule GSIs have been shown to lower levels of plasma, cerebrospinal fluid (CSF), and cortical Aβ peptides in the animal models.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> However, in addition to APP, γ-secretase cleaves a number of other endogenous substrates,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> of which cell-surface receptor Notch has the most physiological significance. Cleavage of Notch by γ-secretase generates Notch intracellular domain (NICD), which relocates to the nucleus of the cell and acts as a transcriptional factor. Adverse effects (AE) of GSIs stemming from the inhibition of Notch processing have been well-characterized in vivo.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a></div><div class="NLM_p">Notch-related AE are viewed as a major obstacle for the development of GSIs for the treatment of AD.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Semagacestat (LY-450139, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), one of the first GSIs to enter clinical trials,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> failed to achieve a useful therapeutic window, leading to discontinuation of phase III clinical trials with this compound.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Because of the Notch-related AE, the AD research field has shifted in recent years from GS inhibition to GS modulation<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and inhibition of BACE.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> However, retrospective analysis of data from the failed Semagacestat trials points to knowledge gaps which must be addressed before prematurely abandoning efforts toward development of GSIs for the treatment of AD.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> A review of recent advances in the identification of GSIs was published in a <i>Journal of Medicinal Chemistry</i> perspective.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The same review also discussed the application of GSIs beyond AD, such as for the treatment of leukemia<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and breast cancer.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/medium/jm-2015-00774k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Current representative GSIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00774&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Interestingly, Notch-sparing GSIs have been discovered. Begacestat<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (GSI-953, WAY-210953, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) and avagacestat<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (BMS-708163, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), both belonging to the sulfonamide GSI class, have respective selectivities of 14-fold<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and 193-fold<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> favoring inhibition of APP cleavage vs Notch. The in vitro selectivities of these compounds have translated into improved safety profiles in animal models.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Unfortunately, clinical trials with Notch-sparing GSIs still have not come to fruition, possibly because the reduction of Aβ in the CNS compartment has not been robust at the studied doses,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> which were limited by AE.</div><div class="NLM_p">Similarly to Notch-sparing GSIs, MRK-560 (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), a representative of sulfone GSI class, has also demonstrated an improved therapeutic window in animals, as after chronic administration in mice it did not show the typical Notch AE.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> This observation was surprising because MRK-560 did not show selectivity in the inhibition of APP vs Notch cleavage in in vitro assays.</div><div class="NLM_p">However, in a follow up study, MRK-560 was found to inhibit the isoform of γ-secretase composed of presenilin-1 (PS-1) 37-fold more potently than that of presenilin-2 (PS-2).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> As separate studies of the PS-1 and PS-2 knockout animals lead to suggest that these isoforms have different pharmacologies, these findings taken together imply that PS-1 selectivity may provide for the improved safety profile of MRK-560.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">The improved safety profile of MRK-560 makes it an attractive starting point for further optimization, and previously two novel series of γ-secretase inhibitors related to MRK-560 were described. Thus, Xu et al. made an additional connection between the C-2 atom of MRK-560 with the difluorophenyl ring (structure <b>I</b>, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Sasikumar et al. demonstrated that trifluoromethanesulfonamide can then be moved to positon C-3 of the scaffold, generating series <b>II</b>.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Several representative compounds <b>I</b> and <b>II</b> were tested in the TgCRND8 mouse model, an animal model of AD, and demonstrated the ability to reduce Aβ levels in vivo.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/medium/jm-2015-00774k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of spirocyclic sulfone γ-secretase inhibitors. <b>X</b> = N(H)SO<sub>2</sub>CF<sub>3</sub> and other polar groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00774&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Capitalizing on the previous research results, herein we describe the synthesis, SAR, and biological profile of a novel spirocyclic series of γ-secretase inhibitors <b>III</b>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The novel spirocyclic series <b>III</b> was designed by borrowing SAR elements of previously known sulfone GSIs but adds a spirocyclic ring to position polar groups at the C-3 position of the scaffold while maintaining the preferred cyclohexane conformation. A few representatives of the series were assessed in a wild-type (nontransgenic) animal model of AD and demonstrated reduction of Aβ after acute dosing.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86701" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86701" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Synthesis of the targets started with preparation of the advanced precursor diols <b>7</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), <b>11</b>, and <b>13</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). In <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, the vinyl sulfone starting material <b>1</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> was condensed with dimethyl allylmalonate using potassium carbonate as the base and THF as the solvent to afford compound <b>2</b>. Hydroboration of compound <b>2</b> under standard conditions was followed by mesylation of the hydroxyl group to afford diester <b>3</b>. Our initial route to diol <b>7</b> included diester <b>4</b> as an intermediate. However, all attempts to achieve intramolecular alkylation of <b>3</b> failed due to decomposition, presumably via a retro-Michael mechanism.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/medium/jm-2015-00774k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00774&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) dimethyl allylmalonate, K<sub>2</sub>CO<sub>3</sub>/THF, RT, 84%; (b) 9-BBN, THF, 12 h, then H<sub>2</sub>O<sub>2</sub>, NaOH, 95% from <b>2</b>, 89% from <b>5</b>; (c) MsCl/Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (d) <i>t</i>-BuOK/THF, −35 °C, 39% (for <b>6</b>; two steps); (e) DIBAL/THF, 60 °C, 68%; (f) 2,2-dimethoxypropane, PPTS/CH<sub>2</sub>Cl<sub>2</sub>, RT, 100%; (g) HOAc, H<sub>2</sub>O, RT, 88%.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/medium/jm-2015-00774k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00774&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions. (a) LDA/THF, −70 °C, 87%; (b) 9-BBN, then H<sub>2</sub>O<sub>2</sub>, NaOH; 87%; (c) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (d) BH<sub>3</sub> (1M/THF), then ICl, 81% (X = I); (e) <i>t</i>-BuOK/THF, −30 °C, column chromatography, crystallization, 28% from <b>9a</b> and 38% from <b>9b</b>; (f) LAH, THF, 0 °C, 88%; (g) DIBAL/CH<sub>2</sub>Cl<sub>2</sub>, −78 °C; (h) 2,6-lutidine/TBSOTf, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 47% (two steps); (i) MeOCH<sub>2</sub>PPh<sub>3</sub>Br/<i>n</i>-BuLi, THF, −40 °C, 66%; (j) Hg(OAc)<sub>2</sub>, THF/H<sub>2</sub>O, then NaBH<sub>4</sub>, 89%; (k) TBAF, THF, 99%.</p></p></figure><div class="NLM_p">This problem was circumvented by the conversion of dimethyl ester <b>2</b> into <b>5</b> by reduction of the dimethyl ester to the corresponding diol, followed by the protection of the diol as an acetonide <b>5</b>. The same synthetic sequence (b–d) was used to elaborate the alkene in <b>5</b> into a leaving group and close to the six-membered ring via intramolecular alkylation, providing intermediate <b>6</b>. Acetonide <b>6</b> was then hydrolyzed under acidic conditions to the diol <b>7</b>.</div><div class="NLM_p">The synthesis of diols <b>11</b> and <b>13</b> is described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. 3-Allyldihydrofuran-2(3<i>H</i>)-one was deprotonated with LDA in THF at −70 °C and condensed with the vinyl sulfone <b>1</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> through a Michael reaction to afford compound <b>8</b> as a mixture of diastereomers. Hydroboration of compound <b>8</b> followed by mesylation, or hydroboration-iodination of <b>8</b> (“Kabalka protocol”<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a>) was used to prepare compound <b>9</b>, which was treated with <i>t</i>-BuOK to give the ring-closed product <b>10</b>. Fortuitously, <b>10</b> was separable from the alternative diastereomer by a combination of silica gel chromatography and crystallization.</div><div class="NLM_p">Hydroboration–iodination of <b>8</b> resulted in better yields than hydroboration-oxidation followed by mesylation. Lactone <b>10</b> served as a precursor for both diols, <b>11</b> and <b>13</b>. To prepare <b>11</b>, lactone <b>10</b> was reduced with lithium aluminum hydride. For the preparation of <b>13</b>, lactone <b>10</b> was converted to enol ether <b>12</b> through reduction to the corresponding lactol, followed by ring-opening of the lactol to expose the aldehyde by trapping of the free primary hydroxyl as its TBS ether. Wittig olefination of the aldehyde led to enol ether <b>12</b>. Attempts at acidic hydrolysis of enol ether <b>12</b> resulted in a complex mixture of products; however, oxymercuration–reduction provided a clean conversion of enol ether to the alcohol. Finally, the TBS group was cleaved by TBAF to give the requisite diol <b>13</b>. The advanced diol precursors <b>7</b>, <b>11</b>, and <b>13</b> were then transformed into the spirocycles (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) to provide the final targets.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/medium/jm-2015-00774k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. <sup>a</sup>,<sup>b</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00774&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label">Scheme a</span>Diol <b>7</b> (n = k = 1); Diol <b>11</b> (n = 1, k = 2), Diol <b>13</b> (n = 2, k = 2)</p><p class="last"><span class="fn-label">Scheme b</span>Reagents and conditions. (a) 1.1 equiv MsCl or TsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>; (b) NaH, DMF, 42% (<b>14a</b>), 67% (<b>14b</b>); (c) 2.2 equiv MsCl, Pyr; (d) Na<sub>2</sub>S, EtOH, pyridine, reflux, 43%; (e) OXONE, acetone, H<sub>2</sub>O, 87%; (f) 3.0 equiv TsCl, Pyridine; 88%; (g) NH<sub>2</sub>SO<sub>2</sub>CF<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 57%; (h) MeP(O)Cl<sub>2</sub>, pyridine, THF, −78 °C to RT, 44% (<b>18a</b>), 70% (<b>18b</b>).</p></p></figure><div class="NLM_p last">In <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, diol <b>7</b> (n = 1, k = 1) or <b>11</b> (n = 1, k = 2) was treated with methanesulfonyl chloride and triethylamine to give monomesylated intermediates which were converted to compounds <b>14a</b>,<b>b</b> by reaction with sodium hydride in DMF. Diol <b>13</b> (n = 2, k = 2) was treated with excess of methanesulfonyl chloride and triethylamine to produce a bis-mesylated intermediate, which was treated with sodium sulfide and pyridine in ethanol to give compound <b>15</b>. Compound <b>15</b> was oxidized to compound <b>16</b> with OXONE in acetone and water. Diol <b>11</b> (n = 1, k = 2) was treated with TsCl and pyridine to give a bis-tosyl intermediate which was treated with trifluoromethanesulfonamide to give compound <b>17</b>. Diols <b>7</b> or <b>11</b> were treated with methylphosphonic dichloride and pyridine to give compounds <b>18a</b> and <b>18b</b>, respectively. The phosphorus atom presents an additional stereogenic center in the molecules <b>18a</b> and <b>18b</b>, and in the case of the six-membered ring in <b>18a</b>, a single diastereomer was isolated, whereas for <b>18b</b> an inseparable mixture of diastereomers was formed.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24846" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24846" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Herein we disclose the design of a series of γ-secretase inhibitors, <b>III</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), utilizing the cyclohexane framework <b>A</b> of MRK-560 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). Although molecule <b>A</b> itself is a potent γ-secretase inhibitor in vitro,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> it requires a polar appendage in order to gain oral bioavailability (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, entry 2),<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and in the case of MRK-560, this role is played by the trifluoromethanesulfonamide group (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, entry 1). Without the polar appendage, molecule <b>A</b> experienced extensive metabolism at the methylene carbons of the cyclohexyl ring in in vitro metabolic stability assays.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> In addition, its poor aqueous solubility may have negatively impacted oral absorption.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/medium/jm-2015-00774k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Conformational considerations for the design of γ-secretase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00774&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biological Data Comparison for Selected Compounds <b>III</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/medium/jm-2015-00774k_0007.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Membrane-based γ-secretase assay, <i>n</i> = 2.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Cell-based γ-secretase assay, <i>n</i> = 2.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">AUC was calculated over a 6 h period after an oral treatment at 10 mg/kg dose (<i>n</i> = 2). B/P, brain/plasma ratio at the 6 h time point; BLQ, below limits of quantitation.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Selectivity for PS-1 vs. PS-2 was determined as a ratio of IC<sub>50</sub> values obtained in reconstituted γ-secretase system (<i>n</i> = 2). Refer to <a href="/doi/suppl/10.1021/acs.jmedchem.5b00774/suppl_file/jm5b00774_si_001.pdf" class="ext-link">Supporting Information</a> for details.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Reduction of total Aβ after PO dose of 10 mg/kg in rat plasma (P), brain (B), and CSF compartments (<i>n</i> = 6). Measurements were taken 3 h after the dosing.</p></div></div><div></div></div><div class="NLM_p">Teall et al.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> showed that the conformation of the cyclohexane ring in the framework <b>A</b> has an important effect on the potency of γ-secretase inhibition, and in the active conformation the inhibitors maintain the equatorial position of the arylsulfone group. This observation was confirmed by Jelley et al.,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> who introduced a substituent, R, at position 3 of the cyclohexane (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, structures <b>B</b>). For molecules with relative <i>cis</i>- stereochemistry of R and the sulfone, equatorial conformation <b>B</b>-<i><b>cis</b></i>-<b>eq</b> was thermodynamically preferred, and these compounds showed high γ-secretase potency. On the other hand, <i>trans</i>- stereochemistry of R and sulfone led to a steric clash between R and the difluorophenyl group in the <b>B</b>-<i><b>trans</b></i>-<b>eq</b> conformation, resulting in a conformational “flip” of the cyclohexane ring. The ensuing conformation <b>B</b>-<i><b>trans</b></i>-<b>ax</b> lost γ-secretase activity due to the axial positioning of the sulfone group.</div><div class="NLM_p">The conformational “flip” similar to the one occurring for <b>B</b>-<i><b>trans</b></i> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) may also occur in the case of gem-substitution or a spirocycle attached to the position 3 of the cyclohexyl ring. To counterbalance this tendency, in addition to the spirocycle attached to the C-3, our design <b>III</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) utilizes an additional ring, connecting C-2 with the difluorophenyl group. This connection was shown by Xu et al.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> to stabilize the active chair conformation of the γ-secretase inhibitor.</div><div class="NLM_p">For the in vitro assays of γ-secretase activity, we utilized the same assay systems as used by Xu et al.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The first-tier assay was conducted in cellular membrane preparations obtained from human embryonic kidney (HEK293) cells, transfected with the substrate of γ-secretase. These membrane preparations could be stored frozen for months and provided the reading of activity after 1 h of incubation with the inhibitor at 37 °C. The active compounds were then assessed in a more labor-intensive whole-cell assay based on HEK293 cells, which required a 6 h period of incubation. For the compounds tested, a consistent inhibition of production of both Aβ<sub>40</sub> and Aβ<sub>42</sub> were observed, indicating that the series acted as inhibitors rather than modulators of γ-secretase. Selected compounds were also tested in reconstituted γ-secretase systems prepared on the basis of either PS-1 or PS-2 isoforms of presenilin. These systems were obtained by expressing the individual constituents of γ-secretase into Sf9 cells<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and allowed to determine selectivity of the inhibitors for the given isoform of presenilin.</div><div class="NLM_p">Geminally disubstituted bis(hydroxymethyl) derivative <b>7</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, entry 3), prepared as a synthetic intermediate for the construction of spirocycles, lost ∼17-fold of potency compared to <b>A</b> (entry 2). This outcome could be possibly attributed either to the overall steric bulk of the hydroxymethyls or to specific unfavorable interaction of the OH groups with the enzyme. Both issues were addressed in spirocycles <b>6</b> and <b>14a</b>,<b>b</b>, where the hydroxyls were capped and the steric hindrance gradually reduced. The activity of the resulting compounds inversely correlated with the steric bulk of the spirocyclic ring, oxetane <b>14a</b> being the most active. As expected based on previously published data for a related sulfone series,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> the (−)-enantiomers were more active in comparison to <b>14b(−)</b> and <b>14b(+)</b>.</div><div class="NLM_p">Although <b>14a</b> and <b>14b(−)</b> reached in vitro potency levels comparable to MRK-560 and showed good cellular penetration as evidenced by data from the whole-cell γ-secretase assay, they demonstrated only a modest effect on Aβ in vivo possibly due to poor pharmacokinetics as seen with <b>A</b> (entry 2). We concluded that, unlike the trifluoromethanesulfonamide group in MRK-560, polarity of a single oxygen atom in the spirocycle was not sufficient to confer good oral bioavailability; therefore, we continued to explore other polar groups. Increased polarity, however, often negatively affected γ-secretase potency in the in vitro assay. For example, introduction of a carbonyl group in <b>10</b> resulted in a ∼15-fold loss of potency compared to <b>14b(−)</b>, sulfone <b>16</b> was 2-fold less potent than thiopyrane <b>15</b>, and the potency of spirocyclic triflamide <b>17</b> also was inferior to triflamide-containing MRK-560. Nevertheless, we were pleased to see that, as expected, polarity had a favorable effect on pharmacokinetics as demonstrated by the excellent rat AUC of <b>16</b>.</div><div class="NLM_p">Ultimately, we identified cyclic phosphonates as in <b>18a(−)</b> and <b>18b</b> as optimal groups for both potency and pharmacokinetics. After oral dosing in rat, these compounds had AUCs superior to MRK-560, and the cyclic phosphonate appeared to be stable in vivo, as there was no detectable circulating metabolite <b>7</b>, corresponding to cleavage of the phosphonate moiety. Unfortunately, in the case of <b>18b</b>, the seven-membered spirocyclic ring contained a mixture of diastereomers at the phosphorus center and we failed to find conditions to separate the diastereomers of this compound for further characterization. This was in contrast to the six-membered phosphorus-containing ring in <b>18a</b>, which had a tendency to form the spirocycle in such a way that the methyl group at phosphorus would occupy the least sterically hindered equatorial configuration. Enantiomerically pure (after chiral chromatography) <b>18a(−)</b> was dosed orally at 10 mg/kg in wild-type rat and demonstrated 39% reduction of brain Aβ<sub>42</sub> levels 3 h after dosing compared to vehicle-treated animals.</div><div class="NLM_p">Gratifyingly, the spirocyclic analogue <b>18a(−)</b> (entry 11) demonstrated a high selectivity ratio favoring PS-1, which is characteristic of MRK-560 and is thought to provide for the improved side effect profile of MRK-560.</div><div class="NLM_p">Although full characterization of the safety profile of our spirocyclic GSI series in preclinical species is out of scope of the present study, it is worth highlighting that the series did not exhibit significant hERG inhibition and resolved the CYP2C9 inhibition liability associated with MRK-560 (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Evidently, the clean CYP2C9 profile of our compounds is a consequence of the newly formed spirocyclic ring because comparison of MRK-560 with a monocyclic analogue <b>19</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> indicates that the cycle connecting C-2 with difluorophenyl has minimal effect on CYP2C9 and repositioning of the triflamide from C-4 to C-3 as in <b>20</b><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> results in only a modest improvement, whereas a spirocyclic triflamide in <b>17</b> leads to complete abrogation of CYP2C9 activity within the range of our assay.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. CYP Data Comparison for Selected Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/medium/jm-2015-00774k_0008.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Data for the preincubation experiment was collected 30 min after addition of the compound to the assay system.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Structures of compounds <b>19</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and <b>20</b><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> are shown below.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/medium/jm-2015-00774k_0010.gif" alt="" id="GRAPHIC-d415e1190-autogenerated" /></img></p></div></div><div></div></div></div><div id="sec99" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53454" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53454" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, using MRK-560 as the lead structure, we designed a novel series <b>III</b> by incorporation of two additional rings on its scaffold, including the cyclization of C-2 to difluorophenyl to stabilize the active chair conformation of GSIs and installation of a spirocyclic heterocycle attached at C-3. The series resolved the CYP2C9 inhibition liability of MRK-560 and demonstrated a high ratio of PS-1 vs PS-2 activity, potentially leading to a safer drug candidate. We identified spirocyclic phosphonates as optimal groups for both potency and pharmacokinetics. A few representatives of the series were assessed in a nontransgenic animal model of AD and showed efficacy by demonstration of partial reduction of Aβ in the brain and CSF after acute dosing in rat.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41013" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41013" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> General</h3><div class="NLM_p last">Purity of final compounds was determined by HPLC and exceeded 95%. LC/MS data analyses were performed using an Applied Biosystems API-100 mass spectrometer and Shimadzu SCL-10A LC column: Alltech platinum C18, 3 μm, 33 mm × 7 mm ID. Gradient flow: 0 min −10% CH<sub>3</sub>CN, 5 min −95% CH<sub>3</sub>CN, 7 min −95% CH<sub>3</sub>CN, 7.5 min −10% CH<sub>3</sub>CN, 9 min, stop. The observed parent ions are given. Preparative chromatography was carried out on Analogix flash chromatography instrument, chiral separations were conducted on chiral OD columns (Daicel Corp) using isopropyl alcohol and hexanes as the mobile phase. <sup>1</sup>H NMR spectra were obtained on either a Varian Gemini-300 (300 MHz) or XL-400 (400 MHz) and are reported as ppm downfield from Me<sub>4</sub>Si with number of protons, multiplicities, and coupling constants in hertz indicated parenthetically. Chemical names were generated from ChemDraw. In vitro assays were conducted in whole cells and cellular membranes (<a href="/doi/suppl/10.1021/acs.jmedchem.5b00774/suppl_file/jm5b00774_si_001.pdf" class="ext-link">Supporting Information</a>). In vivo studies, including pharmacokinetic analysis and efficacy determinations, were conducted in Sprague–Dawley rats (Charles River, Co.) after oral dosing (<a href="/doi/suppl/10.1021/acs.jmedchem.5b00774/suppl_file/jm5b00774_si_001.pdf" class="ext-link">Supporting Information</a>). Assays for CYP inhibition were conducted using recombinant 3A4, 2D6, and 2C9 enzymes by measuring appearance of fluorescent products from nonfluorescent substrates: 3-cyano-7-ethoxy-coumarin, dibenzyl fluorescein, 7-methoxy-4-trifluoromethylcoumarin, 7-methoxy-4-(aminomethyl)-coumarine, and 7-benzyloxy-4-trifluoromethylcoumarin.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Synthesis of Dimethyl 2-Allyl-2-(4-((4-chlorophenyl)sulfonyl)-5,8-difluorochroman-3-yl)malonate (<b>2)</b></h3><div class="NLM_p last">To a solution of dimethyl allylmalonate (17.0 g, 99.0 mmol) in THF (200 mL) was added K<sub>2</sub>CO<sub>3</sub> (12.4 g, 90.0 mmol) as solid at room temperature. The mixture was stirred for 10 min. The vinyl sulfone <b>1</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (10.3 g, 30.0 mmol) was added to the reaction mixture, and the reaction was stirred for 2 h. The reaction was quenched with water, extracted with EtOAc (2 × 200 mL), and the combined oranic phases were dried (MgSO<sub>4</sub>) and concentrated under reduced pressure. The crude product was purified by flash chromatography on silica gel, eluting with 40% EtOAc/hexane to give pure product <b>2</b> (12.87 g, 84%). <sup>1</sup>H NMR: 7.84 (2H, d, <i>J</i> = 8.65), 7.53 (2H, d, <i>J</i> = 7.54), 7.0 (1H, m), 6.46 (1H, m), 5.55 (1H, m), 5.18 (1H, dd), 5.19 (1H, s), 4.88 (1H, s), 4.73 (1H, m), 3.60 (3H, s), 3.54 (1H, d, j = 4.0), 3.21 (3H, s), 2.89 (1H, dd, <i>J</i> = 8.0, 15.1), 2.78 (1H, dd, <i>J</i> = 8.0, 15.1).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Synthesis of Dimethyl 2-(4-((4-Chlorophenyl)sulfonyl)-5,8-difluorochroman-3-yl)-2-(3-((methylsulfonyl)oxy)propyl)malonate <b>3</b></h3><div class="NLM_p">To a solution of compound <b>2</b> (430 mg, 0.84 mmol) in THF (8.0 mL) at 0 °C was added 9-BBN, and the mixture was stirred for 2 h at 0 °C and another 2 h at RT. The reaction mixture was cooled to 0 °C and treated with 3 M NaOH (6 mL) and H<sub>2</sub>O<sub>2</sub> (6 mL). After stirring for 3 h, the reaction mixture was diluted with water and extracted with EtOAc (3 × 30 mL), and the combined organic phases were dried (MgSO<sub>4</sub>) and concentrated in vacuo. The crude product was purified by flash chromatography on silica gel, eluting with 5% MeOH/CH<sub>2</sub>Cl<sub>2</sub> to afford the desired product (197 mg, 44.3%). This product was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (6 mL) at 0 °C, to which was added Et<sub>3</sub>N, and then MsCl. The reaction mixture was stirred at 0 °C for 1 h. The reaction was diluted with water, extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 30 mL), and the combined organic phases were washed with brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo to give compound <b>3</b> (215 mg, 95%). <sup>1</sup>H NMR: 7.80 (2H, d, <i>J</i> = 8.66), 7.53 (2H, d, <i>J</i> = 8.60), 7.0 (1H, m), 6.46 (1H, m), 4.80 (1H, dd, <i>J</i> = 4.4, 12.9), 4.76 (1H, s), 4.64 (1H, d, <i>J</i> = 12.86), 4.2 (2H, m), 3.60 (1H, d, <i>J</i> = 4.1), 3.57 (3H, s), 3.35 (3H, s), 3.03 (3H, s), 2.10 (2H, m), 1.66 (2H, m).</div><div class="NLM_p last">Compound <b>3</b> was dissolved in THF (8 mL) and treated with <i>t</i>-BuOK at −35 °C. This reaction failed to produce dimethyl 10a-((4-chlorophenyl)sulfonyl)-1,4-difluoro-6,6a,8,9,10,10a-hexahydro-7<i>H</i>-benzo[<i>c</i>]chromene-7,7-dicarboxylate <b>4</b>, likely due to a retro-Michael reaction.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Synthesis of 3-(5-Allyl-2,2-dimethyl-1,3-dioxan-5-yl)-4-((4-chlorophenyl) sulfonyl)-5,8-difluorochromane <b>5</b></h3><div class="NLM_p">To a solution of compound <b>2</b> (1.57 g, 3.05 mmol) in THF (20 mL) at 65 °C was added DIBAL (1 M in hexane, 21.38 mL, 21.38 mmol). The reaction was stirred for 15 min and was quenched with 25 mL of 20% sodium potassium tartrate and 25 mL of EtOAc. The mixture was stirred at room temperature overnight and extracted with EtOAc (3 × 25 mL), and the combined organic phases were washed with brine, dried (MgSO<sub>4</sub>), and concentrated. The residue was purified by flash chromatography on silica gel, eluting with a 0–50% EtOAc/hexane gradient to give the diol intermediate (0.95 g, 68%). <sup>1</sup>H NMR: 7.62 (2H, d, <i>J</i> = 8.27), 7.47 (2H, d, <i>J</i> = 8.26), 7.03 (1H, m), 6.48 (1H, m), 5.66 (1H, m), 5.0 (2H, ddd, <i>J</i> = 1.2, 10, 17), 4.85 (1H, s), 4.75 (1H, dd, <i>J</i> = 5.8, 12.1), 4.33 (1H, dd, <i>J</i> = 5.2, 12.1), 3.72 (1H, m), 3.57 (1H, m), 3.41 (1H, dt, <i>J</i> = 1.4, 5.25), 2.59 (1H, t, <i>J</i> = 6.2), 2.03 (1H, dd, <i>J</i> = 7.8, 14.4), 1.85 (1H, dd, 7.4, 15.0).</div><div class="NLM_p last">To a solution of the diol intermediate (0.950 g, 2.07 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (40 mL) at room temperature was added 2,2-dimethoxy propane (648 mg, 6.20 mmol), and then PPTS (18 mg, 0.073 mmol) was added as a solid. The reaction was stirred overnight and was quenched with water and extracted with EtOAc (3 × 100 mL), and the combined organic phases were washed with brine, dried (MgSO<sub>4</sub>), and concentrated to give the crude product, which was purified by chromatography on silica gel using a gradient of 0–30% EtOAc/hexane to furnish <b>5</b> (1.03 g, 100%). <sup>1</sup>H NMR: 7.7 (2H, d, <i>J</i> = 8.48), 7.51 (2H, d, <i>J</i> = 8.40), 7.03 (1H, m), 6.47 (1H, m), 5.63 (1H, m), 5.15 (1H, d, <i>J</i> = 7.25), 5.05 (1H, d, <i>J</i> = 17.1), 4.81 (1H, dd, <i>J</i> = 4.4, 12.7), 3.44–3.68 (4H, m), 2.98 (1H, d, <i>J</i> = 4.0), 2.16 (1H, dd, <i>J</i> = 8.1, 14.8), 1.98 (1H, dd, <i>J</i> = 7.1, 15.4), 1.3 (3H, s), 1.2 (3H, s).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Synthesis of 10a-((4-Chlorophenyl)sulfonyl)-1,4-difluoro-2′,2′-dimethyl-6,6a,8,9,10,10a-hexahydrospiro[benzo[<i>c</i>]chromene-7,5′-[1,3]dioxane] <b>6</b></h3><div class="NLM_p">To alkene <b>5</b> (1.95 g, 3.51 mmol) in THF (35 mL) at 0 °C was added 9-BBN (0.5 M in THF, 42.16 mL, 21.08 mmol), and the reaction mixture was stirred overnight. The reaction mixture was treated with 3.0 M NaOH (30 mL) and H<sub>2</sub>O<sub>2</sub> (30 mL) at 0 °C for 7 h. The mixture was diluted with water, extracted with EtOAc (3 × 200 mL), and the combined organic phases were washed with brine, dried (MgSO<sub><b>4</b></sub>), and concentrated in vacuo. The residue was purified by flash chromatography on silica gel, eluting with 5% MeOH/CH<sub>2</sub>Cl<sub>2</sub> to furnish the intermediate alcohol (1.80 g, 89%). <sup>1</sup>H NMR: 7.76 (2H, d, <i>J</i> = 8.81), 7.52 (2H, d, <i>J</i> = 8.82), 7.02 (1H, m), 6.44 (1H, m), 5.18 (1H, s), 4.83 (1H, dd, <i>J</i> = 4.6, 12.6), 4.56 (1H, dt, <i>J</i> = 1.97, 12.68), 3.84 (1H, m), 3.49–3.67 (5H, m), 2.96 (1H, s), 1.82 (1H, m), 1.68 (1H, m), 1.53 (2H, m), 1.31 (3H, s), 1.21 (3H, s).</div><div class="NLM_p">To the intermediate alcohol (1.80 g, 3.48 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (60 mL) at 0 °C was added Et<sub>3</sub>N (1.2 mL, 8.7 mmol), followed by MsCl (0.35 mL, 4.5 mmol). The reaction mixture was stirred for 1 h at 0 °C, followed by quenching with water. The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 150 mL), and the combined organic phases were washed with brine, dried (MgSO<sub>4</sub>), and concentrated to give intermediate mesylate (2.16 g), which was used for next step without further purification. <sup>1</sup>H NMR: 7.74 (2H, d, <i>J</i> = 8.47), 7.52 (2H, d, <i>J</i> = 8.41), 7.03 (1H, m), 6.44 (1H, m), 4.98 (1H, s), 4.85 (1H, dd, <i>J</i> = 5.95, 14.1), 4.54 (1H, d, 12.6), 4.13 (2H, m), 3.66 (1H, d, <i>J</i> = 12.3), 3.51 (2H, m), 2.99 (3H, s), 1.96 (1H, m), 1.70 (1H, m), 1.55 (1H, m), 1.31 (3H, s), 1.23 (3H, s).</div><div class="NLM_p last">To the mesylate intermediate (2.16 g, 3.64 mmol) in THF (200 mL) at −30 °C was added dropwise a solution of 1 M <i>t</i>-BuOK in THF (4.77 mL, 4.77 mmol). The reaction mixture was stirred at the same temperature for 20 min and was quenched with water, extracted with EtOAc (2 × 200 mL), and the combined organic phases were washed with water and brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo. The residue was purified by flash chromatography on silica gel, eluting with 30% EtOAc/hexane to furnish the compound <b>6</b> (700 mg, 39% in two steps). <sup>1</sup>H NMR: 7.47 (4H, m), 7.06 (1H, m), 6.37 (1H, m), 5.19 (1H, dd, <i>J</i> = 4.87, 12.6), 4.90 (1H, d, <i>J</i> = 12.7), 4.02 (1H, d, <i>J</i> = 11.6), 3.93 (1H, d, <i>J</i> = 11.76), 3.36 (1H, d, <i>J</i> = 11.92), 2.99 (1H, s), 2.96 (1H, dd, <i>J</i> = 1.51, 11.96), 2.55 (1H, d, <i>J</i> = 14.12), 2.47 (1H, d, <i>J</i> = 4.71), 2.42 (1H, d, <i>J</i> = 13.73), 1.1–1.9 (4H, m), 1.41 (3H, s), 1.30 (3H, s).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Synthesis of (10a-((4-Chlorophenyl)sulfonyl)-1,4-difluoro-6a,7,8,9,10,10a-hexahydro-6<i>H</i>-benzo[<i>c</i>]chromene-7,7-diyl)dimethanol <b>7</b></h3><div class="NLM_p last">Compound <b>6</b> (344 mg, 0.691 mmol) was dissolved in 60% aqueous HOAc (15 mL) and 2 mL of CH<sub>2</sub>Cl<sub>2</sub>. The reaction mixture was stirred at room temperature for 18 h, at which point TLC (50% EtOAc/hexane) indicated that the reaction was complete. The reaction mixture was diluted with water and extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 30 mL), and the combined organic phases were washed with brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo. The crude material was purified by preparative TLC (50% EtOAc/hexane) to afford the pure product <b>7</b> (280 mg, 88%). <sup>1</sup>H NMR 7.49 (2H, m), 7.08 (1H, m), 6.40 (1H, m), 5.18 (1H, dd, <i>J</i> = 4.55, 12.56), 4.92 (1H, d, <i>J</i> = 12.38), 3.79 (3H, m), 3.20 (1H, dd, <i>J</i> = 6.56, 11.99), 2.84 (1H, d, 4.57), 2.62 (1H, d, <i>J</i> = 15.21), 2.04 (1H, s), 1.92 (1H, d, <i>J</i> = 13.7), 1.82 (1H, s), 1.6 (1H, d, 17.57), 1.25 (1H, t, <i>J</i> = 7.16).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Synthesis of 3-Allyl-3-(4-((4-chlorophenyl)sulfonyl)-5,8-difluorochroman-3-yl)dihydrofuran-2(3<i>H</i>)-one <b>8</b></h3><div class="NLM_p">To a solution of dihydrofuran-2(3<i>H</i>)-one (4.58 g, 53.2 mmol) in THF (500 mL) at −78 °C was added dropwise LDA (53.2 mL, 106 mmol). The reaction mixture was stirred at −78 °C for 50 min. To the reaction mixture, allyl bromide (13.5 mL, 160 mmol) was added dropwise. The reaction mixture was stirred at −78 °C for 2 h. TLC (25% EtOAc/hexane) showed that the reaction was complete. Water was added to quench the reaction, and the mixture was extracted with EtOAc (2 × 400 mL). The combined organic phases were washed with brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo at room temperature. The crude product was purified by silica gel chromatography, using a gradient of 0–25% of EtOAc in hexanes, to furnish 3-allyldihydrofuran-2(3<i>H</i>)-one (4.65 g, 69%). <sup>1</sup>H NMR: 5.78 (1H, m), 5.19–5.05 (2H, m), 4.34 (1H, q), 4.21 (1H, m), 2.64 (2H, m), 2.36 (1H, m), 2.28 (1H, m), 2.0 (1H, m).</div><div class="NLM_p last">To a solution of 3-allyldihydrofuran-2(3<i>H</i>)-one (3.557 g, 28.22 mmol) in THF (75 mL) at −78 °C was added dropwise a 2 M solution of LDA in THF/heptane (13.5 mL, 27.1 mmol). The mixture was stirred for 50 min prior to addition of vinyl sulfone <b>1</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (3.86 g, 11.3 mmol) at −78 °C as solid. The reaction mixture was stirred for 1 h, quenched with water, and extracted with EtOAc (2 × 300 mL), and the combined organic phases were washed with brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo. The crude product was purified by silica gel chromatography using a gradient of 0–30% EtOAc/hexane to furnish the pure product <b>8</b> (4.6 g, 87%). <sup>1</sup>H NMR: 7.72 (2H, d, <i>J</i> = 8.83), 7.52 (2H, d, <i>J</i> = 8.84), 7.05 (1H, m), 6.48 (1H, m), 5.61 (1H, m), 5.10 (3H, m), 4.90 (1H, dd, <i>J</i> = 4.8, 12.9), 4.4 (1H, dt, <i>J</i> = 1.81, 12.92), 4.23 (1H, m), 4.12 (1H, m), 3.14 (1H, d, <i>J</i> = 4.61), 2.18 (3H, m), 1.96 (1H, m). LCMS found: 469.3 (M + H).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Synthesis of 3-(3-(4-((4-Chlorophenyl)sulfonyl)-5,8-difluorochroman-3-yl)-2-oxotetrahydrofuran-3-yl)propyl Methanesulfonate <b>9a</b> (X = OMs)</h3><div class="NLM_p">To a solution of compound <b>8</b> (4.6 g, 9.8 mmol) in THF (100 mL) at 0 °C was added 9-BBN (0.5 M in THF, 137.6 mL, 68.78 mmol), and the mixture was stirred overnight. The reaction mixture was cooled to 0 °C and treated with 3 M NaOH (100 mL) and H<sub>2</sub>O<sub>2</sub> (100 mL), following by stirring at 0 °C for 7 h. The reaction mixture was diluted with water and extracted with EtOAc (3 × 300 mL), and the combined organic phases were washed with brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo. The crude product was purified by silica gel chromatography, using a gradient of 0–7% MeOH/CH<sub>2</sub>Cl<sub>2</sub>, to afford the hydroxyl intermediate (4.17 g, 87%).</div><div class="NLM_p last">To a solution of the hydroxyl intermediate (0.695 g, 1.43 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) at 0 °C was added Et<sub>3</sub>N (0.50 mL, 3.6 mmol), followed by MsCl (0.14 mL, 1.9 mmol). The reaction mixture was stirred at 0 °C for 1 h. TLC (45% EtOAc/hexane) showed that the reaction was complete. The reaction was quenched with water and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 60 mL), and the combined organic phases were washed with brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo to give the mesylate <b>9a</b> (841 mg), which was used without purification.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Synthesis of 3-(4-((4-Chlorophenyl)sulfonyl)-5,8-difluorochroman-3-yl)-3-(3-iodopropyl)dihydrofuran-2(3<i>H</i>)-one <b>9b</b> (X = I)</h3><div class="NLM_p last">To borane–THF complex (1M, 45.87 mL) was added cyclohexene (11 mL) and THF (15 mL) at 0 °C. The resulting solution was stirred for 1 h at 0 °C. Compound <b>8</b> (17.6 g, 37.6 mmol) in THF (70 mL) was added dropwise. The reaction was allowed to warm up to room temperature slowly and was stirred for 3 h and then cooled down to 0 °C. A solution of NaOAc (8.85 g, 107.9 mmol) in 90 mL of MeOH (used sonicator to dissolve, and then cooled to RT prior to usage) was added. Then ICl (2.3 mL, 45 mmol) in MeOH (50 mL) was added. The resulting reaction mixture was stirred for 30 min, then was quenched with NaHSO<sub>3</sub> (8 g dissolved in 50 mL of water), followed by 150 mL of NH<sub>4</sub>Cl (saturated), extracted with EtOAc (3 × 300 mL), and the combined organic phases were washed with brine, dried (MgSO<sub>4</sub>), and concentrated under reduced pressure. The residue was recrystallized from EtOAc/hexane to obtain 3-(4-((4-chlorophenyl)sulfonyl)-5,8-difluorochroman-3-yl)-3-(3-iodopropyl)dihydrofuran-2(3<i>H</i>)-one <b>9b</b> (18.1 g, 81%).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Synthesis of (6a<i>R</i>,7<i>S</i>,10a<i>S</i>)-10a-((4-Chlorophenyl)sulfonyl)-1,4-difluoro-4′,5′,6,6a,8,9,10,10a-octahydro-2′<i>H</i>-spiro[benzo[<i>c</i>]chromene-7,3′-furan]-2′-one <b>10</b></h3><div class="NLM_p">From <b>9b</b>: To a solution of compound <b>9b</b> (845 mg, 1.42 mmol) in THF (65 mL) at −30 °C was added dropwise a 1.0 M solution of <i>t</i>-BuOK in THF (4.49 mL, 4.49 mmol). The reaction mixture was stirred at −30 °C for 20 min and quenched with water. The mixture was extracted with EtOAc (2 × 100 mL), and the combined organic phases were washed with water and brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo. The crude product was purified by silica gel chromatography, using a gradient of 0–95% EtOAc/hexane, followed by crystallization from the same solvent mixture to afford the compound <b>10</b> (253 mg, 38%). <sup>1</sup>H NMR: 7.49 (2H, m), 7.11 (1H, m), 6.42 (1H, m), 5.26 (1H, m), 4.24 (2H, m), 4.05 (1H, m), 3.25 (1H, d, <i>J</i> = 5.0), 2.68 (1H, d, <i>J</i> = 13.0), 2.34 (1H, q, <i>J</i> = 13.0), 2.06 (1H, tt, <i>J</i> = 3.3, 13.1), 1.82 (1H, m), 1.73 (1H, d, <i>J</i> = 13.5), 1.54 (2H, m), 1.27 (1H, q, <i>J</i> = 13.5). LCMS found: 459.3 (M + H).</div><div class="NLM_p last">From <b>9a</b>: Using the same procedure as above, compound <b>10</b> was obtained in 28% yield.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Synthesis of 2-((6a<i>R</i>,7<i>S</i>,10a<i>S</i>)-10a-((4-Chlorophenyl)sulfonyl)-1,4-difluoro-7-(hydroxymethyl)-6a,7,8,9,10,10a-hexahydro-6<i>H</i>-benzo[<i>c</i>]chromen-7-yl)ethan-1-ol <b>11</b></h3><div class="NLM_p last">To a solution of compound <b>10</b> (120 mg, 0.256 mmol) in THF (5 mL) at 0 °C, was added dropwise LAH (2 M in THF, 0.256 mL, 0.513 mmol). The reaction mixture was stirred at 0 °C for 1 h. TLC (35% EtOAc/hexane) showed both starting material and product. One more equivalent of LAH was added, and the mixture was stirred at 0 °C for another 30 min. TLC analysis then showed that the reaction was complete. The reaction was quenched with water and extracted with EtOAc (2 × 20 mL), and the combined organic phases were dried (MgSO<sub>4</sub>) and concentrated in vacuo. The crude product was purified by silica gel chromatography, using gradient 0–100% EtOAc/hexane to afford the compound <b>11</b> (107 mg, 88%). <sup>1</sup>H NMR: 7.45 (2H, m), 7.05 (1H, m), 6.35 (1H, m), 5.26 (1H, d, <i>J</i> = 12.6), 5.13 (1H, dd, <i>J</i> = 5.0, 12.6), 3.6 (2H, s), 3.55 (2H, m), 2.73 (1H, d, <i>J</i> = 4.91), 2.61 (1H, d, <i>J</i> = 14.6), 1.95 (3H, m), 1.63 (2H, m), 1.18 (2H, m). LCMS found: 473.3 (M + H).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Synthesis of <i>tert</i>-Butyl(2-((6a<i>R</i>,7<i>R</i>,10a<i>S</i>)-10a-((4-chlorophenyl)sulfonyl)-1,4-difluoro-7-(2-methoxyvinyl)-6a,7,8,9,10,10a-hexahydro-6<i>H</i>-benzo[<i>c</i>]chromen-7-yl)ethoxy)dimethylsilane <b>12</b></h3><div class="NLM_p">To a solution of compound <b>10</b> (5.2 g, 11 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (100 mL) at −78 °C was added dropwise DIBAL (1 M in toluene, 14.3 mmol, 1.3 equiv). The reaction mixture was stirred at −78 °C for 1 h. TLC analysis (35% EtOAc/hexane) showed that the reaction was complete with formation of a polar product. The reaction was quenched by the addition of EtOAc, warmed up to room temperature, and treated with a saturated solution of NaK tartarate. After stirring for 2 h, the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 400 mL), and the combined organic phases were washed with water and brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo to give the crude lactol intermediate (5.2 g).</div><div class="NLM_p">To a solution of the lactol intermediate (5.2 g, 11 mmol) and 2,6-lutidine (4.11 mL, 35.4 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (150 mL) at 0 °C was added dropwise TBDMSOTf (5.1 mL, 22 mmol). The reaction mixture was stirred at 0 °C for 1 h. TLC (40% EtOAc/hexane) showed that the reaction was complete. The reaction mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 300 mL), and the combined organic phases were washed with NaHCO<sub>3</sub>, water, and brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo. The crude product was purified by silica gel chromatography (20% EtOAc/hexane) to furnish intermediate aldehyde (3. 0 g, 47%).</div><div class="NLM_p last">Methoxymethyltriphenylphosphonium chloride (5.18 g, 15.1 mmol) was slurried in THF (65 mL), cooled to −78 °C and treated dropwise with <i>t</i>-BuOK (1 M in THF, 15.1 mL, 15.1 mmol) such that the internal temperature did not exceed −40 °C (yellow to orange color). The above aldehyde intermediate (2.94 g, 5.03 mmol, in 25 mL THF) was added slowly while maintaining the internal temperature below −40 °C. The reaction mixture was stirred and allowed to warm up to ambient temperature and stirred overnight. The reaction mixture was diluted with water and extracted with EtOAc (3 × 200 mL), and the combined organic phases were washed with water and brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo. The residue was purified by silica gel chromatography (20% EtOAc/hexane) to give the alkene <b>12</b> (2.08 g, 66%). <sup>1</sup>H NMR: 7.47 (4H, m), 7.03 (1H, m), 6.35 (1H, m), 5.84 (1H, d, <i>J</i> = 7.16), 5.06 (1H, dd, <i>J</i> = 5.47, 12.3), 4.70 (1H, d, <i>J</i> = 12.6), 4.16 (1H, d, <i>J</i> = 7.15), 3.59 (3H, s), 3.47 (3H, m), 2.96 (1H, d, <i>J</i> = 5.34), 2.69 (1H, d, <i>J</i> = 15.3), 2.41 (1H, d, <i>J</i> = 4.56), 2.01 (1H, t, <i>J</i> = 13.0), 1.85 (1H, m), 1.78 (1H, m), 1.36 (1H, m), 1.27 (2H, m), 0.75 (9H, s), 0.14 (6H, s). LCMS found: 613.3 (M + H).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Synthesis of 2,2′-((6a<i>R</i>,10a<i>S</i>)-10a-((4-Chlorophenyl)sulfonyl)-1,4-difluoro-6a,7,8,9,10,10a-hexahydro-6<i>H</i>-benzo[<i>c</i>]chromene-7,7-diyl)bis(ethan-1-ol) <b>13</b></h3><div class="NLM_p">To a solution of alkene <b>12</b> (1.81 g, 2.96 mmol) in THF (10 mL) at 0 °C was slowly added Hg(OAc)<sub>2</sub> (1.13 g, 3.55 mmol) in water (10 mL). The mixture was stirred at room temperature overnight. The reaction mixture was cooled to 0 °C and treated with a solution of NaBH<sub>4</sub> (469.4 mg, 12.418 mmol) in saturated K<sub>2</sub>CO<sub>3</sub> aqueous solution (10 mL). The mixture was stirred for 10 min at 0 °C, at which point TLC analysis (20% EtOAc/hexane) indicated that the reaction was complete. The mixture was extracted with EtOAc (2 × 200 mL), and the combined organic phases were washed with water and brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo. The residue was purified by chromatography on silica gel using a gradient of 0–35% of EtOAc in hexane to afford the mono TBS protected intermediate (1.57 g, 89%).</div><div class="NLM_p last">To the mono TBS protected intermediate (785 mg, 1.31 mmol) in THF (12 mL) was slowly added TBAF (1 M in THF, 2.62 mL, 2.62 mmol), and the reaction was stirred for 2 h. TLC analysis (40% EtOAc/hexane) showed that the reaction was complete. The reaction mixture was extracted with EtOAc (2 × 50 mL), and the combined organic phases were washed with water and brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo. The crude product was purified by recrystallization from CH<sub>2</sub>Cl<sub>2</sub> to obtain pure compound <b>13</b> (630 mg, 99%). <sup>1</sup>H NMR, 7.48 (4H, m), 7.06 (1H, m), 6.36 (1H, m), 5.11 (1H, dd, <i>J</i> = 5.32, 12.8), 4.72 (1H, d, <i>J</i> = 12.7), 3.82 (2H, t, <i>J</i> = 6.22), 3.55 (2H, m), 2.77 (1H, d, <i>J</i> = 5.25), 2.66 (1H, d, <i>J</i> = 12.3), 1.93 (2H, m), 1.38–1.76 (7H, m). LCMS found: 487.5 (M + H).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Synthesis of 10a-((4-Chlorophenyl)sulfonyl)-1,4-difluoro-6,6a,8,9,10,10a-hexahydrospiro[benzo[<i>c</i>]chromene-7,3′-oxetane] <b>14a</b> (n = 1, k = 1)</h3><div class="NLM_p last">To a solution of diol <b>7</b> (216 mg, 0.42 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) at 0 °C was added Et<sub>3</sub>N (0.15 mL, 1.1 mmol) and MsCl (39 μL, 0.59 mmol). The reaction was stirred at 0 °C for 1 h. TLC analysis showed two less polar products. The reaction was diluted with water, extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 20 mL), and the combined organic phases were washed with water and brine, dried (MgSO<sub>4</sub>), and concentrated to give the crude mesylate (216 mg, 0.42 mmol), which was dissolved in DMF (20 mL), cooled down to 0 °C, and treated with NaH (50 mg, 1.26 mmol). The reaction mixture was stirred for 2 h at 0 °C, then was quenched with water and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 30 mL), and the combined organic phases were dried (MgSO<sub>4</sub>) and concentrated in vacuo. The crude product was purified by silica gel chromatography using a gradient of 0–60% of EtOAc in hexane to furnish desired product <b>14a</b> (95.7 mg, 42.1%). <sup>1</sup>H NMR: 7.48 (4H, m), 7.08 (1H, m), 6.36 (1H, m), 5.31 (1H, m), 5.19 (1H, d, <i>J</i> = 12.68), 4.77 (1H, d, <i>J</i> = 6.37), 4.58 (1H, d, <i>J</i> = 7.98), 4.22 (1H, d, <i>J</i> = 6.36), 3.81 (1H, d, <i>J</i> = 6.41), 2.58 (1H, s), 2.55 (1H, d, <i>J</i> = 4.55), 2.39 (1H, d, <i>J</i> = 12.8), 1.93 (1H, tt, <i>J</i> = 3.3, 13.5), 1.72 (1H, m), 1.64 (1H, m), 1.14 (1H, d, <i>J</i> = 13.1). LCMS found: 441.5 (M + H).</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Synthesis of 10a-((4-Chlorophenyl)sulfonyl)-1,4-difluoro-4′,5′,6,6a,8,9,10,10a-octahydro-2′<i>H</i>-spiro[benzo[<i>c</i>]chromene-7,3′-furan] <b>14b</b> (n = 1, k = 2)</h3><div class="NLM_p">To a solution of diol <b>11</b> (48 mg, 0.1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1.5 mL) at 0 °C was added Et<sub>3</sub>N (43 μL, 0.3 mmol) and TsCl (29 mg, 0.15 mmol). The reaction was stirred at 0 °C for 4 h. TLC analysis (45% EtOAc/hexane) showed that the reaction was complete. The reaction mixture was diluted with water and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 20 mL), and the combined organic phases were dried (MgSO<sub>4</sub>) and concentrated in vacuo. The crude product was purified by preparative TLC (45% EtOAc/hexane) to furnish <b>14b</b> (31 mg, 66.9%). <sup>1</sup>H NMR 7.47 (4H, m), 7.08 (1H, m), 6.38 (1H, m), 5.16 (1H, dd, <i>J</i> = 5.26, 12.5), 4.71 (1H, d, <i>J</i> = 12.6), 3.92 (1H, td, <i>J</i> = 2.99, 8.45), 3.87 (1H, d, <i>J</i> = 8.88), 3.64 (1H, q, <i>J</i> = 8.88), 3.49 (1H, d, <i>J</i> = 9.05), 2.72 (1H, d, <i>J</i> = 5.23), 2.61 (1H, d, <i>J</i> = 10.7), 1.96 (1H, t, <i>J</i> = 13.7), 1.83 (1H, q, <i>J</i> = 8.29), 1.71 (2H, d, <i>J</i> = 12.9), 1.38 (1H, t, <i>J</i> = 12.9), 1.26 (1H, t, <i>J</i> = 13.3), 1.15 (1H, m). LCMS found: 455.3.</div><div class="NLM_p last">The desired product was further resolved by chiral HPLC chromatography using an OD chiral column (100% <i>i</i>-PrOH) to give two enantiopure compounds. The first eluting enantiomer was <b>14b(−)</b> (10 mg), [α]<sub>D</sub><sup>20</sup> = −159.74 (EtOH), and the second eluting enantiomer was <b>14b(+)</b> (11 mg), [α]<sub>D</sub><sup>20</sup> = +161.52 (EtOH).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Synthesis of 10a-((4-Chlorophenyl)sulfonyl)-1,4-difluoro-2′,3′,5′,6,6a,6′,8,9,10,10a-decahydrospiro[benzo[<i>c</i>]chromene-7,4′-thiopyran] <b>15</b></h3><div class="NLM_p">To the solution of diol <b>13</b> (110 mg, 0.233 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) at 0 °C was added dropwise MsCl (54 μL, 0.7 mmol), followed by dropwise addition of Et<sub>3</sub>N (98 μL, 0.7 mmol). The reaction mixture was stirred at 0 °C for 0.5 h. TLC analysis (35% EtOAc/hexane) showed that the reaction was complete. The reaction was quenched by addition of water, extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 25 mL), and the combined organic phases were washed with water, HCl (1 M), and brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo.</div><div class="NLM_p">The crude product was purified by silica gel chromatography, using a gradient of 0–50% hexane/EtOAc to furnish the bis-mesylate intermediate (150 mg, 100%). <sup>1</sup>H NMR 7.48 (4H, m), 7.10 (1H, m), 6.42 (1H, m), 5.15 (1H, dd, <i>J</i> = 5.30, 13.0), 4.64 (1H, d, <i>J</i> = 12.9), 4.39 (1H, m), 4.12 (1H, t, <i>J</i> = 6.81), 3.11 (3H, s), 2.91(3H, s), 2.72 (1H, d, <i>J</i> = 5.21), 2.66 (1H, d, <i>J</i> = 14.3), 2.17 (1H, m), 1.90 (3H, m), 1.5–1.7 (5H, m).</div><div class="NLM_p last">To a solution of bis-mesylate intermediate (150 mg, 0.234 mmol) in dry EtOH (4.0 mL) at room temperature was added Na<sub>2</sub>S (36 mg, 0.47 mmol), followed by pyridine (0.5 mL). The reaction mixture was stirred at reflux for 2 h. TLC analysis (35% EtOAc/hexane) showed that the reaction was complete. The reaction was quenched by the addition of water, extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 25 mL), and the combined organic phases were washed with water, HCl (1 M) and brine, dried (MgSO<sub>4</sub>), and concentrated. The crude was purified by silica gel chromatography using a gradient of 0–50% EtOAc/hexane to afford compound <b>15</b> (88 mg, 43%). <sup>1</sup>H NMR: 7.45 (4H, m), 7.05 (1H, m), 6.34 (1H, m), 5.15 (1H, dd, <i>J</i> = 5.29, 12.8), 4.87 (1H, d, <i>J</i> = 12.8), 2.95 (1H, td, <i>J</i> = 13.3, 2.40), 2.64 (2H, qd, <i>J</i> = 2.60, 13.6), 2.36 (1H, d, <i>J</i> = 13.7), 2.31 (1H, d, <i>J</i> = 5.17), 2.22 (2H, td, <i>J</i> = 12.9, 3.66), 2.08 (1H, d, <i>J</i> = 14.0), 1.93 (1H, tt, <i>J</i> = 13.1, 3.25), 1.85 (1H, td, <i>J</i> = 12.4, 3.27), 1.64 (1H, dt, <i>J</i> = 14.0, 3.58), 1.47 (1H, d, <i>J</i> = 12.9), 1.35 (1H, d, <i>J</i> = 13.9), 1.20 (1H, q, <i>J</i> = 13.6), 1.01 (1H, t, <i>J</i> = 12.4). LCMS found: 485.3.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Synthesis of 10a-((4-Chlorophenyl)sulfonyl)-1,4-difluoro-2′,3′,5′,6,6a,6′,8,9,10,10a-decahydrospiro[benzo[<i>c</i>]chromene-7,4′-thiopyran] 1′,1′-Dioxide <b>16</b></h3><div class="NLM_p last">To the solution of compound <b>15</b> (83 mg, 0.17 mmol) in acetone/water (2 mL/0.5 mL) at room temperature was added OXONE (210 mg, 0.34 mmol), and the reaction mixture was stirred for 48 h. TLC analysis (25% EtOAc/hexane) indicated that the reaction was complete. The reaction mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 20 mL), and the combined organic phases were washed with water and brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo. The crude product was purified by silica gel chromatography, using a gradient of 0–70% of EtOAc in hexane to afford compound <b>16</b> (77 mg, 87%). <sup>1</sup>H NMR: 7.47 (4H, m), 7.08 (1H, m), 6.38 (1H, m), 5.19 (1H, dd, <i>J</i> = 5.33, 13.2), 4.79 (1H, d, <i>J</i> = 13.4), 3.15 (1H, td, <i>J</i> = 14.2, 3.62), 2.97 (1H, dd, <i>J</i> = 4.16, 14.6), 2.85 (1H, td, <i>J</i> = 14.6, 4.0), 2.68 (2H, m), 2.52 (1H, d, <i>J</i> = 5.02), 2.3 (1H, td, J= 3.97, 13.7), 2.19 (1H, d, <i>J</i> = 13.5), 1.97 (1H, t, <i>J</i> = 13.1), 1.75 (1H, m), 1.66 (1H, d, <i>J</i> = 3.51), 1.53–1.63 (2H, m), 1.48 (1H, d, <i>J</i> = 3.68), 1.44 (1H, d, <i>J</i> = 3.86), 1.22 (2H, d, <i>J</i> = 11.6). LCMS found: 517.37 (M + H).</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Synthesis of 10a-((4-Chlorophenyl)sulfonyl)-1,4-difluoro-1′-((trifluoromethyl)sulfonyl)-6,6a,8,9,10,10a-hexahydrospiro[benzo[<i>c</i>]chromene-7,3′-pyrrolidine] <b>17</b></h3><div class="NLM_p">To the solution of diol <b>11</b> (73 mg, 0.16 mmol) in a mixture of CH<sub>2</sub>Cl<sub>2</sub> (2.5 mL) and pyridine (37.5 μL, 0.464 mmol) at 0 °C was added DMAP (3.8 mg, 0.03 mmol), followed by portionwise addition of TsCl (88 mg, 0.46 mmol). The reaction mixture was stirred at 0 °C for 1 h. TLC analysis (35% EtOAc/hexane) showed that the reaction was done. The reaction was quenched by the addition of water and warmed to room temperature. The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 25 mL), and the combined organic phases were washed with water and brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo. The residue was purified by preparative TLC (60% EtOAc/hexane) to give the bis-tosylate intermediate (88 mg, 73%). <sup>1</sup>H NMR: 7.81 (2H, d, <i>J</i> = 8.36), 7.67 (2H, d, <i>J</i> = 8.31), 7.42 (2H, d, <i>J</i> = 8.54), 7.35 (2H, d, <i>J</i> = 7.92), 7.08 (1H, m), 6.38 (1H, m), 4.83 (1H, dd, <i>J</i> = 5.07, 13.2), 4.18 (1H, d, <i>J</i> = 13.1), 3.88 (1H, t, <i>J</i> = 4.99), 3.81 (2H, d, <i>J</i> = 8.29), 2.73 (1H, d, <i>J</i> = 4.64), 2.59 (1H, d, <i>J</i> = 14.2), 2.49 (3H, s), 2.45 (3H, s), 1.13–1.86 (8H, m).</div><div class="NLM_p last">To a solution of the bis-tosylate intermediate (12 mg, 0.015 mmol) in DMF (1 mL) was added trifluoromethanesulfonamide (12 mg, 0.08 mmol) and K<sub>2</sub>CO<sub>3</sub> (11 mg, 0.08 mmol). The reaction was stirred at 70 °C overnight. TLC analysis (35% EtOAc/hexane) showed that the reaction was complete. The reaction was cooled and quenched by the addition of water, extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 20 mL), and the combined organic phases were washed with water and brine, dried (MgSO<sub>4</sub>), and concentrated in vacuo. The crude product was purified by preparative TLC (60% EtOAc/hexane) to furnish compound <b>17</b> (5.0 mg, 56.0%). <sup>1</sup>H NMR: 7.48 (4H, m), 7.11 (1H, m), 6.42 (1H, m), 5.24 (1H, dd, <i>J</i> = 5.07, 13.0), 4.62 (1H, d, <i>J</i> = 13.1), 3.67 (1H, d, <i>J</i> = 10.2), 3.60 (1H, t, <i>J</i> = 9.51), 3.37 (2H, m), 2.75 (1H, d, <i>J</i> = 4.74), 2.63 (1H, d, <i>J</i> = 14.0), 2.0 (2H, m), 1.85 (1H, d, <i>J</i> = 14.1), 1.75 (1H, dt, <i>J</i> = 14.7, 3.16), 1.41 (1H, t, <i>J</i> = 12.6), 1.27 (2H, m). LCMS found: 586.35 (M + H).</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Synthesis of (6a<i>R</i>,10a<i>S</i>)-10a-((4-Chlorophenyl)sulfonyl)-1,4-difluoro-2′-methyl-6,6a,8,9,10,10a-hexahydrospiro[benzo[<i>c</i>]chromene-7,5′-[1,3,2]dioxaphosphinane] 2′-Oxide <b>18a</b> (n = 1, k = 1)</h3><div class="NLM_p last">To the diol compound <b>7</b> (500 mg, 1.09 mmol) in THF (15 mL) at −78 °C was added pyridine (194 μL, 2.4 mmol) and methylphosphonic dichloride (160 mg, 1.2 mmol). The mixture was stirred at −78 °C for 2 h. TLC analysis (5% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) showed completion of the reaction. The reaction mixture was diluted with water, extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 60 mL), and the combined organic phases were dried (MgSO<sub>4</sub>) and concentrated in vacuo. The residue was purified by preparative TLC (5% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) and further purified by preparative TLC (100% EtOAc) to give <b>18a</b> (250 mg, 44%). LCMS found: 519.3 (M + H). <sup>1</sup>H NMR: 7.49 (4H, m), 7.13 (1H, m), 6.45 (1H, m), 5.27 (1H, dd, <i>J</i> = 4.66, 13.0), 4.74 (1H, d, <i>J</i> = 13.0), 4.30 (1H, t, <i>J</i> = 11.2), 4.17 (1H, dd, <i>J</i> = 5.5, 12.2), 4.09 (1H, td, <i>J</i> = 13.1, 1.54), 3.67 (1H, m), 2.67 (1H, d, <i>J</i> = 4.38), 2.59 (1H, d, <i>J</i> = 13.2), 2.37 (1H, d, <i>J</i> = 10.6), 1.97 (1H, t, <i>J</i> = 12.5), 1.77 (1H, m), 1.61 (3H, d, <i>J</i> = 16.9), 1.28 (2H, d, <i>J</i> = 9.92). The racemic compound <b>18a</b> was resolved by chiral HPLC with an OD chiral column using 90% <i>i</i>-PrOH/hexane as the eluent; the first eluting enantiomer was <b>18a(−)</b>, [α]<sub>D</sub><sup>20</sup> = −145.34 (EtOH), the second eluting enantiomer was <b>18a(+)</b>, [α]<sub>D</sub><sup>20</sup> = +147.19 (EtOH).</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Synthesis of <b>10a</b>-((4-Chlorophenyl)sulfonyl)-1,4-difluoro-2′-methyl-6,6a,8,9,10,10a-hexahydrospiro[benzo[<i>c</i>]chromene-7,5′-[1,3,2]dioxaphosphepane] 2′-Oxide <b>18b</b> (n = 1, k = 2)</h3><div class="NLM_p last">To the diol <b>11</b> (52 mg, 0.11 mmol) in THF (1.5 mL) at −78 °C was added pyridine (19.6 μL, 0.242 mmol). Then methylphosphonic dichloride (16.1 mg, 0.121 mmol) was added. The reaction was stirred for 2 h. TLC analysis (80% EtOAc/hexane) showed completion of the reaction. The reaction mixture was quenched with water and extracted by CH<sub>2</sub>Cl<sub>2</sub> (2 × 20 mL), and the combined organic phases were dried (MgSO<sub>4</sub>) and concentrated in vacuo. The crude product was purified by preparative TLC, 80% EtOAc/hexane to give compound <b>18b</b> (racemic, mixture of diastereomers, 41 mg, 70%). <sup>1</sup>H NMR: 7.47 (4H, m), 7.09 (1H, m), 6.40 (1H, m), 5.17 (1H, m), 4.63 (2H, m), 4.21 (1H, m), 3.79 (2H, m), 2.58 (2H, m), 2.07 (2H, m), 1.72 (1H, m), 1.55 (3H, d, <i>J</i> = 17.3), 1.49 (3H, d, <i>J</i> = 17.4), 1.22 (3H, m). LCMS found: 533.3 (M + H).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00774">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58137" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58137" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">. The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b00774" class="ext-link">10.1021/acs.jmedchem.5b00774</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Protocols for in vitro studies: membrane-based and cell-based γ-secretase assays, determination of PS-1 vs PS-2 selectivity; protocols for the in vivo studies (<a href="/doi/suppl/10.1021/acs.jmedchem.5b00774/suppl_file/jm5b00774_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.5b00774/suppl_file/jm5b00774_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00774/suppl_file/jm5b00774_si_001.pdf">jm5b00774_si_001.pdf (183.72 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00774/suppl_file/jm5b00774_si_002.csv">jm5b00774_si_002.csv (2.58 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b00774" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28407" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28407" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhiqiang Zhao</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8ff5e7e6fee6eee1e8a1f5e7eee0cfe2eafdece4a1ece0e2"><span class="__cf_email__" data-cfemail="d6acbebfa7bfb7b8b1f8acbeb7b996bbb3a4b5bdf8b5b9bb">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dmitri A. Pissarnitski</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hubert B. Josien</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wen-Lian Wu</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruo Xu</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongmei Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John W. Clader</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Duane A. Burnett</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giuseppe Terracina</span> - <span class="hlFld-Affiliation affiliation">Department
of Neurobiology, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lynn Hyde</span> - <span class="hlFld-Affiliation affiliation">Department
of Neurobiology, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julie Lee</span> - <span class="hlFld-Affiliation affiliation">Department
of Neurobiology, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lixin Song</span> - <span class="hlFld-Affiliation affiliation">Department
of Neurobiology, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lili Zhang</span> - <span class="hlFld-Affiliation affiliation">Department
of Neurobiology, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric M. Parker</span> - <span class="hlFld-Affiliation affiliation">Department
of Neurobiology, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d415e2713-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06200" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06200" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We Thank Dr. Alexander Pasternak for his support and review of this paper, and to Drs. Alexei Buevich, T.-M. Chan, and Rebecca Osterman for the interpretation of NMR spectra.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i33" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i33"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i34" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i34"> Abbreviations Used</h2><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">AE</td><td class="NLM_def"><p class="first last">adverse effects</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid-β</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">BACE</td><td class="NLM_def"><p class="first last">β-amyloid cleaving enzyme</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">GSI</td><td class="NLM_def"><p class="first last">γ-secretase inhibitor</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">the human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">NICD</td><td class="NLM_def"><p class="first last">Notch intracellular domain</p></td></tr><tr><td class="NLM_term">PS</td><td class="NLM_def"><p class="first last">presenilin</p></td></tr><tr><td class="NLM_term">9-BBN</td><td class="NLM_def"><p class="first last">9-borabicyclo[3.3.1]nonane</p></td></tr><tr><td class="NLM_term">DIBAL</td><td class="NLM_def"><p class="first last">diisobutylaluminum hydride</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">LAH</td><td class="NLM_def"><p class="first last">lithium aluminum hydride</p></td></tr><tr><td class="NLM_term">LDA</td><td class="NLM_def"><p class="first last">lithium diisopropylamide</p></td></tr><tr><td class="NLM_term">MsCl</td><td class="NLM_def"><p class="first last">methanesulfonyl chloride</p></td></tr><tr><td class="NLM_term">PPTS</td><td class="NLM_def"><p class="first last">pyridinium <i>p</i>-toluenesulfonate</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last">tetra-<i>n</i>-butylammonium fluoride</p></td></tr><tr><td class="NLM_term">TBDMSTf</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldimethylsilyl trifluoromethanesulfonate</p></td></tr><tr><td class="NLM_term">TBS</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldimethylsilyl</p></td></tr><tr><td class="NLM_term">TsCl</td><td class="NLM_def"><p class="first last">4-toluenesulfonyl chloride</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82833" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82833" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 33 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span>Alzheimer’s Disease Facts and Figures; <span class="NLM_publisher-name">Alzheimer’s Association</span>: <span class="NLM_publisher-loc">Chicago</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span><a href="http://www.alz.org/" class="extLink">http://www.alz.org/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzheimer%E2%80%99s+Disease+Facts+and+Figures%3B+Alzheimer%E2%80%99s+Association%3A+Chicago%2C+2011%3B+http%3A%2F%2Fwww.alz.org%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Disease%2520Facts%2520and%2520Figures%26pub%3DAlzheimer%25E2%2580%2599s%2520Association%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span><span class="refDoi"> DOI: 10.1126/science.1072994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+progress+and+problems+on+the+road+to+therapeutics&doi=10.1126%2Fscience.1072994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lhdvJ7HSBPoJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356%26doi%3D10.1126%2Fscience.1072994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Wolfe, M. S.</span><span> </span><span class="NLM_article-title">γ-Secretase: Structure, function, and modulation for Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.2174/156802608783334024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.2174%2F156802608783334024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=18220927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=2-8&author=M.+S.+Wolfe&title=%CE%B3-Secretase%3A+Structure%2C+function%2C+and+modulation+for+Alzheimer%E2%80%99s+disease&doi=10.2174%2F156802608783334024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase: Structure, function, and modulation for Alzheimer's disease</span></div><div class="casAuthors">Wolfe, Michael S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-8</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  γ-Secretase proteolyzes a variety of membrane-assocd. fragments derived from type I integral membrane proteins, including the amyloid β-protein precursor (APP), involved in Alzheimer's disease, and the Notch receptor, crit. for cellular differentiation.  This protease is composed of 4 integral membrane proteins: presenilin, nicastrin, Aph-1, and Pen-2.  The assembly of these 4 components leads to presenilin autoproteolysis into 2 subunits, each of which contributes 1 Asp residue to the active site of an aspartic protease.  The protease contains an initial docking site for substrate, where it binds prior to passing between the 2 presenilin subunits to the internal water-contg. active site.  The extracellular region of nicastrin also interacts with the N-terminus of the substrate as an essential step in substrate recognition and processing.  Modulation of APP processing without interfering with Notch signaling is an important therapeutic goal, and allosteric sites on the protease allow such selective modulation.  A better structural and mechanistic understanding of γ-secretase should ultimately allow structure-based design of more potent and selective modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvxbwIPN0VQrVg90H21EOLACvtfcHk0lhdvJ7HSBPoJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWntrg%253D&md5=c9e4244e51bcd391dc6eda2daedd8003</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F156802608783334024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608783334024%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26atitle%3D%25CE%25B3-Secretase%253A%2520Structure%252C%2520function%252C%2520and%2520modulation%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D2%26epage%3D8%26doi%3D10.2174%2F156802608783334024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Josien, H.</span><span> </span><span class="NLM_article-title">Recent advances in the development of gamma-secretase inhibitors</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=513-525&author=H.+Josien&title=Recent+advances+in+the+development+of+gamma-secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJosien%26aufirst%3DH.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520gamma-secretase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2002%26volume%3D5%26spage%3D513%26epage%3D525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ziani-Cherif, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mostefa-Kara, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brixi-Gormat, F. Z.</span><span> </span><span class="NLM_article-title">Gamma-secretase as a pharmacological target in Alzheimer disease research: when, why and how?</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4313</span><span class="NLM_x">–</span> <span class="NLM_lpage">4335</span><span class="refDoi"> DOI: 10.2174/138161206778792994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.2174%2F138161206778792994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=17105430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1GntrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=4313-4335&author=C.+Ziani-Cherifauthor=B.+Mostefa-Karaauthor=F.+Z.+Brixi-Gormat&title=Gamma-secretase+as+a+pharmacological+target+in+Alzheimer+disease+research%3A+when%2C+why+and+how%3F&doi=10.2174%2F138161206778792994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Gamma-secretase as a pharmacological target in Alzheimer disease research: when, why and how?</span></div><div class="casAuthors">Ziani-Cherif, Chewki; Mostefa-Kara, Bachir; Brixi-Gormat, Fatima Z.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">4313-4335</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer disease (AD) is characterized by excessive deposition of amyloid β-peptides (Aβ peptides) in the form of senile plaques as well as neurofibrillary tangles (NFTs) in the brain.  In the amyloidogenic pathway, the amyloid-β precursor protein (APP) is cleaved by β-secretase first, followed by γ-secretase cleavage producing therefore Aβ.  This review summarizes the recent findings in the AD field and focuses on the different γ-secretase inhibitors that have been developed as a therapeutic approach toward AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyBZ632d85vLVg90H21EOLACvtfcHk0liv3o7TI1jbNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1GntrbN&md5=65bcf1db2e7d131d22d3f111f491ef0f</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.2174%2F138161206778792994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206778792994%26sid%3Dliteratum%253Aachs%26aulast%3DZiani-Cherif%26aufirst%3DC.%26aulast%3DMostefa-Kara%26aufirst%3DB.%26aulast%3DBrixi-Gormat%26aufirst%3DF.%2BZ.%26atitle%3DGamma-secretase%2520as%2520a%2520pharmacological%2520target%2520in%2520Alzheimer%2520disease%2520research%253A%2520when%252C%2520why%2520and%2520how%253F%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D4313%26epage%3D4335%26doi%3D10.2174%2F138161206778792994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Evin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sernee, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span> </span><span class="NLM_article-title">Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer’s disease: prospects, limitations and strategies</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span><span class="refDoi"> DOI: 10.2165/00023210-200620050-00002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.2165%2F00023210-200620050-00002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=351-372&author=G.+Evinauthor=M.+F.+Serneeauthor=C.+L.+Masters&title=Inhibition+of+gamma-secretase+as+a+therapeutic+intervention+for+Alzheimer%E2%80%99s+disease%3A+prospects%2C+limitations+and+strategies&doi=10.2165%2F00023210-200620050-00002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.2165%2F00023210-200620050-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00023210-200620050-00002%26sid%3Dliteratum%253Aachs%26aulast%3DEvin%26aufirst%3DG.%26aulast%3DSernee%26aufirst%3DM.%2BF.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26atitle%3DInhibition%2520of%2520gamma-secretase%2520as%2520a%2520therapeutic%2520intervention%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520prospects%252C%2520limitations%2520and%2520strategies%26jtitle%3DCNS%2520Drugs%26date%3D2006%26volume%3D20%26spage%3D351%26epage%3D372%26doi%3D10.2165%2F00023210-200620050-00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Wu, W.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">γ-Secretase inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span><span class="refDoi"> DOI: 10.1002/ddr.20288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1002%2Fddr.20288" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2009&pages=94-100&author=W.-L.+Wuauthor=L.+Zhang&title=%CE%B3-Secretase+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fddr.20288"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fddr.20288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fddr.20288%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.-L.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3D%25CE%25B3-Secretase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2009%26volume%3D70%26spage%3D94%26epage%3D100%26doi%3D10.1002%2Fddr.20288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Lleo, A.</span><span> </span><span class="NLM_article-title">Activity of γ-secretase on substrates other than APP</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span><span class="refDoi"> DOI: 10.2174/156802608783334060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.2174%2F156802608783334060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=18220928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWntrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=9-16&author=A.+Lleo&title=Activity+of+%CE%B3-secretase+on+substrates+other+than+APP&doi=10.2174%2F156802608783334060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of γ-secretase on substrates other than APP</span></div><div class="casAuthors">Lleo, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-16</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  γ-Secretase is an intramembranous protein complex that cleaves many type-I membrane proteins, including the Notch receptor and the β-amyloid precursor protein (APP).  Interest in γ-secretase comes, in part, from the fact that this multiprotein complex is responsible for the cleavage of APP that generates the amyloid-β peptide (Aβ), one of the primary components of amyloid plaques in Alzheimer's disease (AD).  Over the last years, mol. identification of the complex has shown that γ-secretase is an aspartic protease composed of 4 different members that are essential for the enzymic activity: presenilin 1, aph1, pen-2, and nicastrin.  In recent years, an increasing no. of type-I membrane proteins have been shown to be cleaved by γ-secretase.  How the enzyme cleaves such a set of substrates with diverse functions and subcellular localizations is not well understood.  In overexpression assays, the γ-secretase cleavage of some substrates releases intracellular domains with signaling properties.  On the other hand, the loose specificity required for intramembrane cleavage has raised the possibility of γ-secretase as the membrane proteasome.  The impact of γ-secretase on other substrates has clear implications for the development of new therapies for AD, and in particular for the search of γ-secretase inhibitors or modulators.  Interference with the cleavage of some of the γ-secretase substrates has been shown to be assocd. with serious adverse effects in animal models.  The understanding of the mechanism by which γ-secretase recognizes and cleaves all of these proteins is of great importance to clarify the function of γ-secretase and its role as a therapeutic target in AD, and possibly in other diseases in which γ-secretase is involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsYywVodUb-bVg90H21EOLACvtfcHk0liy5CcZKxxVCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWntrk%253D&md5=3739586a3fb928bab945b7b74fd52fce</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F156802608783334060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608783334060%26sid%3Dliteratum%253Aachs%26aulast%3DLleo%26aufirst%3DA.%26atitle%3DActivity%2520of%2520%25CE%25B3-secretase%2520on%2520substrates%2520other%2520than%2520APP%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D9%26epage%3D16%26doi%3D10.2174%2F156802608783334060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Wong, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfra, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josien, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engstrom, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinzon-Ortiz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span> </span><span class="NLM_article-title">Chronic treatment with the γ-secretase inhibitor LY-411575 inhibits β-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">12876</span><span class="NLM_x">–</span> <span class="NLM_lpage">12882</span><span class="refDoi"> DOI: 10.1074/jbc.M311652200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1074%2Fjbc.M311652200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=12876-12882&author=G.+T.+Wongauthor=D.+Manfraauthor=F.+Pouletauthor=Q.+Zhangauthor=H.+Josienauthor=T.+Baraauthor=L.+Engstromauthor=M.+Pinzon-Ortizauthor=J.+S.+Fineauthor=H.-J.+Leeauthor=L.+Zhangauthor=G.+A.+Higginsauthor=E.+M.+Parker&title=Chronic+treatment+with+the+%CE%B3-secretase+inhibitor+LY-411575+inhibits+%CE%B2-amyloid+peptide+production+and+alters+lymphopoiesis+and+intestinal+cell+differentiation&doi=10.1074%2Fjbc.M311652200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M311652200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M311652200%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DG.%2BT.%26aulast%3DManfra%26aufirst%3DD.%26aulast%3DPoulet%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DEngstrom%26aufirst%3DL.%26aulast%3DPinzon-Ortiz%26aufirst%3DM.%26aulast%3DFine%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DH.-J.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26atitle%3DChronic%2520treatment%2520with%2520the%2520%25CE%25B3-secretase%2520inhibitor%2520LY-411575%2520inhibits%2520%25CE%25B2-amyloid%2520peptide%2520production%2520and%2520alters%2520lymphopoiesis%2520and%2520intestinal%2520cell%2520differentiation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D12876%26epage%3D12882%26doi%3D10.1074%2Fjbc.M311652200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Milano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dagenais, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster-Brown, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pognan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadient, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciaccio, P. J.</span><span> </span><span class="NLM_article-title">Modulation of Notch processing by γ-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation</span> <span class="citation_source-journal">Toxicol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span><span class="refDoi"> DOI: 10.1093/toxsci/kfh254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1093%2Ftoxsci%2Fkfh254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=15319485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVOhsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2004&pages=341-358&author=J.+Milanoauthor=J.+McKayauthor=C.+Dagenaisauthor=L.+Foster-Brownauthor=F.+Pognanauthor=R.+Gadientauthor=R.+T.+Jacobsauthor=A.+Zaccoauthor=B.+Greenbergauthor=P.+J.+Ciaccio&title=Modulation+of+Notch+processing+by+%CE%B3-secretase+inhibitors+causes+intestinal+goblet+cell+metaplasia+and+induction+of+genes+known+to+specify+gut+secretory+lineage+differentiation&doi=10.1093%2Ftoxsci%2Fkfh254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of Notch Processing by γ-Secretase Inhibitors Causes Intestinal Goblet Cell Metaplasia and Induction of Genes Known to Specify Gut Secretory Lineage Differentiation</span></div><div class="casAuthors">Milano, Joseph; McKay, Jenny; Dagenais, Claude; Foster-Brown, Linda; Pognan, Francois; Gadient, Reto; Jacobs, Robert T.; Zacco, Anna; Greenberg, Barry; Ciaccio, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">341-358</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">It is anticipated that γ-secretase inhibitors (γ-Sec-I) that modulate Notch processing will alter differentiation in tissues whose architecture is governed by Notch signaling.  To explore this hypothesis, Han Wistar rats were dosed for up to 5 days with 10-100 μmol/kg b.i.d. γ-Sec-I from three chem. series that inhibit Notch processing in vitro at various potencies (Notch IC50).  These included an arylsulfonamide (AS) (142 nM), a dibenzazepine (DBZ) (1.7 nM), and a benzodiazepine (BZ) (2.2 nM).  The DBZ and BZ caused dose-dependent intestinal goblet cell metaplasia.  In contrast, the AS produced no detectable in vivo toxicity, despite higher exposure to free drug.  In a time course using BZ, small intestinal crypt cell and large intestinal glandular cell epithelial apoptosis was obsd. on days 1-5, followed by goblet cell metaplasia on days 2-5 and crypt epithelial and glandular epithelial regenerative hyperplasia on days 4-5.  Gene expression profiling of duodenal samples from BZ-dosed animals revealed significant time-dependent deregulation of mRNAs for various panendocrine, hormonal, and transcription factor genes.  Somatostatin, secretin, mucin, CCK, and gastrin mRNAs were elevated twofold or more by day 2, and a no. of candidate early-predictive' genes were altered on days 1-2, remaining changed for 4-5 days; these included Delta1, NeuroD, Hes1-regulated adipsin, and the Hes-regulated transcriptional activator of gut secretory lineage differentiation, the rat homolog of Drosophila atonal, Rath1.  Western blotting of fecal protein from BZ-and DBZ-dosed animals exhibited increased levels of both anti-Rath1 reactive protein and anti-adipsin reactive proteins, confirming their potential value as noninvasive biomarkers of intestinal goblet metaplasia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2qB_JewBHJrVg90H21EOLACvtfcHk0liy5CcZKxxVCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVOhsLc%253D&md5=ba57bf26d54ef933a6dc738468bb07e4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfh254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfh254%26sid%3Dliteratum%253Aachs%26aulast%3DMilano%26aufirst%3DJ.%26aulast%3DMcKay%26aufirst%3DJ.%26aulast%3DDagenais%26aufirst%3DC.%26aulast%3DFoster-Brown%26aufirst%3DL.%26aulast%3DPognan%26aufirst%3DF.%26aulast%3DGadient%26aufirst%3DR.%26aulast%3DJacobs%26aufirst%3DR.%2BT.%26aulast%3DZacco%26aufirst%3DA.%26aulast%3DGreenberg%26aufirst%3DB.%26aulast%3DCiaccio%26aufirst%3DP.%2BJ.%26atitle%3DModulation%2520of%2520Notch%2520processing%2520by%2520%25CE%25B3-secretase%2520inhibitors%2520causes%2520intestinal%2520goblet%2520cell%2520metaplasia%2520and%2520induction%2520of%2520genes%2520known%2520to%2520specify%2520gut%2520secretory%2520lineage%2520differentiation%26jtitle%3DToxicol.%2520Sci.%26date%3D2004%26volume%3D82%26spage%3D341%26epage%3D358%26doi%3D10.1093%2Ftoxsci%2Fkfh254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Grosveld, G. C.</span><span> </span><span class="NLM_article-title">γ-Secretase inhibitors: Notch so bad</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span><span class="refDoi"> DOI: 10.1038/nm0109-20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1038%2Fnm0109-20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=19129776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD1MXis1Oqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=20-21&author=G.+C.+Grosveld&title=%CE%B3-Secretase+inhibitors%3A+Notch+so+bad&doi=10.1038%2Fnm0109-20"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">γ-secretase inhibitors: Notch so bad</span></div><div class="casAuthors">Grosveld, Gerard C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-21</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  γ-Secretase inhibitors inhibit Notch, a transmembrane receptor that drives many cases of T cell acute lymphoblastic leukemia - but there are safety concerns with such drugs.  Combining these inhibitors with glucocorticoids could provide a more effective and safer approach (pages 50-58).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprLPK5315EjbVg90H21EOLACvtfcHk0liy5CcZKxxVCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXis1Oqtg%253D%253D&md5=5c681c9ba6ce540e935386a264b1c785</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnm0109-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0109-20%26sid%3Dliteratum%253Aachs%26aulast%3DGrosveld%26aufirst%3DG.%2BC.%26atitle%3D%25CE%25B3-Secretase%2520inhibitors%253A%2520Notch%2520so%2520bad%26jtitle%3DNat.%2520Med.%26date%3D2009%26volume%3D15%26spage%3D20%26epage%3D21%26doi%3D10.1038%2Fnm0109-20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Choi, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norstrom, E.</span><span> </span><span class="NLM_article-title">Moderate reduction of γ-secretase: is there a therapeutic sweet spot?</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">13579</span><span class="NLM_x">–</span> <span class="NLM_lpage">13580</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.4821-07.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1523%2FJNEUROSCI.4821-07.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=18077669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmt1E%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=13579-13580&author=S.+H.+Choiauthor=E.+Norstrom&title=Moderate+reduction+of+%CE%B3-secretase%3A+is+there+a+therapeutic+sweet+spot%3F&doi=10.1523%2FJNEUROSCI.4821-07.2007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Moderate reduction of γ-secretase: is there a therapeutic sweet spot?</span></div><div class="casAuthors">Choi, Se Hoon; Norstrom, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">13579-13580</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotAKtkugqpzbVg90H21EOLACvtfcHk0lgQ2Hn6rjJJ-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmt1E%253D&md5=5ec22d5a052ec226a3721ddad4b04b5b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4821-07.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4821-07.2007%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DS.%2BH.%26aulast%3DNorstrom%26aufirst%3DE.%26atitle%3DModerate%2520reduction%2520of%2520%25CE%25B3-secretase%253A%2520is%2520there%2520a%2520therapeutic%2520sweet%2520spot%253F%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D13579%26epage%3D13580%26doi%3D10.1523%2FJNEUROSCI.4821-07.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Henley, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E. R.</span><span> </span><span class="NLM_article-title">Development of semagacestat (LY450139), a functional γ-secretase inhibitor, for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1657</span><span class="NLM_x">–</span> <span class="NLM_lpage">1664</span><span class="refDoi"> DOI: 10.1517/14656560903044982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1517%2F14656560903044982" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=19527190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Oru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=1657-1664&author=D.+B.+Henleyauthor=P.+C.+Mayauthor=R.+A.+Deanauthor=E.+R.+Siemers&title=Development+of+semagacestat+%28LY450139%29%2C+a+functional+%CE%B3-secretase+inhibitor%2C+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1517%2F14656560903044982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Development of semagacestat (LY450139), a functional γ-secretase inhibitor, for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Henley, David B.; May, Patrick C.; Dean, Robert A.; Siemers, Eric R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1657-1664</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Alzheimer's disease is thought to be caused by increased formations of neurotoxic amyloid beta (Aβ) peptides, which give rise to the hallmark amyloid plaques.  Therefore, pharmacol. agents that reduce Aβ formation may be of therapeutic benefit.  Objective: This paper reviews the pharmacol. and chem. efficacy of an Aβ-lowering agent, semagacestat (LY450139).  Methods: A review of the published literature pertaining to semagacestat was obtained using several electronic search engines; unpublished data on file at Eli Lilly and Co. were used as supplementary material.  Results/conclusions: Semagacestat treatment lowers plasma, cerebrospinal fluid and brain Aβ in a dose-dependent manner in animals and plasma and cerebrospinal fluid Aβ in humans, compared with placebo-treated patients.  On the basis of extant data, semagacestat seems to be well tolerated, with most adverse events related to its actions on inhibition of peripheral Notch cleavage.  Thus far, clin. efficacy has not been detectable because of the short duration of the current trials.  Phase III trials with 21 mo of active treatment are currently underway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3x83njCfOwrVg90H21EOLACvtfcHk0lgQ2Hn6rjJJ-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Oru7g%253D&md5=add24473eeb348fd5ef73c7829b11edf</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1517%2F14656560903044982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656560903044982%26sid%3Dliteratum%253Aachs%26aulast%3DHenley%26aufirst%3DD.%2BB.%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DSiemers%26aufirst%3DE.%2BR.%26atitle%3DDevelopment%2520of%2520semagacestat%2520%2528LY450139%2529%252C%2520a%2520functional%2520%25CE%25B3-secretase%2520inhibitor%252C%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2009%26volume%3D10%26spage%3D1657%26epage%3D1664%26doi%3D10.1517%2F14656560903044982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">McKee, S.</span><span> </span><span class="NLM_article-title">Lilly hit by spectacular failure of phase III Alzheimer’s candidate</span>.  <span class="citation_source-journal">PharmaTimes [Online]</span>, <span class="NLM_month">Aug</span><span class="NLM_day">18</span>,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+McKee&title=Lilly+hit+by+spectacular+failure+of+phase+III+Alzheimer%E2%80%99s+candidate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcKee%26aufirst%3DS.%26atitle%3DLilly%2520hit%2520by%2520spectacular%2520failure%2520of%2520phase%2520III%2520Alzheimer%25E2%2580%2599s%2520candidate%26jtitle%3DPharmaTimes%2520%255BOnline%255D%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanlon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, P.</span><span> </span><span class="NLM_article-title">γ-Secretase modulator in Alzheimer’s disease: shifting the end</span> <span class="citation_source-journal">J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">696</span><span class="refDoi"> DOI: 10.3233/JAD-2012-120751</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.3233%2FJAD-2012-120751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=22710916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A280%3ADC%252BC38jivV2guw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=685-696&author=W.+Xiaauthor=S.+T.+Wongauthor=E.+Hanlonauthor=P.+Morin&title=%CE%B3-Secretase+modulator+in+Alzheimer%E2%80%99s+disease%3A+shifting+the+end&doi=10.3233%2FJAD-2012-120751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">γ-secretase modulator in Alzheimer's disease: shifting the end</span></div><div class="casAuthors">Xia Weiming; Wong Stephen T; Hanlon Eugene; Morin Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">685-96</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The outcomes of the clinical trials of the γ-secretase inhibitor Semagacestat (LY-450139) and the γ-secretase modulator (GSM) Tarenflurbil were disappointing, but may not represent the end of the γ-secretase era.  γ-Secretase modulators, by definition, only block the γ-secretase cleavage of amyloid-β protein precursor (AβPP) to generate the longer, 42-residue amyloid-β (Aβ42) without changing the production of total Aβ.  The first generation GSMs were shown to block Aβ42 generation while increasing Aβ38.  The non-steroidal anti-inflammatory drug, Tarenflurbil, binds to AβPP and shifts the cleavage site from Aβ42 to Aβ38.  In addition, Tarenflurbil does not affect the γ-secretase cleavage of Notch.  Even before the failed clinical trials of Tarenflurbil, second generation GSMs had emerged, and some of these GSMs interact with presenilin, which carries the active site of the γ-secretase.  While second generation GSMs are pharmacologically superior to first generation GSMs, in vivo Aβ profiles (decreased levels of Aβ38, Aβ40, and Aβ42) in animals treated with potent GSMs are strikingly different from those in cultured cells.  Thus, the unique pharmacologic properties of new GSMs and their mechanisms of action need to be elucidated in order to avoid the fate of Tarenflurbil.  It is critical to understand how GSMs shift the "end" in vivo, i.e., shifting the γ-secretase cleavage at the C-terminal end of Aβ.  In view of the myriad effects of candidate GSMs on Aβ production in cells and animals, drug development would benefit from better definition of the target-GSM interaction and physiological function of shorter Aβ peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQlMyfkj9Q7cMK3uFsUIZtkfW6udTcc2eYR1he-7U5LcLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38jivV2guw%253D%253D&md5=cb9e0ac6ec8b4eac86c8b0a1a5529a92</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3233%2FJAD-2012-120751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2012-120751%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DS.%2BT.%26aulast%3DHanlon%26aufirst%3DE.%26aulast%3DMorin%26aufirst%3DP.%26atitle%3D%25CE%25B3-Secretase%2520modulator%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520shifting%2520the%2520end%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2012%26volume%3D31%26spage%3D685%26epage%3D696%26doi%3D10.3233%2FJAD-2012-120751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span> </span><span class="NLM_article-title">Targeting the β-secretase BACE1 for Alzheimer’s disease therapy</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span><span class="refDoi"> DOI: 10.1016/S1474-4422(13)70276-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1016%2FS1474-4422%2813%2970276-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=24556009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1Cntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=319-329&author=R.+Yanauthor=R.+Vassar&title=Targeting+the+%CE%B2-secretase+BACE1+for+Alzheimer%E2%80%99s+disease+therapy&doi=10.1016%2FS1474-4422%2813%2970276-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the β secretase BACE1 for Alzheimer's disease therapy</span></div><div class="casAuthors">Yan, Riqiang; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-329</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The β secretase, widely known as β-site amyloid precursor protein cleaving enzyme 1 (BACE1), initiates the prodn. of the toxic amyloid β (Aβ) that plays a crucial early part in Alzheimer's disease pathogenesis.  BACE1 is a prime therapeutic target for lowering cerebral Aβ concns. in Alzheimer's disease, and clin. development of BACE1 inhibitors is being intensely pursued.  Although BACE1 inhibitor drug development has proven challenging, several promising BACE1 inhibitors have recently entered human clin. trials.  The safety and efficacy of these drugs are being tested at present in healthy individuals and patients with Alzheimer's disease, and will soon be tested in individuals with presymptomatic Alzheimer's disease.  Although hopes are high that BACE1 inhibitors might be efficacious for the prevention or treatment of Alzheimer's disease, concerns have been raised about potential mechanism-based side-effects of these drugs.  The potential of therapeutic BACE1 inhibition might prove to be a watershed in the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8SsSfCAC6nbVg90H21EOLACvtfcHk0lgRvqc2LbEqDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1Cntbo%253D&md5=11aeb06fee19cafc0b361e2c43900806</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2813%2970276-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252813%252970276-X%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DTargeting%2520the%2520%25CE%25B2-secretase%2520BACE1%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%26jtitle%3DLancet%2520Neurol.%26date%3D2014%26volume%3D13%26spage%3D319%26epage%3D329%26doi%3D10.1016%2FS1474-4422%2813%2970276-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Lessons from a failed γ-secretase Alzheimer trial</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span><span class="refDoi"> DOI: 10.1016/j.cell.2014.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1016%2Fj.cell.2014.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=25417150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2msrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2014&pages=721-726&author=B.+De+Strooper&title=Lessons+from+a+failed+%CE%B3-secretase+Alzheimer+trial&doi=10.1016%2Fj.cell.2014.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons from a Failed γ-Secretase Alzheimer Trial</span></div><div class="casAuthors">De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">721-726</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  γ-Secretase proteases have been assocd. with pathol. in Alzheimer disease (AD), but we are just beginning to understand their basic mechanisms and physiol. roles.  A neg. drug trial with a broad spectrum γ-secretase inhibitor in AD patients has severely dampened enthusiasm for the potential of pursuing γ-secretase research therapeutically.  This pessimism is unwarranted: anal. of available information presented here demonstrates significant confounds for interpreting the outcome of the trial and argues that the major lessons pertain to broad knowledge gaps that are imperative to fill.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoltWoN44tWybVg90H21EOLACvtfcHk0lgRvqc2LbEqDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2msrnI&md5=9d19644a7135552c6c4ef2b812b4b665</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2014.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2014.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DLessons%2520from%2520a%2520failed%2520%25CE%25B3-secretase%2520Alzheimer%2520trial%26jtitle%3DCell%26date%3D2014%26volume%3D159%26spage%3D721%26epage%3D726%26doi%3D10.1016%2Fj.cell.2014.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kreft, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porte, A.</span><span> </span><span class="NLM_article-title">Recent advances in the identification of γ-secretase inhibitors to clinically test the Aβ oligomer hypothesis of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6169</span><span class="NLM_x">–</span> <span class="NLM_lpage">6188</span><span class="refDoi"> DOI: 10.1021/jm900188z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900188z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6169-6188&author=A.+F.+Kreftauthor=R.+Martoneauthor=A.+Porte&title=Recent+advances+in+the+identification+of+%CE%B3-secretase+inhibitors+to+clinically+test+the+A%CE%B2+oligomer+hypothesis+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm900188z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm900188z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900188z%26sid%3Dliteratum%253Aachs%26aulast%3DKreft%26aufirst%3DA.%2BF.%26aulast%3DMartone%26aufirst%3DR.%26aulast%3DPorte%26aufirst%3DA.%26atitle%3DRecent%2520advances%2520in%2520the%2520identification%2520of%2520%25CE%25B3-secretase%2520inhibitors%2520to%2520clinically%2520test%2520the%2520A%25CE%25B2%2520oligomer%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6169%26epage%3D6188%26doi%3D10.1021%2Fjm900188z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">DeAngelo, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stock, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attar, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fearen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallob, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aster, J.</span><span> </span><span class="NLM_article-title">A phase I clinical trial of the Notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and other leukemias</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">6585</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=6585&author=D.+J.+DeAngeloauthor=R.+M.+Stoneauthor=L.+B.+Silvermanauthor=W.+Stockauthor=E.+C.+Attarauthor=I.+Fearenauthor=A.+Dallobauthor=C.+Matthewsauthor=J.+Stoneauthor=S.+J.+Freedmanauthor=J.+Aster&title=A+phase+I+clinical+trial+of+the+Notch+inhibitor+MK-0752+in+patients+with+T-cell+acute+lymphoblastic+leukemia%2Flymphoma+%28T-ALL%29+and+other+leukemias"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeAngelo%26aufirst%3DD.%2BJ.%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DSilverman%26aufirst%3DL.%2BB.%26aulast%3DStock%26aufirst%3DW.%26aulast%3DAttar%26aufirst%3DE.%2BC.%26aulast%3DFearen%26aufirst%3DI.%26aulast%3DDallob%26aufirst%3DA.%26aulast%3DMatthews%26aufirst%3DC.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DFreedman%26aufirst%3DS.%2BJ.%26aulast%3DAster%26aufirst%3DJ.%26atitle%3DA%2520phase%2520I%2520clinical%2520trial%2520of%2520the%2520Notch%2520inhibitor%2520MK-0752%2520in%2520patients%2520with%2520T-cell%2520acute%2520lymphoblastic%2520leukemia%252Flymphoma%2520%2528T-ALL%2529%2520and%2520other%2520leukemias%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D6585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Schott, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dontu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Layman, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krop, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paskett, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrolecki, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froehlich, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paranilam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wicha, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. C.</span><span> </span><span class="NLM_article-title">Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1512</span><span class="NLM_x">–</span> <span class="NLM_lpage">1524</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-3326</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1158%2F1078-0432.CCR-11-3326" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=23340294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFKktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1512-1524&author=A.+F.+Schottauthor=M.+D.+Landisauthor=G.+Dontuauthor=K.+A.+Griffithauthor=R.+M.+Laymanauthor=I.+Kropauthor=L.+A.+Paskettauthor=H.+Wongauthor=L.+E.+Dobroleckiauthor=M.+T.+Lewisauthor=A.+M.+Froehlichauthor=J.+Paranilamauthor=D.+F.+Hayesauthor=M.+S.+Wichaauthor=J.+C.+Chang&title=Preclinical+and+clinical+studies+of+gamma+secretase+inhibitors+with+docetaxel+on+human+breast+tumors&doi=10.1158%2F1078-0432.CCR-11-3326"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors</span></div><div class="casAuthors">Schott, Anne F.; Landis, Melissa D.; Dontu, Gabriela; Griffith, Kent A.; Layman, Rachel M.; Krop, Ian; Paskett, Lacey A.; Wong, Helen; Dobrolecki, Lacey E.; Lewis, Michael T.; Froehlich, Amber M.; Paranilam, Jaya; Hayes, Daniel F.; Wicha, Max S.; Chang, Jenny C.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1512-1524</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Accumulating evidence supports the existence of breast cancer stem cells (BCSC), which are characterized by their capacity to self-renew and divide indefinitely and resistance to conventional therapies.  The Notch pathway is important for stem cell renewal and is a potential target for BCSC-directed therapy.  Exptl. Design: Using human breast tumorgraft studies, we evaluated the impact of gamma secretase inhibitors (GSI) on the BCSC population and the efficacy of combining GSI with docetaxel treatment.  The mouse exptl. therapy paralleled a concurrent clin. trial in patients with advanced breast cancer, designed to det. the max.-tolerated dose of the GSI, MK-0752, administered sequentially with docetaxel, and to evaluate BCSC markers in serial tumor biopsies.  Results: Treatment with GSI reduced BCSCs in MC1 and BCM-2147 tumorgrafts by inhibition of the Notch pathway.  GSI enhanced the efficacy of docetaxel in preclin. studies.  In the clin. trial, 30 patients with advanced breast cancer were treated with escalating doses of MK-0752 plus docetaxel.  Clin., meaningful doses of both drugs were possible with manageable toxicity and preliminary evidence of efficacy.  A decrease in CD44+/CD24-, ALDH+, and mammosphere-forming efficiency were obsd. in tumors of patients undergoing serial biopsies.  Conclusions: These preclin. data show that pharmacol. inhibition of the Notch pathway can reduce BCSCs in breast tumorgraft models.  The clin. trial shows feasibility of combination GSI and chemotherapy, and together these results encourage further study of Notch pathway inhibitors in combination with chemotherapy in breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSPyKUMdOCRrVg90H21EOLACvtfcHk0lgxIz7l8COEwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFKktL0%253D&md5=4123f8b7f5f732252f7cafb7b2ef859c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-3326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-3326%26sid%3Dliteratum%253Aachs%26aulast%3DSchott%26aufirst%3DA.%2BF.%26aulast%3DLandis%26aufirst%3DM.%2BD.%26aulast%3DDontu%26aufirst%3DG.%26aulast%3DGriffith%26aufirst%3DK.%2BA.%26aulast%3DLayman%26aufirst%3DR.%2BM.%26aulast%3DKrop%26aufirst%3DI.%26aulast%3DPaskett%26aufirst%3DL.%2BA.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DDobrolecki%26aufirst%3DL.%2BE.%26aulast%3DLewis%26aufirst%3DM.%2BT.%26aulast%3DFroehlich%26aufirst%3DA.%2BM.%26aulast%3DParanilam%26aufirst%3DJ.%26aulast%3DHayes%26aufirst%3DD.%2BF.%26aulast%3DWicha%26aufirst%3DM.%2BS.%26aulast%3DChang%26aufirst%3DJ.%2BC.%26atitle%3DPreclinical%2520and%2520clinical%2520studies%2520of%2520gamma%2520secretase%2520inhibitors%2520with%2520docetaxel%2520on%2520human%2520breast%2520tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D1512%26epage%3D1524%26doi%3D10.1158%2F1078-0432.CCR-11-3326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Martone, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atchison, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreft, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschmies, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaleska, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonnenberg-Reines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oganesian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkins, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huryn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frick, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forlow, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balliet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burczynski, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, J. S.</span><span> </span><span class="NLM_article-title">Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein γ-secretase for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">331</span><span class="NLM_x">, </span> <span class="NLM_fpage">598</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span><span class="refDoi"> DOI: 10.1124/jpet.109.152975</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1124%2Fjpet.109.152975" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=19671883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlKnu73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=2009&pages=598-608&author=R.+L.+Martoneauthor=H.+Zhouauthor=K.+Atchisonauthor=T.+Comeryauthor=J.+Z.+Xuauthor=X.+Huangauthor=X.+Gongauthor=M.+Jinauthor=A.+Kreftauthor=B.+Harrisonauthor=S.+C.+Mayerauthor=S.+Aschmiesauthor=C.+Gonzalesauthor=M.+M.+Zaleskaauthor=D.+R.+Riddellauthor=E.+Wagnerauthor=P.+Luauthor=S.-C.+Sunauthor=J.+Sonnenberg-Reinesauthor=A.+Oganesianauthor=K.+Adkinsauthor=M.+W.+Leachauthor=D.+W.+Clarkeauthor=D.+Hurynauthor=M.+Abou-Gharbiaauthor=R.+Magoldaauthor=J.+Bardauthor=G.+Frickauthor=S.+Rajeauthor=S.+B.+Forlowauthor=C.+Ballietauthor=M.+E.+Burczynskiauthor=P.+H.+Reinhartauthor=H.+I.+Wanauthor=M.+N.+Pangalosauthor=J.+S.+Jacobsen&title=Begacestat+%28GSI-953%29%3A+a+novel%2C+selective+thiophene+sulfonamide+inhibitor+of+amyloid+precursor+protein+%CE%B3-secretase+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1124%2Fjpet.109.152975"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein γ-secretase for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Martone, Robert L.; Zhou, Hua; Atchison, Kevin; Comery, Thomas; Xu, Jane Z.; Huang, Xinyi; Gong, Xioahai; Jin, Mei; Kreft, Anthony; Harrison, Boyd; Mayer, Scott C.; Aschmies, Suzan; Gonzales, Cathleen; Zaleska, Margaret M.; Riddell, David R.; Wagner, Erik; Lu, Peimin; Sun, Shaiu-Ching; Sonnenberg-Reines, June; Oganesian, Aram; Adkins, Karissa; Leach, Michael W.; Clarke, David W.; Huryn, Donna; Abou-Gharbia, Magid; Magolda, Ronald; Bard, Jonathan; Frick, Glen; Raje, Sangeeta; Forlow, S. Bradley; Balliet, Carrie; Burczynski, Michael E.; Reinhart, Peter H.; Wan, Hong I.; Pangalos, Menelas N.; Jacobsen, J. Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">598-608</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The presenilin contg. γ-secretase complex is responsible for the regulated intramembraneous proteolysis of the amyloid precursor protein (APP), the Notch receptor, and a multitude of other substrates.  γ-Secretase catalyzes the final step in the generation of Aβ40 and Aβ42 peptides from APP.  Amyloid β-peptides (Aβ peptides) aggregate to form neurotoxic oligomers, senile plaques, and congophilic angiopathy, some of the cardinal pathologies assocd. with Alzheimer's disease.  Although inhibition of this protease acting on APP may result in potentially therapeutic redns. of neurotoxic Aβ peptides, nonselective inhibition of the enzyme may cause severe adverse events as a result of impaired Notch receptor processing.  Here, we report the preclin. pharmacol. profile of GSI-953 (begacestat), a novel thiophene sulfonamide γ-secretase inhibitor (GSI) that selectively inhibits cleavage of APP over Notch.  This GSI inhibits Aβ prodn. with low nanomolar potency in cellular and cell-free assays of γ-secretase function, and displaces a tritiated analog of GSI-953 from enriched γ-secretase enzyme complexes with similar potency.  Cellular assays of Notch cleavage reveal that this compd. is approx. 16-fold selective for the inhibition of APP cleavage.  In the human APP-overexpressing Tg2576 transgenic mouse, treatment with this orally active compd. results in a robust redn. in brain, plasma, and cerebral spinal fluid Aβ levels, and a reversal of contextual fear-conditioning deficits that are correlated with Aβ load.  In healthy human volunteers, oral administration of a single dose of GSI-953 produces dose-dependent changes in plasma Aβ levels, confirming pharmacodynamic activity of GSI-953 in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3bpCy_xTzAbVg90H21EOLACvtfcHk0lgxIz7l8COEwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlKnu73I&md5=575a31bab5d79e60dc2c12bd22790b23</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.152975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.152975%26sid%3Dliteratum%253Aachs%26aulast%3DMartone%26aufirst%3DR.%2BL.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DComery%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DJ.%2BZ.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DGong%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DM.%26aulast%3DKreft%26aufirst%3DA.%26aulast%3DHarrison%26aufirst%3DB.%26aulast%3DMayer%26aufirst%3DS.%2BC.%26aulast%3DAschmies%26aufirst%3DS.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DZaleska%26aufirst%3DM.%2BM.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DS.-C.%26aulast%3DSonnenberg-Reines%26aufirst%3DJ.%26aulast%3DOganesian%26aufirst%3DA.%26aulast%3DAdkins%26aufirst%3DK.%26aulast%3DLeach%26aufirst%3DM.%2BW.%26aulast%3DClarke%26aufirst%3DD.%2BW.%26aulast%3DHuryn%26aufirst%3DD.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DMagolda%26aufirst%3DR.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DFrick%26aufirst%3DG.%26aulast%3DRaje%26aufirst%3DS.%26aulast%3DForlow%26aufirst%3DS.%2BB.%26aulast%3DBalliet%26aufirst%3DC.%26aulast%3DBurczynski%26aufirst%3DM.%2BE.%26aulast%3DReinhart%26aufirst%3DP.%2BH.%26aulast%3DWan%26aufirst%3DH.%2BI.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26aulast%3DJacobsen%26aufirst%3DJ.%2BS.%26atitle%3DBegacestat%2520%2528GSI-953%2529%253A%2520a%2520novel%252C%2520selective%2520thiophene%2520sulfonamide%2520inhibitor%2520of%2520amyloid%2520precursor%2520protein%2520%25CE%25B3-secretase%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D331%26spage%3D598%26epage%3D608%26doi%3D10.1124%2Fjpet.109.152975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Gillman, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starrett, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcin, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElhone, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mate, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barten, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaczek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decicco, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span> </span><span class="NLM_article-title">Discovery and evaluation of BMS-708163, a potent, selective and orally bioavailable γ-secretase inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1021/ml1000239</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml1000239" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1WrsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=120-124&author=K.+W.+Gillmanauthor=J.+E.+Starrettauthor=M.+F.+Parkerauthor=K.+Xieauthor=J.+J.+Bronsonauthor=L.+R.+Marcinauthor=K.+E.+McElhoneauthor=C.+P.+Bergstromauthor=R.+A.+Mateauthor=R.+Williamsauthor=J.+E.+Meredithauthor=C.+R.+Burtonauthor=D.+M.+Bartenauthor=J.+H.+Toynauthor=S.+B.+Robertsauthor=K.+A.+Lentzauthor=J.+G.+Houstonauthor=R.+Zaczekauthor=C.+F.+Albrightauthor=C.+P.+Deciccoauthor=J.+E.+Macorauthor=R.+E.+Olson&title=Discovery+and+evaluation+of+BMS-708163%2C+a+potent%2C+selective+and+orally+bioavailable+%CE%B3-secretase+inhibitor&doi=10.1021%2Fml1000239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor</span></div><div class="casAuthors">Gillman, Kevin W.; Starrett, John E.; Parker, Michael F.; Xie, Kai; Bronson, Joanne J.; Marcin, Lawrence R.; McElhone, Kate E.; Bergstrom, Carl P.; Mate, Robert A.; Williams, Richard; Meredith, Jere E.; Burton, Catherine R.; Barten, Donna M.; Toyn, Jeremy H.; Roberts, Susan B.; Lentz, Kimberley A.; Houston, John G.; Zaczek, Robert; Albright, Charles F.; Decicco, Carl P.; Macor, John E.; Olson, Richard E.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">120-124</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">During the course of our research efforts to develop a potent and selective γ-secretase inhibitor for the treatment of Alzheimer's disease, we investigated a series of carboxamide-substituted sulfonamides.  Optimization based on potency, Notch/amyloid-β precursor protein selectivity, and brain efficacy after oral dosing led to the discovery of 4 (BMS-708163).  Compd. 4 is a potent inhibitor of γ-secretase (Aβ40 IC50 = 0.30 nM), demonstrating a 193-fold selectivity against Notch.  Oral administration of 4 significantly reduced Aβ40 levels for sustained periods in brain, plasma, and cerebrospinal fluid in rats and dogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5cpf2l0bVB7Vg90H21EOLACvtfcHk0lgSWrLyMDRUHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1WrsL0%253D&md5=f28ebc4be6022fdbe9297c8663588440</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fml1000239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1000239%26sid%3Dliteratum%253Aachs%26aulast%3DGillman%26aufirst%3DK.%2BW.%26aulast%3DStarrett%26aufirst%3DJ.%2BE.%26aulast%3DParker%26aufirst%3DM.%2BF.%26aulast%3DXie%26aufirst%3DK.%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26aulast%3DMarcin%26aufirst%3DL.%2BR.%26aulast%3DMcElhone%26aufirst%3DK.%2BE.%26aulast%3DBergstrom%26aufirst%3DC.%2BP.%26aulast%3DMate%26aufirst%3DR.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DMeredith%26aufirst%3DJ.%2BE.%26aulast%3DBurton%26aufirst%3DC.%2BR.%26aulast%3DBarten%26aufirst%3DD.%2BM.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DRoberts%26aufirst%3DS.%2BB.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26aulast%3DHouston%26aufirst%3DJ.%2BG.%26aulast%3DZaczek%26aufirst%3DR.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DDecicco%26aufirst%3DC.%2BP.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26atitle%3DDiscovery%2520and%2520evaluation%2520of%2520BMS-708163%252C%2520a%2520potent%252C%2520selective%2520and%2520orally%2520bioavailable%2520%25CE%25B3-secretase%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D120%26epage%3D124%26doi%3D10.1021%2Fml1000239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Mayer, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreft, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antane, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschmies, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atchison, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chlenov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamantidis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingboe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galante, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoke, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huryn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubrak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oganesian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resnick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonnenberg-Reines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stock, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaleska, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeldis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, J. S.</span><span> </span><span class="NLM_article-title">Discovery of begacestat, a Notch-1-sparing γ-secretase inhibitor for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7348</span><span class="NLM_x">–</span> <span class="NLM_lpage">7351</span><span class="refDoi"> DOI: 10.1021/jm801252w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801252w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2jsbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7348-7351&author=S.+C.+Mayerauthor=A.+F.+Kreftauthor=B.+Harrisonauthor=M.+Abou-Gharbiaauthor=M.+Antaneauthor=S.+Aschmiesauthor=K.+Atchisonauthor=M.+Chlenovauthor=D.+C.+Coleauthor=T.+Comeryauthor=G.+Diamantidisauthor=J.+Ellingboeauthor=K.+Fanauthor=R.+Galanteauthor=C.+Gonzalesauthor=D.+M.+Hoauthor=M.+E.+Hokeauthor=Y.+Huauthor=D.+Hurynauthor=U.+Jainauthor=M.+Jinauthor=K.+Kremerauthor=D.+Kubrakauthor=M.+Linauthor=P.+Luauthor=R.+Magoldaauthor=R.+Martoneauthor=W.+Mooreauthor=A.+Oganesianauthor=M.+N.+Pangalosauthor=A.+Porteauthor=P.+Reinhartauthor=L.+Resnickauthor=D.+R.+Riddellauthor=J.+Sonnenberg-Reinesauthor=J.+R.+Stockauthor=S.-C.+Sunauthor=E.+Wagnerauthor=T.+Wangauthor=K.+Wollerauthor=Z.+Xuauthor=M.+M.+Zaleskaauthor=J.+Zeldisauthor=M.+Zhangauthor=H.+Zhouauthor=J.+S.+Jacobsen&title=Discovery+of+begacestat%2C+a+Notch-1-sparing+%CE%B3-secretase+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm801252w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Begacestat, a Notch-1-Sparing γ-Secretase Inhibitor for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Mayer, Scott C.; Kreft, Anthony F.; Harrison, Boyd; Abou-Gharbia, Magid; Antane, Madelene; Aschmies, Suzan; Atchison, Kevin; Chlenov, Michael; Cole, Derek C.; Comery, Thomas; Diamantidis, George; Ellingboe, John; Fan, Kristi; Galante, Rocco; Gonzales, Cathleen; Ho, Douglas M.; Hoke, Molly E.; Hu, Yun; Huryn, Donna; Jain, Uday; Jin, Mei; Kremer, Kenneth; Kubrak, Dennis; Lin, Melissa; Lu, Peimin; Magolda, Ron; Martone, Robert; Moore, William; Oganesian, Aram; Pangalos, Menelas N.; Porte, Alex; Reinhart, Peter; Resnick, Lynn; Riddell, David R.; Sonnenberg-Reines, June; Stock, Joseph R.; Sun, Shaiu-Ching; Wagner, Erik; Wang, Ting; Woller, Kevin; Xu, Zheng; Zaleska, Margaret M.; Zeldis, Joseph; Zhang, Minsheng; Zhou, Hua; Jacobsen, J. Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7348-7351</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">SAR on HTS hits 1 and 2 led to the potent, Notch-1-sparing GSI 9, which lowered brain Aβ in Tg2576 mice at 100 mg/kg po.  Converting the metabolically labile Me groups in 9 to trifluoromethyl groups afforded the more stable analog 10, which had improved in vivo potency.  Further side chain modification afforded the potent Notch-1-sparing GSI begacestat (5), which was selected for development for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs3eNPOOjp4rVg90H21EOLACvtfcHk0lgSWrLyMDRUHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2jsbjL&md5=c67a1b8bf40825f2d1b1eb707c8d5c25</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm801252w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801252w%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DS.%2BC.%26aulast%3DKreft%26aufirst%3DA.%2BF.%26aulast%3DHarrison%26aufirst%3DB.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DAntane%26aufirst%3DM.%26aulast%3DAschmies%26aufirst%3DS.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DChlenov%26aufirst%3DM.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DComery%26aufirst%3DT.%26aulast%3DDiamantidis%26aufirst%3DG.%26aulast%3DEllingboe%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DGalante%26aufirst%3DR.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DHo%26aufirst%3DD.%2BM.%26aulast%3DHoke%26aufirst%3DM.%2BE.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DHuryn%26aufirst%3DD.%26aulast%3DJain%26aufirst%3DU.%26aulast%3DJin%26aufirst%3DM.%26aulast%3DKremer%26aufirst%3DK.%26aulast%3DKubrak%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DMagolda%26aufirst%3DR.%26aulast%3DMartone%26aufirst%3DR.%26aulast%3DMoore%26aufirst%3DW.%26aulast%3DOganesian%26aufirst%3DA.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26aulast%3DPorte%26aufirst%3DA.%26aulast%3DReinhart%26aufirst%3DP.%26aulast%3DResnick%26aufirst%3DL.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DSonnenberg-Reines%26aufirst%3DJ.%26aulast%3DStock%26aufirst%3DJ.%2BR.%26aulast%3DSun%26aufirst%3DS.-C.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWoller%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DZaleska%26aufirst%3DM.%2BM.%26aulast%3DZeldis%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DJacobsen%26aufirst%3DJ.%2BS.%26atitle%3DDiscovery%2520of%2520begacestat%252C%2520a%2520Notch-1-sparing%2520%25CE%25B3-secretase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7348%26epage%3D7351%26doi%3D10.1021%2Fjm801252w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dockens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slemmon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denton, R. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhyne, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raybon, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barten, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankaranarayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guss, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simutis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillman, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starrett, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sverdlov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaneda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coric, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaczek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, G.</span><span> </span><span class="NLM_article-title">Pharmacodynamics of selective inhibition of γ-secretase by avagacestat</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">686</span><span class="NLM_x">–</span> <span class="NLM_lpage">695</span><span class="refDoi"> DOI: 10.1124/jpet.112.199356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1124%2Fjpet.112.199356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=23275065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVaisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2013&pages=686-695&author=C.+F.+Albrightauthor=R.+C.+Dockensauthor=J.+E.+Meredithauthor=R.+E.+Olsonauthor=R.+Slemmonauthor=K.+A.+Lentzauthor=J.-S.+Wangauthor=R.+X.+Dentonauthor=G.+Pilcherauthor=P.+W.+Rhyneauthor=J.+J.+Raybonauthor=D.+M.+Bartenauthor=C.+Burtonauthor=J.+H.+Toynauthor=S.+Sankaranarayananauthor=C.+Polsonauthor=V.+Gussauthor=R.+Whiteauthor=F.+Simutisauthor=T.+Sandersonauthor=K.+W.+Gillmanauthor=J.+E.+Starrettauthor=J.+Bronsonauthor=O.+Sverdlovauthor=S.-P.+Huangauthor=L.+Castanedaauthor=H.+Feldmanauthor=V.+Coricauthor=R.+Zaczekauthor=J.+E.+Macorauthor=J.+Houstonauthor=R.+M.+Bermanauthor=G.+Tong&title=Pharmacodynamics+of+selective+inhibition+of+%CE%B3-secretase+by+avagacestat&doi=10.1124%2Fjpet.112.199356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamics of selective inhibition of γ-secretase by avagacestat</span></div><div class="casAuthors">Albright, Charles F.; Dockens, Randy C.; Meredith, Jere E., Jr.; Olson, Richard E.; Slemmon, Randy; Lentz, Kimberley A.; Wang, Jun-Sheng; Denton, R. Rex; Pilcher, Gary; Rhyne, Paul W.; Raybon, Joseph J.; Barten, Donna M.; Burton, Catherine; Toyn, Jeremy H.; Sankaranarayanan, Sethu; Polson, Craig; Guss, Valerie; White, Randy; Simutis, Frank; Sanderson, Thomas; Gillman, Kevin W.; Starrett, John E., Jr.; Bronson, Joanne; Sverdlov, Oleksandr; Huang, Shu-Pang; Castaneda, Loma; Feldman, Howard; Coric, Vlad; Zaczek, Robert; Macor, John E.; Houston, John; Berman, Robert M.; Tong, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">686-695</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A hallmark of Alzheimer's disease (AD) pathol. is the accumulation of brain amyloid β-peptide (Aβ), generated by γ-secretase-mediated cleavage of the amyloid precursor protein (APP).  Therefore, γ-secretase inhibitors (GSIs) may lower brain Aβ and offer a potential new approach to treat AD.  As γ-secretase also cleaves Notch proteins, GSIs can have undesirable effects due to interference with Notch signaling.  Avagacestat (BMS-708163) is a GSI developed for selective inhibition of APP over Notch cleavage.  Avagacestat inhibition of APP and Notch cleavage was evaluated in cell culture by measuring levels of Aβ and human Notch proteins.  In rats, dogs, and humans, selectivity was evaluated by measuring plasma blood concns. in relation to effects on cerebrospinal fluid (CSF) Aβ levels and Notch-related toxicities.  Measurements of Notch-related toxicity included goblet cell metaplasia in the gut, marginal-zone depletion in the spleen, redns. in B cells, and changes in expression of the Notch-regulated hairy and enhancer of split homolog-1 from blood cells.  In rats and dogs, acute administration of avagacestat robustly reduced CSF Aβ40 and Aβ42 levels similarly.  Chronic administration in rats and dogs, and 28-day, single- and multiple-ascending-dose administration in healthy human subjects caused similar exposure-dependent redns. in CSF Aβ40.  Consistent with the 137-fold selectivity measured in cell culture, we identified doses of avagacestat that reduce CSF Aβ levels without causing Notch-related toxicities.  Our results demonstrate the selectivity of avagacestat for APP over Notch cleavage, supporting further evaluation of avagacestat for AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5fAxZamNybbVg90H21EOLACvtfcHk0lipiFTQpfcVgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVaisr8%253D&md5=91241c812b36909ea783288520bc6af5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.199356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.199356%26sid%3Dliteratum%253Aachs%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DDockens%26aufirst%3DR.%2BC.%26aulast%3DMeredith%26aufirst%3DJ.%2BE.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26aulast%3DSlemmon%26aufirst%3DR.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DJ.-S.%26aulast%3DDenton%26aufirst%3DR.%2BX.%26aulast%3DPilcher%26aufirst%3DG.%26aulast%3DRhyne%26aufirst%3DP.%2BW.%26aulast%3DRaybon%26aufirst%3DJ.%2BJ.%26aulast%3DBarten%26aufirst%3DD.%2BM.%26aulast%3DBurton%26aufirst%3DC.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DSankaranarayanan%26aufirst%3DS.%26aulast%3DPolson%26aufirst%3DC.%26aulast%3DGuss%26aufirst%3DV.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DSimutis%26aufirst%3DF.%26aulast%3DSanderson%26aufirst%3DT.%26aulast%3DGillman%26aufirst%3DK.%2BW.%26aulast%3DStarrett%26aufirst%3DJ.%2BE.%26aulast%3DBronson%26aufirst%3DJ.%26aulast%3DSverdlov%26aufirst%3DO.%26aulast%3DHuang%26aufirst%3DS.-P.%26aulast%3DCastaneda%26aufirst%3DL.%26aulast%3DFeldman%26aufirst%3DH.%26aulast%3DCoric%26aufirst%3DV.%26aulast%3DZaczek%26aufirst%3DR.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DHouston%26aufirst%3DJ.%26aulast%3DBerman%26aufirst%3DR.%2BM.%26aulast%3DTong%26aufirst%3DG.%26atitle%3DPharmacodynamics%2520of%2520selective%2520inhibition%2520of%2520%25CE%25B3-secretase%2520by%2520avagacestat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D344%26spage%3D686%26epage%3D695%26doi%3D10.1124%2Fjpet.112.199356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Niva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Schaick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundkvist, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, S. A. G.</span><span> </span><span class="NLM_article-title">Has inhibition of Aβ production adequately been tested as therapeutic approach in mild AD? A model-based meta-analysis of γ-secretase inhibitor data</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1247</span><span class="NLM_x">–</span> <span class="NLM_lpage">1260</span><span class="refDoi"> DOI: 10.1007/s00228-012-1459-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1007%2Fs00228-012-1459-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1247-1260&author=C.+Nivaauthor=J.+Parkinsonauthor=F.+Olssonauthor=E.+van+Schaickauthor=J.+Lundkvistauthor=S.+A.+G.+Visser&title=Has+inhibition+of+A%CE%B2+production+adequately+been+tested+as+therapeutic+approach+in+mild+AD%3F+A+model-based+meta-analysis+of+%CE%B3-secretase+inhibitor+data&doi=10.1007%2Fs00228-012-1459-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2Fs00228-012-1459-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00228-012-1459-3%26sid%3Dliteratum%253Aachs%26aulast%3DNiva%26aufirst%3DC.%26aulast%3DParkinson%26aufirst%3DJ.%26aulast%3DOlsson%26aufirst%3DF.%26aulast%3Dvan%2BSchaick%26aufirst%3DE.%26aulast%3DLundkvist%26aufirst%3DJ.%26aulast%3DVisser%26aufirst%3DS.%2BA.%2BG.%26atitle%3DHas%2520inhibition%2520of%2520A%25CE%25B2%2520production%2520adequately%2520been%2520tested%2520as%2520therapeutic%2520approach%2520in%2520mild%2520AD%253F%2520A%2520model-based%2520meta-analysis%2520of%2520%25CE%25B3-secretase%2520inhibitor%2520data%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2013%26volume%3D69%26spage%3D1247%26epage%3D1260%26doi%3D10.1007%2Fs00228-012-1459-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Best, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Donnell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkie, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosahl, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laroque, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boussiquet-Leroux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churcher, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atack, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M. S.</span><span> </span><span class="NLM_article-title">The novel γ secretase inhibitor N-[cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide (MRK-560) reduces amyloid plaque deposition without evidence of Notch-related pathology in the Tg2576 mouse</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">552</span><span class="NLM_x">–</span> <span class="NLM_lpage">558</span><span class="refDoi"> DOI: 10.1124/jpet.106.114330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1124%2Fjpet.106.114330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=17099072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhs1Wktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=552-558&author=J.+D.+Bestauthor=D.+W.+Smithauthor=M.+A.+Reillyauthor=R.+O%27Donnellauthor=H.+D.+Lewisauthor=S.+Ellisauthor=N.+Wilkieauthor=T.+W.+Rosahlauthor=P.+A.+Laroqueauthor=C.+Boussiquet-Lerouxauthor=I.+Churcherauthor=J.+R.+Atackauthor=T.+Harrisonauthor=M.+S.+Shearman&title=The+novel+%CE%B3+secretase+inhibitor+N-%5Bcis-4-%5B%284-chlorophenyl%29sulfonyl%5D-4-%282%2C5-difluorophenyl%29cyclohexyl%5D-1%2C1%2C1-trifluoromethanesulfonamide+%28MRK-560%29+reduces+amyloid+plaque+deposition+without+evidence+of+Notch-related+pathology+in+the+Tg2576+mouse&doi=10.1124%2Fjpet.106.114330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The novel γ secretase inhibitor N-[cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]- 1,1,1-trifluoromethanesulfonamide (MRK-560) reduces amyloid plaque deposition without evidence of notch-related pathology in the Tg2576 mouse</span></div><div class="casAuthors">Best, Jonathan D.; Smith, David W.; Reilly, Michael A.; O'Donnell, Ruth; Lewis, Huw D.; Ellis, Semantha; Wilkie, Neil; Rosahl, Thomas W.; Laroque, Philippe A.; Boussiquet-Leroux, Christine; Churcher, Ian; Atack, John R.; Harrison, Timothy; Shearman, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">552-558</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">There is a substantial body of evidence indicating that β-amyloid peptides (Aβ) are crit. factors in the onset and development of Alzheimer's disease (AD).  One strategy for combating AD is to reduce or eliminate the prodn. of Aβ through inhibition of the γ-secretase enzyme, which cleaves Aβ from the amyloid precursor protein (APP).  We demonstrate here that chronic treatment for 3 mo with 3 mg/kg of the potent, orally bioavailable and brain-penetrant γ-secretase inhibitor N-[cis-4-[(4-chlorophenyl)-sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]- 1,1,1-trifluoromethanesulfonamide (MRK-560) attenuates the appearance of amyloid plaques in the Tg2576 mouse.  These redns. in plaques were also accompanied by a decrease in the level of reactive gliosis.  The morphometric and histol. measures agreed with biochem. anal. of Aβ(40) and Aβ(42) in the cortex.  Interestingly, the vol. of the plaques across treatment groups did not change, indicating that reducing Aβ levels does not significantly alter deposit growth once initiated.  Furthermore, we demonstrate that these beneficial effects can be achieved without causing histopathol. changes in the ileum, spleen, or thymus as a consequence of blockade of the processing of alternative substrates, such as the Notch family of receptors.  This indicates that in vivo a therapeutic window between these substrates seems possible-a key concern in the development of this approach to AD.  An understanding of the mechanisms whereby MRK-560 shows differentiation between the APP and Notch proteolytic pathway of γ-secretase should provide the basis for the next generation of γ-secretase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH9vXalcQ5HbVg90H21EOLACvtfcHk0lipiFTQpfcVgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhs1Wktbc%253D&md5=22c7762b019fede18826bd47cb901705</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.114330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.114330%26sid%3Dliteratum%253Aachs%26aulast%3DBest%26aufirst%3DJ.%2BD.%26aulast%3DSmith%26aufirst%3DD.%2BW.%26aulast%3DReilly%26aufirst%3DM.%2BA.%26aulast%3DO%2527Donnell%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DH.%2BD.%26aulast%3DEllis%26aufirst%3DS.%26aulast%3DWilkie%26aufirst%3DN.%26aulast%3DRosahl%26aufirst%3DT.%2BW.%26aulast%3DLaroque%26aufirst%3DP.%2BA.%26aulast%3DBoussiquet-Leroux%26aufirst%3DC.%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DAtack%26aufirst%3DJ.%2BR.%26aulast%3DHarrison%26aufirst%3DT.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26atitle%3DThe%2520novel%2520%25CE%25B3%2520secretase%2520inhibitor%2520N-%255Bcis-4-%255B%25284-chlorophenyl%2529sulfonyl%255D-4-%25282%252C5-difluorophenyl%2529cyclohexyl%255D-1%252C1%252C1-trifluoromethanesulfonamide%2520%2528MRK-560%2529%2520reduces%2520amyloid%2520plaque%2520deposition%2520without%2520evidence%2520of%2520Notch-related%2520pathology%2520in%2520the%2520Tg2576%2520mouse%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D552%26epage%3D558%26doi%3D10.1124%2Fjpet.106.114330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josien, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asberom, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasikumar, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">Identification of presenilin 1-selective γ-secretase inhibitors with reconstituted γ-secretase complexes</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4973</span><span class="NLM_x">–</span> <span class="NLM_lpage">4980</span><span class="refDoi"> DOI: 10.1021/bi200026m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi200026m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=4973-4980&author=J.+Leeauthor=L.+Songauthor=G.+Terracinaauthor=T.+Baraauthor=H.+Josienauthor=T.+Asberomauthor=T.+K.+Sasikumarauthor=D.+A.+Burnettauthor=J.+Claderauthor=E.+M.+Parkerauthor=L.+Zhang&title=Identification+of+presenilin+1-selective+%CE%B3-secretase+inhibitors+with+reconstituted+%CE%B3-secretase+complexes&doi=10.1021%2Fbi200026m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fbi200026m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi200026m%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DAsberom%26aufirst%3DT.%26aulast%3DSasikumar%26aufirst%3DT.%2BK.%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DIdentification%2520of%2520presenilin%25201-selective%2520%25CE%25B3-secretase%2520inhibitors%2520with%2520reconstituted%2520%25CE%25B3-secretase%2520complexes%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D4973%26epage%3D4980%26doi%3D10.1021%2Fbi200026m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Xu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asberom, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domalski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josien, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBriar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhail, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pissarnitski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasikumar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span> </span><span class="NLM_article-title">Design and synthesis of tricyclic sulfones as γ-secretase inhibitors with greatly reduced Notch toxicity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2591</span><span class="NLM_x">–</span> <span class="NLM_lpage">2596</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.02.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1016%2Fj.bmcl.2010.02.080" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2591-2596&author=R.+Xuauthor=D.+Coleauthor=T.+Asberomauthor=T.+Baraauthor=C.+Bennettauthor=D.+A.+Burnettauthor=J.+Claderauthor=M.+Domalskiauthor=W.+Greenleeauthor=L.+Hydeauthor=H.+Josienauthor=H.+Liauthor=M.+McBriarauthor=B.+McKittrickauthor=A.+T.+McPhailauthor=D.+Pissarnitskiauthor=L.+Qiangauthor=M.+Rajagopalanauthor=T.+Sasikumarauthor=J.+Suauthor=H.+Tangauthor=W.-L.+Wuauthor=L.+Zhangauthor=Z.+Zhao&title=Design+and+synthesis+of+tricyclic+sulfones+as+%CE%B3-secretase+inhibitors+with+greatly+reduced+Notch+toxicity&doi=10.1016%2Fj.bmcl.2010.02.080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.02.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.02.080%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DR.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DAsberom%26aufirst%3DT.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DBennett%26aufirst%3DC.%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DDomalski%26aufirst%3DM.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMcBriar%26aufirst%3DM.%26aulast%3DMcKittrick%26aufirst%3DB.%26aulast%3DMcPhail%26aufirst%3DA.%2BT.%26aulast%3DPissarnitski%26aufirst%3DD.%26aulast%3DQiang%26aufirst%3DL.%26aulast%3DRajagopalan%26aufirst%3DM.%26aulast%3DSasikumar%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DW.-L.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DZ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520tricyclic%2520sulfones%2520as%2520%25CE%25B3-secretase%2520inhibitors%2520with%2520greatly%2520reduced%2520Notch%2520toxicity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2591%26epage%3D2596%26doi%3D10.1016%2Fj.bmcl.2010.02.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Sasikumar, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span> </span><span class="NLM_article-title">Tricyclic sulfones as orally active γ-secretase inhibitors: synthesis and structure-activity relationship studies</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3632</span><span class="NLM_x">–</span> <span class="NLM_lpage">3635</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.04.104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1016%2Fj.bmcl.2010.04.104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3632-3635&author=T.+K.+Sasikumarauthor=L.+Qiangauthor=D.+A.+Burnettauthor=D.+Coleauthor=R.+Xuauthor=H.+Liauthor=W.+J.+Greenleeauthor=J.+Claderauthor=L.+Zhangauthor=L.+Hyde&title=Tricyclic+sulfones+as+orally+active+%CE%B3-secretase+inhibitors%3A+synthesis+and+structure-activity+relationship+studies&doi=10.1016%2Fj.bmcl.2010.04.104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.04.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.04.104%26sid%3Dliteratum%253Aachs%26aulast%3DSasikumar%26aufirst%3DT.%2BK.%26aulast%3DQiang%26aufirst%3DL.%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHyde%26aufirst%3DL.%26atitle%3DTricyclic%2520sulfones%2520as%2520orally%2520active%2520%25CE%25B3-secretase%2520inhibitors%253A%2520synthesis%2520and%2520structure-activity%2520relationship%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3632%26epage%3D3635%26doi%3D10.1016%2Fj.bmcl.2010.04.104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Pissarnitski, D.; Zhao, Z.</span><span> </span><span class="NLM_article-title">Spirocyclic sulfones as gamma secretase inhibitors</span>. PCT Int. Appl. WO 2014085211 A2 20140605,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+Pissarnitski&author=Z.+Zhao&title=Spirocyclic+sulfones+as+gamma+secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPissarnitski%26aufirst%3DD.%26atitle%3DSpirocyclic%2520sulfones%2520as%2520gamma%2520secretase%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Kabalka, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gooch, E. E.,  III.</span><span> </span><span class="NLM_article-title">A mild and convenient procedure for conversion of alkenes into alkyl iodides via reaction of iodine monochloride with organoboranes</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3578</span><span class="NLM_x">–</span> <span class="NLM_lpage">3580</span><span class="refDoi"> DOI: 10.1021/jo01306a007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01306a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1980&pages=3578-3580&author=G.+W.+Kabalkaauthor=E.+E.+Gooch&title=A+mild+and+convenient+procedure+for+conversion+of+alkenes+into+alkyl+iodides+via+reaction+of+iodine+monochloride+with+organoboranes&doi=10.1021%2Fjo01306a007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjo01306a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01306a007%26sid%3Dliteratum%253Aachs%26aulast%3DKabalka%26aufirst%3DG.%2BW.%26aulast%3DGooch%26aufirst%3DE.%2BE.%26atitle%3DA%2520mild%2520and%2520convenient%2520procedure%2520for%2520conversion%2520of%2520alkenes%2520into%2520alkyl%2520iodides%2520via%2520reaction%2520of%2520iodine%2520monochloride%2520with%2520organoboranes%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1980%26volume%3D45%26spage%3D3578%26epage%3D3580%26doi%3D10.1021%2Fjo01306a007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Teall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhard, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, N. N.</span><span> </span><span class="NLM_article-title">Aryl sulfones: a new class of γ-secretase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2685</span><span class="NLM_x">–</span> <span class="NLM_lpage">2688</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2004.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1016%2Fj.bmcl.2004.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=15863342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslyqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2685-2688&author=M.+Teallauthor=P.+Oakleyauthor=T.+Harrisonauthor=D.+Shawauthor=E.+Kayauthor=J.+Elliottauthor=U.+Gerhardauthor=J.+L.+Castroauthor=M.+Shearmanauthor=R.+G.+Ballauthor=N.+N.+Tsou&title=Aryl+sulfones%3A+a+new+class+of+%CE%B3-secretase+inhibitors&doi=10.1016%2Fj.bmcl.2004.12.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Aryl sulfones: a new class of γ-secretase inhibitors</span></div><div class="casAuthors">Teall, Martin; Oakley, Paul; Harrison, Timothy; Shaw, Duncan; Kay, Euan; Elliott, Jason; Gerhard, Ute; Castro, Jose L.; Shearman, Mark; Ball, Richard G.; Tsou, Nancy N.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2685-2688</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The development of a novel series of 4-aryl, 4-phenylsulfonyl cyclohexananone-derived γ-secretase inhibitors for the potential treatment of Alzheimer's disease is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomTv1qLIbi97Vg90H21EOLACvtfcHk0ljTmKKscbTjRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslyqs7w%253D&md5=bf29cf1204c347cc983b51e6b1883a7d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DTeall%26aufirst%3DM.%26aulast%3DOakley%26aufirst%3DP.%26aulast%3DHarrison%26aufirst%3DT.%26aulast%3DShaw%26aufirst%3DD.%26aulast%3DKay%26aufirst%3DE.%26aulast%3DElliott%26aufirst%3DJ.%26aulast%3DGerhard%26aufirst%3DU.%26aulast%3DCastro%26aufirst%3DJ.%2BL.%26aulast%3DShearman%26aufirst%3DM.%26aulast%3DBall%26aufirst%3DR.%2BG.%26aulast%3DTsou%26aufirst%3DN.%2BN.%26atitle%3DAryl%2520sulfones%253A%2520a%2520new%2520class%2520of%2520%25CE%25B3-secretase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2685%26epage%3D2688%26doi%3D10.1016%2Fj.bmcl.2004.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Churcher, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Best, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitzel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerrad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morentin-Gutierrez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortishire-Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakley, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teall, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrigley, J. D. J.</span><span> </span><span class="NLM_article-title">4-Substituted cyclohexyl sulfones as potent, orally active γ-secretase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">280</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2005.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1016%2Fj.bmcl.2005.10.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=280-284&author=I.+Churcherauthor=D.+Beherauthor=J.+D.+Bestauthor=J.+L.+Castroauthor=E.+E.+Clarkeauthor=A.+Gentryauthor=T.+Harrisonauthor=L.+Hitzelauthor=E.+Kayauthor=S.+Kerradauthor=H.+D.+Lewisauthor=P.+Morentin-Gutierrezauthor=R.+Mortishire-Smithauthor=P.+J.+Oakleyauthor=M.+Reillyauthor=D.+E.+Shawauthor=M.+S.+Shearmanauthor=M.+R.+Teallauthor=S.+Williamsauthor=J.+D.+J.+Wrigley&title=4-Substituted+cyclohexyl+sulfones+as+potent%2C+orally+active+%CE%B3-secretase+inhibitors&doi=10.1016%2Fj.bmcl.2005.10.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DBeher%26aufirst%3DD.%26aulast%3DBest%26aufirst%3DJ.%2BD.%26aulast%3DCastro%26aufirst%3DJ.%2BL.%26aulast%3DClarke%26aufirst%3DE.%2BE.%26aulast%3DGentry%26aufirst%3DA.%26aulast%3DHarrison%26aufirst%3DT.%26aulast%3DHitzel%26aufirst%3DL.%26aulast%3DKay%26aufirst%3DE.%26aulast%3DKerrad%26aufirst%3DS.%26aulast%3DLewis%26aufirst%3DH.%2BD.%26aulast%3DMorentin-Gutierrez%26aufirst%3DP.%26aulast%3DMortishire-Smith%26aufirst%3DR.%26aulast%3DOakley%26aufirst%3DP.%2BJ.%26aulast%3DReilly%26aufirst%3DM.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26aulast%3DTeall%26aufirst%3DM.%2BR.%26aulast%3DWilliams%26aufirst%3DS.%26aulast%3DWrigley%26aufirst%3DJ.%2BD.%2BJ.%26atitle%3D4-Substituted%2520cyclohexyl%2520sulfones%2520as%2520potent%252C%2520orally%2520active%2520%25CE%25B3-secretase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D280%26epage%3D284%26doi%3D10.1016%2Fj.bmcl.2005.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Jelley, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrigley, J. D. J.</span><span> </span><span class="NLM_article-title">3-Substituted gem-cyclohexane sulfone based γ-secretase inhibitors for Alzheimer’s disease: Conformational analysis and biological activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3839</span><span class="NLM_x">–</span> <span class="NLM_lpage">3842</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.04.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1016%2Fj.bmcl.2006.04.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3839-3842&author=R.+A.+Jelleyauthor=J.+Elliottauthor=K.+R.+Gibsonauthor=T.+Harrisonauthor=D.+Beherauthor=E.+E.+Clarkeauthor=H.+D.+Lewisauthor=M.+Shearmanauthor=J.+D.+J.+Wrigley&title=3-Substituted+gem-cyclohexane+sulfone+based+%CE%B3-secretase+inhibitors+for+Alzheimer%E2%80%99s+disease%3A+Conformational+analysis+and+biological+activity&doi=10.1016%2Fj.bmcl.2006.04.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DJelley%26aufirst%3DR.%2BA.%26aulast%3DElliott%26aufirst%3DJ.%26aulast%3DGibson%26aufirst%3DK.%2BR.%26aulast%3DHarrison%26aufirst%3DT.%26aulast%3DBeher%26aufirst%3DD.%26aulast%3DClarke%26aufirst%3DE.%2BE.%26aulast%3DLewis%26aufirst%3DH.%2BD.%26aulast%3DShearman%26aufirst%3DM.%26aulast%3DWrigley%26aufirst%3DJ.%2BD.%2BJ.%26atitle%3D3-Substituted%2520gem-cyclohexane%2520sulfone%2520based%2520%25CE%25B3-secretase%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Conformational%2520analysis%2520and%2520biological%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3839%26epage%3D3842%26doi%3D10.1016%2Fj.bmcl.2006.04.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span> </span><span class="NLM_article-title">Characterization of the reconstituted γ-secretase complex from Sf9 cells co-expressing presenilin 1, nicastrin, aph-1a, and pen-2</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4450</span><span class="NLM_x">–</span> <span class="NLM_lpage">4457</span><span class="refDoi"> DOI: 10.1021/bi0481500</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0481500" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=4450-4457&author=L.+Zhangauthor=J.+Leeauthor=L.+Songauthor=X.+Sunauthor=J.+Shenauthor=G.+Terracinaauthor=E.+M.+Parker&title=Characterization+of+the+reconstituted+%CE%B3-secretase+complex+from+Sf9+cells+co-expressing+presenilin+1%2C+nicastrin%2C+aph-1a%2C+and+pen-2&doi=10.1021%2Fbi0481500"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fbi0481500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0481500%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DParker%26aufirst%3DE.%2BM.%26atitle%3DCharacterization%2520of%2520the%2520reconstituted%2520%25CE%25B3-secretase%2520complex%2520from%2520Sf9%2520cells%2520co-expressing%2520presenilin%25201%252C%2520nicastrin%252C%2520aph-1a%252C%2520and%2520pen-2%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D4450%26epage%3D4457%26doi%3D10.1021%2Fbi0481500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ángel Santiago, Dulce C. Guzmán-Ocampo, Rodrigo Aguayo-Ortiz, <span class="NLM_string-name hlFld-ContribAuthor">Laura Dominguez</span>. </span><span class="cited-content_cbyCitation_article-title">Characterizing the Chemical Space of γ-Secretase Inhibitors and Modulators. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (15)
                                     , 2765-2775. <a href="https://doi.org/10.1021/acschemneuro.1c00313" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00313%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DCharacterizing%252Bthe%252BChemical%252BSpace%252Bof%252B%2525CE%2525B3-Secretase%252BInhibitors%252Band%252BModulators%26aulast%3DSantiago%26aufirst%3D%25C3%2581ngel%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D21052021%26date%3D09072021%26date%3D22072021%26volume%3D12%26issue%3D15%26spage%3D2765%26epage%3D2775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yuxin Gong, Zhaodong Zhu, Qun Qian, Weiqi Tong, <span class="NLM_string-name hlFld-ContribAuthor">Hegui Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Zn- and Cu-Catalyzed Coupling of Tertiary Alkyl Bromides and Oxalates to Forge Challenging C–O, C–S, and C–N Bonds. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (3)
                                     , 1005-1010. <a href="https://doi.org/10.1021/acs.orglett.0c04206" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c04206</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c04206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c04206%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DZn-%252Band%252BCu-Catalyzed%252BCoupling%252Bof%252BTertiary%252BAlkyl%252BBromides%252Band%252BOxalates%252Bto%252BForge%252BChallenging%252BC%2525E2%252580%252593O%25252C%252BC%2525E2%252580%252593S%25252C%252Band%252BC%2525E2%252580%252593N%252BBonds%26aulast%3DGong%26aufirst%3DYuxin%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D20122020%26date%3D14012021%26volume%3D23%26issue%3D3%26spage%3D1005%26epage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kerstin Hiesinger, Dmitry Dar’in, Ewgenij Proschak, <span class="NLM_string-name hlFld-ContribAuthor">Mikhail Krasavin</span>. </span><span class="cited-content_cbyCitation_article-title">Spirocyclic Scaffolds in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 150-183. <a href="https://doi.org/10.1021/acs.jmedchem.0c01473" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01473</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01473%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSpirocyclic%252BScaffolds%252Bin%252BMedicinal%252BChemistry%26aulast%3DHiesinger%26aufirst%3DKerstin%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D24082020%26date%3D31122020%26volume%3D64%26issue%3D1%26spage%3D150%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mihirbaran Mandal, Alexei Buevich, John P. Caldwell, Lynn Hyde, Xianhai Huang, Xiaoxiang Liu, Brian McKittrick, Robert D. Mazzola, Dmitri Pissarnitski, Anandan Palani, Lili Zhang, Eric Parker, Li Xiao, Diane Rindgen, <span class="NLM_string-name hlFld-ContribAuthor">Zhaoning Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Generation of Leads for γ-Secretase Modulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 8216-8230. <a href="https://doi.org/10.1021/acs.jmedchem.0c00446" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00446</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00446%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGeneration%252Bof%252BLeads%252Bfor%252B%2525CE%2525B3-Secretase%252BModulation%26aulast%3DMandal%26aufirst%3DMihirbaran%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16032020%26date%3D04082020%26date%3D27072020%26volume%3D63%26issue%3D15%26spage%3D8216%26epage%3D8230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-Jing  Guo</span>, <span class="hlFld-ContribAuthor ">Shuai  Lu</span>, <span class="hlFld-ContribAuthor ">Lu-Lu  Tian</span>, <span class="hlFld-ContribAuthor ">En-Ling  Huang</span>, <span class="hlFld-ContribAuthor ">Xin-Qi  Hao</span>, <span class="hlFld-ContribAuthor ">Xinju  Zhu</span>, <span class="hlFld-ContribAuthor ">Tian  Shao</span>, and <span class="hlFld-ContribAuthor ">Mao-Ping  Song</span>  . </span><span class="cited-content_cbyCitation_article-title">Iodine-Mediated Difunctionalization of Imidazopyridines with Sodium Sulfinates: Synthesis of Sulfones and Sulfides. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (1)
                                     , 338-349. <a href="https://doi.org/10.1021/acs.joc.7b02734" title="DOI URL">https://doi.org/10.1021/acs.joc.7b02734</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b02734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b02734%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DIodine-Mediated%252BDifunctionalization%252Bof%252BImidazopyridines%252Bwith%252BSodium%252BSulfinates%25253A%252BSynthesis%252Bof%252BSulfones%252Band%252BSulfides%26aulast%3DGuo%26aufirst%3DYu-Jing%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D28102017%26date%3D27122017%26date%3D05012018%26date%3D16122017%26volume%3D83%26issue%3D1%26spage%3D338%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Helmut M.  Hügel</span>, <span class="hlFld-ContribAuthor ">Nilamuni H.  de Silva</span>, <span class="hlFld-ContribAuthor ">Aimen  Siddiqui</span>, <span class="hlFld-ContribAuthor ">Ewan  Blanch</span>, <span class="hlFld-ContribAuthor ">Anthony  Lingham</span>. </span><span class="cited-content_cbyCitation_article-title">Natural spirocyclic alkaloids and polyphenols as multi target dementia leads. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>43 </em>, 116270. <a href="https://doi.org/10.1016/j.bmc.2021.116270" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116270%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNatural%252Bspirocyclic%252Balkaloids%252Band%252Bpolyphenols%252Bas%252Bmulti%252Btarget%252Bdementia%252Bleads%26aulast%3DH%25C3%25BCgel%26aufirst%3DHelmut%2BM.%26date%3D2021%26volume%3D43%26spage%3D116270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huan  Sun</span>, <span class="hlFld-ContribAuthor ">Yue  Jiang</span>, <span class="hlFld-ContribAuthor ">Ying-Sha  Yang</span>, <span class="hlFld-ContribAuthor ">Yun-Yun  Li</span>, <span class="hlFld-ContribAuthor ">Lin  Li</span>, <span class="hlFld-ContribAuthor ">Wen-Xuan  Wang</span>, <span class="hlFld-ContribAuthor ">Tao  Feng</span>, <span class="hlFld-ContribAuthor ">Zheng-Hui  Li</span>, <span class="hlFld-ContribAuthor ">Ji-Kai  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of difluoromethylated 2-oxindoles and quinoline-2,4-diones
              via
              visible light-induced tandem radical cyclization of
              N
              -arylacrylamides. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (27)
                                     , 6629-6638. <a href="https://doi.org/10.1039/C9OB01213C" title="DOI URL">https://doi.org/10.1039/C9OB01213C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01213C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01213C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bdifluoromethylated%252B2-oxindoles%252Band%252Bquinoline-2%25252C4-diones%252Bvia%252Bvisible%252Blight-induced%252Btandem%252Bradical%252Bcyclization%252Bof%252BN%252B-arylacrylamides%26aulast%3DSun%26aufirst%3DHuan%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D27%26spage%3D6629%26epage%3D6638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Gu</span>, <span class="hlFld-ContribAuthor ">Qi  Li</span>, <span class="hlFld-ContribAuthor ">Hongzhi  Lin</span>, <span class="hlFld-ContribAuthor ">Jie  Zhu</span>, <span class="hlFld-ContribAuthor ">Jun  Mo</span>, <span class="hlFld-ContribAuthor ">Siyu  He</span>, <span class="hlFld-ContribAuthor ">Xin  Lu</span>, <span class="hlFld-ContribAuthor ">Xueyang  Jiang</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Gamma secretase inhibitors: a patent review (2013 - 2015). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (7)
                                     , 851-866. <a href="https://doi.org/10.1080/13543776.2017.1313231" title="DOI URL">https://doi.org/10.1080/13543776.2017.1313231</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1313231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1313231%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DGamma%252Bsecretase%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282013%252B-%252B2015%252529%26aulast%3DGu%26aufirst%3DKai%26date%3D2017%26date%3D2017%26volume%3D27%26issue%3D7%26spage%3D851%26epage%3D866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.M.  Tice</span>, <span class="hlFld-ContribAuthor ">Y.  Zheng</span>, <span class="hlFld-ContribAuthor ">S.B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Spirocyclic Scaffolds in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 211-263. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12291-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12291-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12291-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12291-7%26sid%3Dliteratum%253Aachs%26atitle%3DSpirocyclic%252BScaffolds%252Bin%252BDrug%252BDiscovery%26aulast%3DTice%26aufirst%3DC.M.%26date%3D2017%26spage%3D211%26epage%3D263%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiqiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Dmitri A.  Pissarnitski</span>, <span class="hlFld-ContribAuthor ">Hubert B.  Josien</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Bara</span>, <span class="hlFld-ContribAuthor ">John W.  Clader</span>, <span class="hlFld-ContribAuthor ">Hongmei  Li</span>, <span class="hlFld-ContribAuthor ">Mark D.  McBriar</span>, <span class="hlFld-ContribAuthor ">Murali  Rajagopalan</span>, <span class="hlFld-ContribAuthor ">Ruo  Xu</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Terracina</span>, <span class="hlFld-ContribAuthor ">Lynn  Hyde</span>, <span class="hlFld-ContribAuthor ">Lixin  Song</span>, <span class="hlFld-ContribAuthor ">Lili  Zhang</span>, <span class="hlFld-ContribAuthor ">Eric M.  Parker</span>, <span class="hlFld-ContribAuthor ">Rebecca  Osterman</span>, <span class="hlFld-ContribAuthor ">Alexei V.  Buevich</span>. </span><span class="cited-content_cbyCitation_article-title">Substituted 4-morpholine N -arylsulfonamides as γ-secretase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>124 </em>, 36-48. <a href="https://doi.org/10.1016/j.ejmech.2016.08.024" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.08.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.08.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.08.024%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSubstituted%252B4-morpholine%252BN%252B-arylsulfonamides%252Bas%252B%2525CE%2525B3-secretase%252Binhibitors%26aulast%3DZhao%26aufirst%3DZhiqiang%26date%3D2016%26volume%3D124%26spage%3D36%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming-Zhong  Zhang</span>, <span class="hlFld-ContribAuthor ">Peng-Yi  Ji</span>, <span class="hlFld-ContribAuthor ">Yu-Feng  Liu</span>, <span class="hlFld-ContribAuthor ">Jing-Wen  Xu</span>, <span class="hlFld-ContribAuthor ">Can-Cheng  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Disulfides as Sulfonylating Precursors for the Synthesis of Sulfone-Containing Oxindoles. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2016,</strong> <em>358 </em>
                                    (18)
                                     , 2976-2983. <a href="https://doi.org/10.1002/adsc.201600200" title="DOI URL">https://doi.org/10.1002/adsc.201600200</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201600200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201600200%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DDisulfides%252Bas%252BSulfonylating%252BPrecursors%252Bfor%252Bthe%252BSynthesis%252Bof%252BSulfone-Containing%252BOxindoles%26aulast%3DZhang%26aufirst%3DMing-Zhong%26date%3D2016%26date%3D2016%26volume%3D358%26issue%3D18%26spage%3D2976%26epage%3D2983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexios N.  Matralis</span>, <span class="hlFld-ContribAuthor ">Youla S.  Tsantrizos</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Benzothiophene-Containing 10- and 11-Membered Cyclic Phostones. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>2016 </em>
                                    (22)
                                     , 3728-3736. <a href="https://doi.org/10.1002/ejoc.201600333" title="DOI URL">https://doi.org/10.1002/ejoc.201600333</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201600333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201600333%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BBenzothiophene-Containing%252B10-%252Band%252B11-Membered%252BCyclic%252BPhostones%26aulast%3DMatralis%26aufirst%3DAlexios%2BN.%26date%3D2016%26date%3D2016%26volume%3D2016%26issue%3D22%26spage%3D3728%26epage%3D3736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taylor M.  Lord</span>, <span class="hlFld-ContribAuthor ">Stephanie L.  Casino</span>, <span class="hlFld-ContribAuthor ">Susan E.  Hartzell</span>, <span class="hlFld-ContribAuthor ">Kevin J.  Garcia</span>, <span class="hlFld-ContribAuthor ">Robert D.  Pike</span>, <span class="hlFld-ContribAuthor ">Robert A.  Stockland</span>. </span><span class="cited-content_cbyCitation_article-title">Convenient Access to Arylated Spirocyclic Bisphosphonates. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2016,</strong> <em>1 </em>
                                    (10)
                                     , 2188-2191. <a href="https://doi.org/10.1002/slct.201600479" title="DOI URL">https://doi.org/10.1002/slct.201600479</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201600479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201600479%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DConvenient%252BAccess%252Bto%252BArylated%252BSpirocyclic%252BBisphosphonates%26aulast%3DLord%26aufirst%3DTaylor%2BM.%26date%3D2016%26date%3D2016%26volume%3D1%26issue%3D10%26spage%3D2188%26epage%3D2191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/medium/jm-2015-00774k_0009.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00774&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/medium/jm-2015-00774k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Current representative GSIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00774&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/medium/jm-2015-00774k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of spirocyclic sulfone γ-secretase inhibitors. <b>X</b> = N(H)SO<sub>2</sub>CF<sub>3</sub> and other polar groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00774&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/medium/jm-2015-00774k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00774&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) dimethyl allylmalonate, K<sub>2</sub>CO<sub>3</sub>/THF, RT, 84%; (b) 9-BBN, THF, 12 h, then H<sub>2</sub>O<sub>2</sub>, NaOH, 95% from <b>2</b>, 89% from <b>5</b>; (c) MsCl/Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (d) <i>t</i>-BuOK/THF, −35 °C, 39% (for <b>6</b>; two steps); (e) DIBAL/THF, 60 °C, 68%; (f) 2,2-dimethoxypropane, PPTS/CH<sub>2</sub>Cl<sub>2</sub>, RT, 100%; (g) HOAc, H<sub>2</sub>O, RT, 88%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/medium/jm-2015-00774k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00774&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions. (a) LDA/THF, −70 °C, 87%; (b) 9-BBN, then H<sub>2</sub>O<sub>2</sub>, NaOH; 87%; (c) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (d) BH<sub>3</sub> (1M/THF), then ICl, 81% (X = I); (e) <i>t</i>-BuOK/THF, −30 °C, column chromatography, crystallization, 28% from <b>9a</b> and 38% from <b>9b</b>; (f) LAH, THF, 0 °C, 88%; (g) DIBAL/CH<sub>2</sub>Cl<sub>2</sub>, −78 °C; (h) 2,6-lutidine/TBSOTf, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 47% (two steps); (i) MeOCH<sub>2</sub>PPh<sub>3</sub>Br/<i>n</i>-BuLi, THF, −40 °C, 66%; (j) Hg(OAc)<sub>2</sub>, THF/H<sub>2</sub>O, then NaBH<sub>4</sub>, 89%; (k) TBAF, THF, 99%.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/medium/jm-2015-00774k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. <sup>a</sup>,<sup>b</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00774&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label">Scheme a</span>Diol <b>7</b> (n = k = 1); Diol <b>11</b> (n = 1, k = 2), Diol <b>13</b> (n = 2, k = 2)</p><p class="last"><span class="fn-label">Scheme b</span>Reagents and conditions. (a) 1.1 equiv MsCl or TsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>; (b) NaH, DMF, 42% (<b>14a</b>), 67% (<b>14b</b>); (c) 2.2 equiv MsCl, Pyr; (d) Na<sub>2</sub>S, EtOH, pyridine, reflux, 43%; (e) OXONE, acetone, H<sub>2</sub>O, 87%; (f) 3.0 equiv TsCl, Pyridine; 88%; (g) NH<sub>2</sub>SO<sub>2</sub>CF<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 57%; (h) MeP(O)Cl<sub>2</sub>, pyridine, THF, −78 °C to RT, 44% (<b>18a</b>), 70% (<b>18b</b>).</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/medium/jm-2015-00774k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Conformational considerations for the design of γ-secretase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b00774/20151119/images/large/jm-2015-00774k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00774&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08066" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08066" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 33 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span>Alzheimer’s Disease Facts and Figures; <span class="NLM_publisher-name">Alzheimer’s Association</span>: <span class="NLM_publisher-loc">Chicago</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span><a href="http://www.alz.org/" class="extLink">http://www.alz.org/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzheimer%E2%80%99s+Disease+Facts+and+Figures%3B+Alzheimer%E2%80%99s+Association%3A+Chicago%2C+2011%3B+http%3A%2F%2Fwww.alz.org%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Disease%2520Facts%2520and%2520Figures%26pub%3DAlzheimer%25E2%2580%2599s%2520Association%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span><span class="refDoi"> DOI: 10.1126/science.1072994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+progress+and+problems+on+the+road+to+therapeutics&doi=10.1126%2Fscience.1072994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0ljiR_oAVg2EBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356%26doi%3D10.1126%2Fscience.1072994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Wolfe, M. S.</span><span> </span><span class="NLM_article-title">γ-Secretase: Structure, function, and modulation for Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.2174/156802608783334024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.2174%2F156802608783334024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=18220927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=2-8&author=M.+S.+Wolfe&title=%CE%B3-Secretase%3A+Structure%2C+function%2C+and+modulation+for+Alzheimer%E2%80%99s+disease&doi=10.2174%2F156802608783334024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase: Structure, function, and modulation for Alzheimer's disease</span></div><div class="casAuthors">Wolfe, Michael S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-8</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  γ-Secretase proteolyzes a variety of membrane-assocd. fragments derived from type I integral membrane proteins, including the amyloid β-protein precursor (APP), involved in Alzheimer's disease, and the Notch receptor, crit. for cellular differentiation.  This protease is composed of 4 integral membrane proteins: presenilin, nicastrin, Aph-1, and Pen-2.  The assembly of these 4 components leads to presenilin autoproteolysis into 2 subunits, each of which contributes 1 Asp residue to the active site of an aspartic protease.  The protease contains an initial docking site for substrate, where it binds prior to passing between the 2 presenilin subunits to the internal water-contg. active site.  The extracellular region of nicastrin also interacts with the N-terminus of the substrate as an essential step in substrate recognition and processing.  Modulation of APP processing without interfering with Notch signaling is an important therapeutic goal, and allosteric sites on the protease allow such selective modulation.  A better structural and mechanistic understanding of γ-secretase should ultimately allow structure-based design of more potent and selective modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvxbwIPN0VQrVg90H21EOLACvtfcHk0ljiR_oAVg2EBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWntrg%253D&md5=c9e4244e51bcd391dc6eda2daedd8003</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F156802608783334024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608783334024%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DM.%2BS.%26atitle%3D%25CE%25B3-Secretase%253A%2520Structure%252C%2520function%252C%2520and%2520modulation%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D2%26epage%3D8%26doi%3D10.2174%2F156802608783334024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Josien, H.</span><span> </span><span class="NLM_article-title">Recent advances in the development of gamma-secretase inhibitors</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=513-525&author=H.+Josien&title=Recent+advances+in+the+development+of+gamma-secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJosien%26aufirst%3DH.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520gamma-secretase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2002%26volume%3D5%26spage%3D513%26epage%3D525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ziani-Cherif, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mostefa-Kara, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brixi-Gormat, F. Z.</span><span> </span><span class="NLM_article-title">Gamma-secretase as a pharmacological target in Alzheimer disease research: when, why and how?</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4313</span><span class="NLM_x">–</span> <span class="NLM_lpage">4335</span><span class="refDoi"> DOI: 10.2174/138161206778792994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.2174%2F138161206778792994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=17105430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1GntrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=4313-4335&author=C.+Ziani-Cherifauthor=B.+Mostefa-Karaauthor=F.+Z.+Brixi-Gormat&title=Gamma-secretase+as+a+pharmacological+target+in+Alzheimer+disease+research%3A+when%2C+why+and+how%3F&doi=10.2174%2F138161206778792994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Gamma-secretase as a pharmacological target in Alzheimer disease research: when, why and how?</span></div><div class="casAuthors">Ziani-Cherif, Chewki; Mostefa-Kara, Bachir; Brixi-Gormat, Fatima Z.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">4313-4335</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer disease (AD) is characterized by excessive deposition of amyloid β-peptides (Aβ peptides) in the form of senile plaques as well as neurofibrillary tangles (NFTs) in the brain.  In the amyloidogenic pathway, the amyloid-β precursor protein (APP) is cleaved by β-secretase first, followed by γ-secretase cleavage producing therefore Aβ.  This review summarizes the recent findings in the AD field and focuses on the different γ-secretase inhibitors that have been developed as a therapeutic approach toward AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyBZ632d85vLVg90H21EOLACvtfcHk0ljiR_oAVg2EBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1GntrbN&md5=65bcf1db2e7d131d22d3f111f491ef0f</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.2174%2F138161206778792994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206778792994%26sid%3Dliteratum%253Aachs%26aulast%3DZiani-Cherif%26aufirst%3DC.%26aulast%3DMostefa-Kara%26aufirst%3DB.%26aulast%3DBrixi-Gormat%26aufirst%3DF.%2BZ.%26atitle%3DGamma-secretase%2520as%2520a%2520pharmacological%2520target%2520in%2520Alzheimer%2520disease%2520research%253A%2520when%252C%2520why%2520and%2520how%253F%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D4313%26epage%3D4335%26doi%3D10.2174%2F138161206778792994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Evin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sernee, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span> </span><span class="NLM_article-title">Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer’s disease: prospects, limitations and strategies</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span><span class="refDoi"> DOI: 10.2165/00023210-200620050-00002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.2165%2F00023210-200620050-00002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=351-372&author=G.+Evinauthor=M.+F.+Serneeauthor=C.+L.+Masters&title=Inhibition+of+gamma-secretase+as+a+therapeutic+intervention+for+Alzheimer%E2%80%99s+disease%3A+prospects%2C+limitations+and+strategies&doi=10.2165%2F00023210-200620050-00002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.2165%2F00023210-200620050-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00023210-200620050-00002%26sid%3Dliteratum%253Aachs%26aulast%3DEvin%26aufirst%3DG.%26aulast%3DSernee%26aufirst%3DM.%2BF.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26atitle%3DInhibition%2520of%2520gamma-secretase%2520as%2520a%2520therapeutic%2520intervention%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520prospects%252C%2520limitations%2520and%2520strategies%26jtitle%3DCNS%2520Drugs%26date%3D2006%26volume%3D20%26spage%3D351%26epage%3D372%26doi%3D10.2165%2F00023210-200620050-00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Wu, W.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">γ-Secretase inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span><span class="refDoi"> DOI: 10.1002/ddr.20288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1002%2Fddr.20288" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2009&pages=94-100&author=W.-L.+Wuauthor=L.+Zhang&title=%CE%B3-Secretase+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fddr.20288"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fddr.20288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fddr.20288%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.-L.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3D%25CE%25B3-Secretase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D2009%26volume%3D70%26spage%3D94%26epage%3D100%26doi%3D10.1002%2Fddr.20288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Lleo, A.</span><span> </span><span class="NLM_article-title">Activity of γ-secretase on substrates other than APP</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span><span class="refDoi"> DOI: 10.2174/156802608783334060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.2174%2F156802608783334060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=18220928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWntrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=9-16&author=A.+Lleo&title=Activity+of+%CE%B3-secretase+on+substrates+other+than+APP&doi=10.2174%2F156802608783334060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of γ-secretase on substrates other than APP</span></div><div class="casAuthors">Lleo, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-16</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  γ-Secretase is an intramembranous protein complex that cleaves many type-I membrane proteins, including the Notch receptor and the β-amyloid precursor protein (APP).  Interest in γ-secretase comes, in part, from the fact that this multiprotein complex is responsible for the cleavage of APP that generates the amyloid-β peptide (Aβ), one of the primary components of amyloid plaques in Alzheimer's disease (AD).  Over the last years, mol. identification of the complex has shown that γ-secretase is an aspartic protease composed of 4 different members that are essential for the enzymic activity: presenilin 1, aph1, pen-2, and nicastrin.  In recent years, an increasing no. of type-I membrane proteins have been shown to be cleaved by γ-secretase.  How the enzyme cleaves such a set of substrates with diverse functions and subcellular localizations is not well understood.  In overexpression assays, the γ-secretase cleavage of some substrates releases intracellular domains with signaling properties.  On the other hand, the loose specificity required for intramembrane cleavage has raised the possibility of γ-secretase as the membrane proteasome.  The impact of γ-secretase on other substrates has clear implications for the development of new therapies for AD, and in particular for the search of γ-secretase inhibitors or modulators.  Interference with the cleavage of some of the γ-secretase substrates has been shown to be assocd. with serious adverse effects in animal models.  The understanding of the mechanism by which γ-secretase recognizes and cleaves all of these proteins is of great importance to clarify the function of γ-secretase and its role as a therapeutic target in AD, and possibly in other diseases in which γ-secretase is involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsYywVodUb-bVg90H21EOLACvtfcHk0ljZhg2KXG-gwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWntrk%253D&md5=3739586a3fb928bab945b7b74fd52fce</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F156802608783334060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608783334060%26sid%3Dliteratum%253Aachs%26aulast%3DLleo%26aufirst%3DA.%26atitle%3DActivity%2520of%2520%25CE%25B3-secretase%2520on%2520substrates%2520other%2520than%2520APP%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D9%26epage%3D16%26doi%3D10.2174%2F156802608783334060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Wong, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfra, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josien, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engstrom, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinzon-Ortiz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span> </span><span class="NLM_article-title">Chronic treatment with the γ-secretase inhibitor LY-411575 inhibits β-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">12876</span><span class="NLM_x">–</span> <span class="NLM_lpage">12882</span><span class="refDoi"> DOI: 10.1074/jbc.M311652200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1074%2Fjbc.M311652200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=12876-12882&author=G.+T.+Wongauthor=D.+Manfraauthor=F.+Pouletauthor=Q.+Zhangauthor=H.+Josienauthor=T.+Baraauthor=L.+Engstromauthor=M.+Pinzon-Ortizauthor=J.+S.+Fineauthor=H.-J.+Leeauthor=L.+Zhangauthor=G.+A.+Higginsauthor=E.+M.+Parker&title=Chronic+treatment+with+the+%CE%B3-secretase+inhibitor+LY-411575+inhibits+%CE%B2-amyloid+peptide+production+and+alters+lymphopoiesis+and+intestinal+cell+differentiation&doi=10.1074%2Fjbc.M311652200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M311652200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M311652200%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DG.%2BT.%26aulast%3DManfra%26aufirst%3DD.%26aulast%3DPoulet%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DEngstrom%26aufirst%3DL.%26aulast%3DPinzon-Ortiz%26aufirst%3DM.%26aulast%3DFine%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DH.-J.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26atitle%3DChronic%2520treatment%2520with%2520the%2520%25CE%25B3-secretase%2520inhibitor%2520LY-411575%2520inhibits%2520%25CE%25B2-amyloid%2520peptide%2520production%2520and%2520alters%2520lymphopoiesis%2520and%2520intestinal%2520cell%2520differentiation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D12876%26epage%3D12882%26doi%3D10.1074%2Fjbc.M311652200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Milano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dagenais, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster-Brown, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pognan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadient, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciaccio, P. J.</span><span> </span><span class="NLM_article-title">Modulation of Notch processing by γ-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation</span> <span class="citation_source-journal">Toxicol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span><span class="refDoi"> DOI: 10.1093/toxsci/kfh254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1093%2Ftoxsci%2Fkfh254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=15319485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVOhsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2004&pages=341-358&author=J.+Milanoauthor=J.+McKayauthor=C.+Dagenaisauthor=L.+Foster-Brownauthor=F.+Pognanauthor=R.+Gadientauthor=R.+T.+Jacobsauthor=A.+Zaccoauthor=B.+Greenbergauthor=P.+J.+Ciaccio&title=Modulation+of+Notch+processing+by+%CE%B3-secretase+inhibitors+causes+intestinal+goblet+cell+metaplasia+and+induction+of+genes+known+to+specify+gut+secretory+lineage+differentiation&doi=10.1093%2Ftoxsci%2Fkfh254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of Notch Processing by γ-Secretase Inhibitors Causes Intestinal Goblet Cell Metaplasia and Induction of Genes Known to Specify Gut Secretory Lineage Differentiation</span></div><div class="casAuthors">Milano, Joseph; McKay, Jenny; Dagenais, Claude; Foster-Brown, Linda; Pognan, Francois; Gadient, Reto; Jacobs, Robert T.; Zacco, Anna; Greenberg, Barry; Ciaccio, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicological Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">341-358</span>CODEN:
                <span class="NLM_cas:coden">TOSCF2</span>;
        ISSN:<span class="NLM_cas:issn">1096-6080</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">It is anticipated that γ-secretase inhibitors (γ-Sec-I) that modulate Notch processing will alter differentiation in tissues whose architecture is governed by Notch signaling.  To explore this hypothesis, Han Wistar rats were dosed for up to 5 days with 10-100 μmol/kg b.i.d. γ-Sec-I from three chem. series that inhibit Notch processing in vitro at various potencies (Notch IC50).  These included an arylsulfonamide (AS) (142 nM), a dibenzazepine (DBZ) (1.7 nM), and a benzodiazepine (BZ) (2.2 nM).  The DBZ and BZ caused dose-dependent intestinal goblet cell metaplasia.  In contrast, the AS produced no detectable in vivo toxicity, despite higher exposure to free drug.  In a time course using BZ, small intestinal crypt cell and large intestinal glandular cell epithelial apoptosis was obsd. on days 1-5, followed by goblet cell metaplasia on days 2-5 and crypt epithelial and glandular epithelial regenerative hyperplasia on days 4-5.  Gene expression profiling of duodenal samples from BZ-dosed animals revealed significant time-dependent deregulation of mRNAs for various panendocrine, hormonal, and transcription factor genes.  Somatostatin, secretin, mucin, CCK, and gastrin mRNAs were elevated twofold or more by day 2, and a no. of candidate early-predictive' genes were altered on days 1-2, remaining changed for 4-5 days; these included Delta1, NeuroD, Hes1-regulated adipsin, and the Hes-regulated transcriptional activator of gut secretory lineage differentiation, the rat homolog of Drosophila atonal, Rath1.  Western blotting of fecal protein from BZ-and DBZ-dosed animals exhibited increased levels of both anti-Rath1 reactive protein and anti-adipsin reactive proteins, confirming their potential value as noninvasive biomarkers of intestinal goblet metaplasia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2qB_JewBHJrVg90H21EOLACvtfcHk0ljZhg2KXG-gwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVOhsLc%253D&md5=ba57bf26d54ef933a6dc738468bb07e4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfh254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfh254%26sid%3Dliteratum%253Aachs%26aulast%3DMilano%26aufirst%3DJ.%26aulast%3DMcKay%26aufirst%3DJ.%26aulast%3DDagenais%26aufirst%3DC.%26aulast%3DFoster-Brown%26aufirst%3DL.%26aulast%3DPognan%26aufirst%3DF.%26aulast%3DGadient%26aufirst%3DR.%26aulast%3DJacobs%26aufirst%3DR.%2BT.%26aulast%3DZacco%26aufirst%3DA.%26aulast%3DGreenberg%26aufirst%3DB.%26aulast%3DCiaccio%26aufirst%3DP.%2BJ.%26atitle%3DModulation%2520of%2520Notch%2520processing%2520by%2520%25CE%25B3-secretase%2520inhibitors%2520causes%2520intestinal%2520goblet%2520cell%2520metaplasia%2520and%2520induction%2520of%2520genes%2520known%2520to%2520specify%2520gut%2520secretory%2520lineage%2520differentiation%26jtitle%3DToxicol.%2520Sci.%26date%3D2004%26volume%3D82%26spage%3D341%26epage%3D358%26doi%3D10.1093%2Ftoxsci%2Fkfh254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Grosveld, G. C.</span><span> </span><span class="NLM_article-title">γ-Secretase inhibitors: Notch so bad</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span><span class="refDoi"> DOI: 10.1038/nm0109-20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1038%2Fnm0109-20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=19129776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD1MXis1Oqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=20-21&author=G.+C.+Grosveld&title=%CE%B3-Secretase+inhibitors%3A+Notch+so+bad&doi=10.1038%2Fnm0109-20"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">γ-secretase inhibitors: Notch so bad</span></div><div class="casAuthors">Grosveld, Gerard C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-21</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  γ-Secretase inhibitors inhibit Notch, a transmembrane receptor that drives many cases of T cell acute lymphoblastic leukemia - but there are safety concerns with such drugs.  Combining these inhibitors with glucocorticoids could provide a more effective and safer approach (pages 50-58).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprLPK5315EjbVg90H21EOLACvtfcHk0lgbjXWNdu8xhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXis1Oqtg%253D%253D&md5=5c681c9ba6ce540e935386a264b1c785</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnm0109-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0109-20%26sid%3Dliteratum%253Aachs%26aulast%3DGrosveld%26aufirst%3DG.%2BC.%26atitle%3D%25CE%25B3-Secretase%2520inhibitors%253A%2520Notch%2520so%2520bad%26jtitle%3DNat.%2520Med.%26date%3D2009%26volume%3D15%26spage%3D20%26epage%3D21%26doi%3D10.1038%2Fnm0109-20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Choi, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norstrom, E.</span><span> </span><span class="NLM_article-title">Moderate reduction of γ-secretase: is there a therapeutic sweet spot?</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">13579</span><span class="NLM_x">–</span> <span class="NLM_lpage">13580</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.4821-07.2007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1523%2FJNEUROSCI.4821-07.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=18077669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmt1E%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=13579-13580&author=S.+H.+Choiauthor=E.+Norstrom&title=Moderate+reduction+of+%CE%B3-secretase%3A+is+there+a+therapeutic+sweet+spot%3F&doi=10.1523%2FJNEUROSCI.4821-07.2007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Moderate reduction of γ-secretase: is there a therapeutic sweet spot?</span></div><div class="casAuthors">Choi, Se Hoon; Norstrom, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">13579-13580</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotAKtkugqpzbVg90H21EOLACvtfcHk0lgbjXWNdu8xhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmt1E%253D&md5=5ec22d5a052ec226a3721ddad4b04b5b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4821-07.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4821-07.2007%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DS.%2BH.%26aulast%3DNorstrom%26aufirst%3DE.%26atitle%3DModerate%2520reduction%2520of%2520%25CE%25B3-secretase%253A%2520is%2520there%2520a%2520therapeutic%2520sweet%2520spot%253F%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D13579%26epage%3D13580%26doi%3D10.1523%2FJNEUROSCI.4821-07.2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Henley, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E. R.</span><span> </span><span class="NLM_article-title">Development of semagacestat (LY450139), a functional γ-secretase inhibitor, for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1657</span><span class="NLM_x">–</span> <span class="NLM_lpage">1664</span><span class="refDoi"> DOI: 10.1517/14656560903044982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1517%2F14656560903044982" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=19527190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Oru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=1657-1664&author=D.+B.+Henleyauthor=P.+C.+Mayauthor=R.+A.+Deanauthor=E.+R.+Siemers&title=Development+of+semagacestat+%28LY450139%29%2C+a+functional+%CE%B3-secretase+inhibitor%2C+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1517%2F14656560903044982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Development of semagacestat (LY450139), a functional γ-secretase inhibitor, for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Henley, David B.; May, Patrick C.; Dean, Robert A.; Siemers, Eric R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1657-1664</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Alzheimer's disease is thought to be caused by increased formations of neurotoxic amyloid beta (Aβ) peptides, which give rise to the hallmark amyloid plaques.  Therefore, pharmacol. agents that reduce Aβ formation may be of therapeutic benefit.  Objective: This paper reviews the pharmacol. and chem. efficacy of an Aβ-lowering agent, semagacestat (LY450139).  Methods: A review of the published literature pertaining to semagacestat was obtained using several electronic search engines; unpublished data on file at Eli Lilly and Co. were used as supplementary material.  Results/conclusions: Semagacestat treatment lowers plasma, cerebrospinal fluid and brain Aβ in a dose-dependent manner in animals and plasma and cerebrospinal fluid Aβ in humans, compared with placebo-treated patients.  On the basis of extant data, semagacestat seems to be well tolerated, with most adverse events related to its actions on inhibition of peripheral Notch cleavage.  Thus far, clin. efficacy has not been detectable because of the short duration of the current trials.  Phase III trials with 21 mo of active treatment are currently underway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3x83njCfOwrVg90H21EOLACvtfcHk0lgbjXWNdu8xhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Oru7g%253D&md5=add24473eeb348fd5ef73c7829b11edf</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1517%2F14656560903044982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656560903044982%26sid%3Dliteratum%253Aachs%26aulast%3DHenley%26aufirst%3DD.%2BB.%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DSiemers%26aufirst%3DE.%2BR.%26atitle%3DDevelopment%2520of%2520semagacestat%2520%2528LY450139%2529%252C%2520a%2520functional%2520%25CE%25B3-secretase%2520inhibitor%252C%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2009%26volume%3D10%26spage%3D1657%26epage%3D1664%26doi%3D10.1517%2F14656560903044982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">McKee, S.</span><span> </span><span class="NLM_article-title">Lilly hit by spectacular failure of phase III Alzheimer’s candidate</span>.  <span class="citation_source-journal">PharmaTimes [Online]</span>, <span class="NLM_month">Aug</span><span class="NLM_day">18</span>,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+McKee&title=Lilly+hit+by+spectacular+failure+of+phase+III+Alzheimer%E2%80%99s+candidate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcKee%26aufirst%3DS.%26atitle%3DLilly%2520hit%2520by%2520spectacular%2520failure%2520of%2520phase%2520III%2520Alzheimer%25E2%2580%2599s%2520candidate%26jtitle%3DPharmaTimes%2520%255BOnline%255D%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanlon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, P.</span><span> </span><span class="NLM_article-title">γ-Secretase modulator in Alzheimer’s disease: shifting the end</span> <span class="citation_source-journal">J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">696</span><span class="refDoi"> DOI: 10.3233/JAD-2012-120751</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.3233%2FJAD-2012-120751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=22710916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A280%3ADC%252BC38jivV2guw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=685-696&author=W.+Xiaauthor=S.+T.+Wongauthor=E.+Hanlonauthor=P.+Morin&title=%CE%B3-Secretase+modulator+in+Alzheimer%E2%80%99s+disease%3A+shifting+the+end&doi=10.3233%2FJAD-2012-120751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">γ-secretase modulator in Alzheimer's disease: shifting the end</span></div><div class="casAuthors">Xia Weiming; Wong Stephen T; Hanlon Eugene; Morin Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">685-96</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The outcomes of the clinical trials of the γ-secretase inhibitor Semagacestat (LY-450139) and the γ-secretase modulator (GSM) Tarenflurbil were disappointing, but may not represent the end of the γ-secretase era.  γ-Secretase modulators, by definition, only block the γ-secretase cleavage of amyloid-β protein precursor (AβPP) to generate the longer, 42-residue amyloid-β (Aβ42) without changing the production of total Aβ.  The first generation GSMs were shown to block Aβ42 generation while increasing Aβ38.  The non-steroidal anti-inflammatory drug, Tarenflurbil, binds to AβPP and shifts the cleavage site from Aβ42 to Aβ38.  In addition, Tarenflurbil does not affect the γ-secretase cleavage of Notch.  Even before the failed clinical trials of Tarenflurbil, second generation GSMs had emerged, and some of these GSMs interact with presenilin, which carries the active site of the γ-secretase.  While second generation GSMs are pharmacologically superior to first generation GSMs, in vivo Aβ profiles (decreased levels of Aβ38, Aβ40, and Aβ42) in animals treated with potent GSMs are strikingly different from those in cultured cells.  Thus, the unique pharmacologic properties of new GSMs and their mechanisms of action need to be elucidated in order to avoid the fate of Tarenflurbil.  It is critical to understand how GSMs shift the "end" in vivo, i.e., shifting the γ-secretase cleavage at the C-terminal end of Aβ.  In view of the myriad effects of candidate GSMs on Aβ production in cells and animals, drug development would benefit from better definition of the target-GSM interaction and physiological function of shorter Aβ peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQlMyfkj9Q7cMK3uFsUIZtkfW6udTcc2eY7MfOfo39FVbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38jivV2guw%253D%253D&md5=cb9e0ac6ec8b4eac86c8b0a1a5529a92</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3233%2FJAD-2012-120751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2012-120751%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DS.%2BT.%26aulast%3DHanlon%26aufirst%3DE.%26aulast%3DMorin%26aufirst%3DP.%26atitle%3D%25CE%25B3-Secretase%2520modulator%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520shifting%2520the%2520end%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2012%26volume%3D31%26spage%3D685%26epage%3D696%26doi%3D10.3233%2FJAD-2012-120751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span> </span><span class="NLM_article-title">Targeting the β-secretase BACE1 for Alzheimer’s disease therapy</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span><span class="refDoi"> DOI: 10.1016/S1474-4422(13)70276-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1016%2FS1474-4422%2813%2970276-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=24556009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1Cntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=319-329&author=R.+Yanauthor=R.+Vassar&title=Targeting+the+%CE%B2-secretase+BACE1+for+Alzheimer%E2%80%99s+disease+therapy&doi=10.1016%2FS1474-4422%2813%2970276-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the β secretase BACE1 for Alzheimer's disease therapy</span></div><div class="casAuthors">Yan, Riqiang; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-329</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The β secretase, widely known as β-site amyloid precursor protein cleaving enzyme 1 (BACE1), initiates the prodn. of the toxic amyloid β (Aβ) that plays a crucial early part in Alzheimer's disease pathogenesis.  BACE1 is a prime therapeutic target for lowering cerebral Aβ concns. in Alzheimer's disease, and clin. development of BACE1 inhibitors is being intensely pursued.  Although BACE1 inhibitor drug development has proven challenging, several promising BACE1 inhibitors have recently entered human clin. trials.  The safety and efficacy of these drugs are being tested at present in healthy individuals and patients with Alzheimer's disease, and will soon be tested in individuals with presymptomatic Alzheimer's disease.  Although hopes are high that BACE1 inhibitors might be efficacious for the prevention or treatment of Alzheimer's disease, concerns have been raised about potential mechanism-based side-effects of these drugs.  The potential of therapeutic BACE1 inhibition might prove to be a watershed in the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8SsSfCAC6nbVg90H21EOLACvtfcHk0lgRu6ROpXygQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1Cntbo%253D&md5=11aeb06fee19cafc0b361e2c43900806</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2813%2970276-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252813%252970276-X%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DTargeting%2520the%2520%25CE%25B2-secretase%2520BACE1%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%26jtitle%3DLancet%2520Neurol.%26date%3D2014%26volume%3D13%26spage%3D319%26epage%3D329%26doi%3D10.1016%2FS1474-4422%2813%2970276-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Lessons from a failed γ-secretase Alzheimer trial</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span><span class="refDoi"> DOI: 10.1016/j.cell.2014.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1016%2Fj.cell.2014.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=25417150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2msrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2014&pages=721-726&author=B.+De+Strooper&title=Lessons+from+a+failed+%CE%B3-secretase+Alzheimer+trial&doi=10.1016%2Fj.cell.2014.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons from a Failed γ-Secretase Alzheimer Trial</span></div><div class="casAuthors">De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">721-726</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  γ-Secretase proteases have been assocd. with pathol. in Alzheimer disease (AD), but we are just beginning to understand their basic mechanisms and physiol. roles.  A neg. drug trial with a broad spectrum γ-secretase inhibitor in AD patients has severely dampened enthusiasm for the potential of pursuing γ-secretase research therapeutically.  This pessimism is unwarranted: anal. of available information presented here demonstrates significant confounds for interpreting the outcome of the trial and argues that the major lessons pertain to broad knowledge gaps that are imperative to fill.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoltWoN44tWybVg90H21EOLACvtfcHk0lgRu6ROpXygQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2msrnI&md5=9d19644a7135552c6c4ef2b812b4b665</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2014.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2014.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DLessons%2520from%2520a%2520failed%2520%25CE%25B3-secretase%2520Alzheimer%2520trial%26jtitle%3DCell%26date%3D2014%26volume%3D159%26spage%3D721%26epage%3D726%26doi%3D10.1016%2Fj.cell.2014.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kreft, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porte, A.</span><span> </span><span class="NLM_article-title">Recent advances in the identification of γ-secretase inhibitors to clinically test the Aβ oligomer hypothesis of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6169</span><span class="NLM_x">–</span> <span class="NLM_lpage">6188</span><span class="refDoi"> DOI: 10.1021/jm900188z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900188z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6169-6188&author=A.+F.+Kreftauthor=R.+Martoneauthor=A.+Porte&title=Recent+advances+in+the+identification+of+%CE%B3-secretase+inhibitors+to+clinically+test+the+A%CE%B2+oligomer+hypothesis+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm900188z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm900188z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900188z%26sid%3Dliteratum%253Aachs%26aulast%3DKreft%26aufirst%3DA.%2BF.%26aulast%3DMartone%26aufirst%3DR.%26aulast%3DPorte%26aufirst%3DA.%26atitle%3DRecent%2520advances%2520in%2520the%2520identification%2520of%2520%25CE%25B3-secretase%2520inhibitors%2520to%2520clinically%2520test%2520the%2520A%25CE%25B2%2520oligomer%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6169%26epage%3D6188%26doi%3D10.1021%2Fjm900188z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">DeAngelo, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stock, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attar, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fearen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallob, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aster, J.</span><span> </span><span class="NLM_article-title">A phase I clinical trial of the Notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and other leukemias</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">6585</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=6585&author=D.+J.+DeAngeloauthor=R.+M.+Stoneauthor=L.+B.+Silvermanauthor=W.+Stockauthor=E.+C.+Attarauthor=I.+Fearenauthor=A.+Dallobauthor=C.+Matthewsauthor=J.+Stoneauthor=S.+J.+Freedmanauthor=J.+Aster&title=A+phase+I+clinical+trial+of+the+Notch+inhibitor+MK-0752+in+patients+with+T-cell+acute+lymphoblastic+leukemia%2Flymphoma+%28T-ALL%29+and+other+leukemias"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeAngelo%26aufirst%3DD.%2BJ.%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DSilverman%26aufirst%3DL.%2BB.%26aulast%3DStock%26aufirst%3DW.%26aulast%3DAttar%26aufirst%3DE.%2BC.%26aulast%3DFearen%26aufirst%3DI.%26aulast%3DDallob%26aufirst%3DA.%26aulast%3DMatthews%26aufirst%3DC.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DFreedman%26aufirst%3DS.%2BJ.%26aulast%3DAster%26aufirst%3DJ.%26atitle%3DA%2520phase%2520I%2520clinical%2520trial%2520of%2520the%2520Notch%2520inhibitor%2520MK-0752%2520in%2520patients%2520with%2520T-cell%2520acute%2520lymphoblastic%2520leukemia%252Flymphoma%2520%2528T-ALL%2529%2520and%2520other%2520leukemias%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2006%26volume%3D24%26spage%3D6585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Schott, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dontu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Layman, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krop, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paskett, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrolecki, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froehlich, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paranilam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wicha, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. C.</span><span> </span><span class="NLM_article-title">Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1512</span><span class="NLM_x">–</span> <span class="NLM_lpage">1524</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-3326</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1158%2F1078-0432.CCR-11-3326" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=23340294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFKktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1512-1524&author=A.+F.+Schottauthor=M.+D.+Landisauthor=G.+Dontuauthor=K.+A.+Griffithauthor=R.+M.+Laymanauthor=I.+Kropauthor=L.+A.+Paskettauthor=H.+Wongauthor=L.+E.+Dobroleckiauthor=M.+T.+Lewisauthor=A.+M.+Froehlichauthor=J.+Paranilamauthor=D.+F.+Hayesauthor=M.+S.+Wichaauthor=J.+C.+Chang&title=Preclinical+and+clinical+studies+of+gamma+secretase+inhibitors+with+docetaxel+on+human+breast+tumors&doi=10.1158%2F1078-0432.CCR-11-3326"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors</span></div><div class="casAuthors">Schott, Anne F.; Landis, Melissa D.; Dontu, Gabriela; Griffith, Kent A.; Layman, Rachel M.; Krop, Ian; Paskett, Lacey A.; Wong, Helen; Dobrolecki, Lacey E.; Lewis, Michael T.; Froehlich, Amber M.; Paranilam, Jaya; Hayes, Daniel F.; Wicha, Max S.; Chang, Jenny C.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1512-1524</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Accumulating evidence supports the existence of breast cancer stem cells (BCSC), which are characterized by their capacity to self-renew and divide indefinitely and resistance to conventional therapies.  The Notch pathway is important for stem cell renewal and is a potential target for BCSC-directed therapy.  Exptl. Design: Using human breast tumorgraft studies, we evaluated the impact of gamma secretase inhibitors (GSI) on the BCSC population and the efficacy of combining GSI with docetaxel treatment.  The mouse exptl. therapy paralleled a concurrent clin. trial in patients with advanced breast cancer, designed to det. the max.-tolerated dose of the GSI, MK-0752, administered sequentially with docetaxel, and to evaluate BCSC markers in serial tumor biopsies.  Results: Treatment with GSI reduced BCSCs in MC1 and BCM-2147 tumorgrafts by inhibition of the Notch pathway.  GSI enhanced the efficacy of docetaxel in preclin. studies.  In the clin. trial, 30 patients with advanced breast cancer were treated with escalating doses of MK-0752 plus docetaxel.  Clin., meaningful doses of both drugs were possible with manageable toxicity and preliminary evidence of efficacy.  A decrease in CD44+/CD24-, ALDH+, and mammosphere-forming efficiency were obsd. in tumors of patients undergoing serial biopsies.  Conclusions: These preclin. data show that pharmacol. inhibition of the Notch pathway can reduce BCSCs in breast tumorgraft models.  The clin. trial shows feasibility of combination GSI and chemotherapy, and together these results encourage further study of Notch pathway inhibitors in combination with chemotherapy in breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSPyKUMdOCRrVg90H21EOLACvtfcHk0ljgbSKqnXldgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFKktL0%253D&md5=4123f8b7f5f732252f7cafb7b2ef859c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-3326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-3326%26sid%3Dliteratum%253Aachs%26aulast%3DSchott%26aufirst%3DA.%2BF.%26aulast%3DLandis%26aufirst%3DM.%2BD.%26aulast%3DDontu%26aufirst%3DG.%26aulast%3DGriffith%26aufirst%3DK.%2BA.%26aulast%3DLayman%26aufirst%3DR.%2BM.%26aulast%3DKrop%26aufirst%3DI.%26aulast%3DPaskett%26aufirst%3DL.%2BA.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DDobrolecki%26aufirst%3DL.%2BE.%26aulast%3DLewis%26aufirst%3DM.%2BT.%26aulast%3DFroehlich%26aufirst%3DA.%2BM.%26aulast%3DParanilam%26aufirst%3DJ.%26aulast%3DHayes%26aufirst%3DD.%2BF.%26aulast%3DWicha%26aufirst%3DM.%2BS.%26aulast%3DChang%26aufirst%3DJ.%2BC.%26atitle%3DPreclinical%2520and%2520clinical%2520studies%2520of%2520gamma%2520secretase%2520inhibitors%2520with%2520docetaxel%2520on%2520human%2520breast%2520tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D1512%26epage%3D1524%26doi%3D10.1158%2F1078-0432.CCR-11-3326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Martone, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atchison, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreft, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschmies, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaleska, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonnenberg-Reines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oganesian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkins, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huryn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frick, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forlow, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balliet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burczynski, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, J. S.</span><span> </span><span class="NLM_article-title">Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein γ-secretase for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">331</span><span class="NLM_x">, </span> <span class="NLM_fpage">598</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span><span class="refDoi"> DOI: 10.1124/jpet.109.152975</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1124%2Fjpet.109.152975" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=19671883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlKnu73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=2009&pages=598-608&author=R.+L.+Martoneauthor=H.+Zhouauthor=K.+Atchisonauthor=T.+Comeryauthor=J.+Z.+Xuauthor=X.+Huangauthor=X.+Gongauthor=M.+Jinauthor=A.+Kreftauthor=B.+Harrisonauthor=S.+C.+Mayerauthor=S.+Aschmiesauthor=C.+Gonzalesauthor=M.+M.+Zaleskaauthor=D.+R.+Riddellauthor=E.+Wagnerauthor=P.+Luauthor=S.-C.+Sunauthor=J.+Sonnenberg-Reinesauthor=A.+Oganesianauthor=K.+Adkinsauthor=M.+W.+Leachauthor=D.+W.+Clarkeauthor=D.+Hurynauthor=M.+Abou-Gharbiaauthor=R.+Magoldaauthor=J.+Bardauthor=G.+Frickauthor=S.+Rajeauthor=S.+B.+Forlowauthor=C.+Ballietauthor=M.+E.+Burczynskiauthor=P.+H.+Reinhartauthor=H.+I.+Wanauthor=M.+N.+Pangalosauthor=J.+S.+Jacobsen&title=Begacestat+%28GSI-953%29%3A+a+novel%2C+selective+thiophene+sulfonamide+inhibitor+of+amyloid+precursor+protein+%CE%B3-secretase+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1124%2Fjpet.109.152975"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein γ-secretase for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Martone, Robert L.; Zhou, Hua; Atchison, Kevin; Comery, Thomas; Xu, Jane Z.; Huang, Xinyi; Gong, Xioahai; Jin, Mei; Kreft, Anthony; Harrison, Boyd; Mayer, Scott C.; Aschmies, Suzan; Gonzales, Cathleen; Zaleska, Margaret M.; Riddell, David R.; Wagner, Erik; Lu, Peimin; Sun, Shaiu-Ching; Sonnenberg-Reines, June; Oganesian, Aram; Adkins, Karissa; Leach, Michael W.; Clarke, David W.; Huryn, Donna; Abou-Gharbia, Magid; Magolda, Ronald; Bard, Jonathan; Frick, Glen; Raje, Sangeeta; Forlow, S. Bradley; Balliet, Carrie; Burczynski, Michael E.; Reinhart, Peter H.; Wan, Hong I.; Pangalos, Menelas N.; Jacobsen, J. Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">598-608</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The presenilin contg. γ-secretase complex is responsible for the regulated intramembraneous proteolysis of the amyloid precursor protein (APP), the Notch receptor, and a multitude of other substrates.  γ-Secretase catalyzes the final step in the generation of Aβ40 and Aβ42 peptides from APP.  Amyloid β-peptides (Aβ peptides) aggregate to form neurotoxic oligomers, senile plaques, and congophilic angiopathy, some of the cardinal pathologies assocd. with Alzheimer's disease.  Although inhibition of this protease acting on APP may result in potentially therapeutic redns. of neurotoxic Aβ peptides, nonselective inhibition of the enzyme may cause severe adverse events as a result of impaired Notch receptor processing.  Here, we report the preclin. pharmacol. profile of GSI-953 (begacestat), a novel thiophene sulfonamide γ-secretase inhibitor (GSI) that selectively inhibits cleavage of APP over Notch.  This GSI inhibits Aβ prodn. with low nanomolar potency in cellular and cell-free assays of γ-secretase function, and displaces a tritiated analog of GSI-953 from enriched γ-secretase enzyme complexes with similar potency.  Cellular assays of Notch cleavage reveal that this compd. is approx. 16-fold selective for the inhibition of APP cleavage.  In the human APP-overexpressing Tg2576 transgenic mouse, treatment with this orally active compd. results in a robust redn. in brain, plasma, and cerebral spinal fluid Aβ levels, and a reversal of contextual fear-conditioning deficits that are correlated with Aβ load.  In healthy human volunteers, oral administration of a single dose of GSI-953 produces dose-dependent changes in plasma Aβ levels, confirming pharmacodynamic activity of GSI-953 in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3bpCy_xTzAbVg90H21EOLACvtfcHk0lith6DZhoNzFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlKnu73I&md5=575a31bab5d79e60dc2c12bd22790b23</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.152975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.152975%26sid%3Dliteratum%253Aachs%26aulast%3DMartone%26aufirst%3DR.%2BL.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DComery%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DJ.%2BZ.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DGong%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DM.%26aulast%3DKreft%26aufirst%3DA.%26aulast%3DHarrison%26aufirst%3DB.%26aulast%3DMayer%26aufirst%3DS.%2BC.%26aulast%3DAschmies%26aufirst%3DS.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DZaleska%26aufirst%3DM.%2BM.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DS.-C.%26aulast%3DSonnenberg-Reines%26aufirst%3DJ.%26aulast%3DOganesian%26aufirst%3DA.%26aulast%3DAdkins%26aufirst%3DK.%26aulast%3DLeach%26aufirst%3DM.%2BW.%26aulast%3DClarke%26aufirst%3DD.%2BW.%26aulast%3DHuryn%26aufirst%3DD.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DMagolda%26aufirst%3DR.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DFrick%26aufirst%3DG.%26aulast%3DRaje%26aufirst%3DS.%26aulast%3DForlow%26aufirst%3DS.%2BB.%26aulast%3DBalliet%26aufirst%3DC.%26aulast%3DBurczynski%26aufirst%3DM.%2BE.%26aulast%3DReinhart%26aufirst%3DP.%2BH.%26aulast%3DWan%26aufirst%3DH.%2BI.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26aulast%3DJacobsen%26aufirst%3DJ.%2BS.%26atitle%3DBegacestat%2520%2528GSI-953%2529%253A%2520a%2520novel%252C%2520selective%2520thiophene%2520sulfonamide%2520inhibitor%2520of%2520amyloid%2520precursor%2520protein%2520%25CE%25B3-secretase%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D331%26spage%3D598%26epage%3D608%26doi%3D10.1124%2Fjpet.109.152975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Gillman, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starrett, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcin, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElhone, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mate, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barten, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaczek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decicco, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span> </span><span class="NLM_article-title">Discovery and evaluation of BMS-708163, a potent, selective and orally bioavailable γ-secretase inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1021/ml1000239</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml1000239" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1WrsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=120-124&author=K.+W.+Gillmanauthor=J.+E.+Starrettauthor=M.+F.+Parkerauthor=K.+Xieauthor=J.+J.+Bronsonauthor=L.+R.+Marcinauthor=K.+E.+McElhoneauthor=C.+P.+Bergstromauthor=R.+A.+Mateauthor=R.+Williamsauthor=J.+E.+Meredithauthor=C.+R.+Burtonauthor=D.+M.+Bartenauthor=J.+H.+Toynauthor=S.+B.+Robertsauthor=K.+A.+Lentzauthor=J.+G.+Houstonauthor=R.+Zaczekauthor=C.+F.+Albrightauthor=C.+P.+Deciccoauthor=J.+E.+Macorauthor=R.+E.+Olson&title=Discovery+and+evaluation+of+BMS-708163%2C+a+potent%2C+selective+and+orally+bioavailable+%CE%B3-secretase+inhibitor&doi=10.1021%2Fml1000239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor</span></div><div class="casAuthors">Gillman, Kevin W.; Starrett, John E.; Parker, Michael F.; Xie, Kai; Bronson, Joanne J.; Marcin, Lawrence R.; McElhone, Kate E.; Bergstrom, Carl P.; Mate, Robert A.; Williams, Richard; Meredith, Jere E.; Burton, Catherine R.; Barten, Donna M.; Toyn, Jeremy H.; Roberts, Susan B.; Lentz, Kimberley A.; Houston, John G.; Zaczek, Robert; Albright, Charles F.; Decicco, Carl P.; Macor, John E.; Olson, Richard E.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">120-124</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">During the course of our research efforts to develop a potent and selective γ-secretase inhibitor for the treatment of Alzheimer's disease, we investigated a series of carboxamide-substituted sulfonamides.  Optimization based on potency, Notch/amyloid-β precursor protein selectivity, and brain efficacy after oral dosing led to the discovery of 4 (BMS-708163).  Compd. 4 is a potent inhibitor of γ-secretase (Aβ40 IC50 = 0.30 nM), demonstrating a 193-fold selectivity against Notch.  Oral administration of 4 significantly reduced Aβ40 levels for sustained periods in brain, plasma, and cerebrospinal fluid in rats and dogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5cpf2l0bVB7Vg90H21EOLACvtfcHk0lith6DZhoNzFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1WrsL0%253D&md5=f28ebc4be6022fdbe9297c8663588440</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fml1000239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1000239%26sid%3Dliteratum%253Aachs%26aulast%3DGillman%26aufirst%3DK.%2BW.%26aulast%3DStarrett%26aufirst%3DJ.%2BE.%26aulast%3DParker%26aufirst%3DM.%2BF.%26aulast%3DXie%26aufirst%3DK.%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26aulast%3DMarcin%26aufirst%3DL.%2BR.%26aulast%3DMcElhone%26aufirst%3DK.%2BE.%26aulast%3DBergstrom%26aufirst%3DC.%2BP.%26aulast%3DMate%26aufirst%3DR.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DMeredith%26aufirst%3DJ.%2BE.%26aulast%3DBurton%26aufirst%3DC.%2BR.%26aulast%3DBarten%26aufirst%3DD.%2BM.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DRoberts%26aufirst%3DS.%2BB.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26aulast%3DHouston%26aufirst%3DJ.%2BG.%26aulast%3DZaczek%26aufirst%3DR.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DDecicco%26aufirst%3DC.%2BP.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26atitle%3DDiscovery%2520and%2520evaluation%2520of%2520BMS-708163%252C%2520a%2520potent%252C%2520selective%2520and%2520orally%2520bioavailable%2520%25CE%25B3-secretase%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D120%26epage%3D124%26doi%3D10.1021%2Fml1000239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Mayer, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreft, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antane, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschmies, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atchison, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chlenov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamantidis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingboe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galante, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoke, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huryn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubrak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oganesian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resnick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonnenberg-Reines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stock, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaleska, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeldis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, J. S.</span><span> </span><span class="NLM_article-title">Discovery of begacestat, a Notch-1-sparing γ-secretase inhibitor for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7348</span><span class="NLM_x">–</span> <span class="NLM_lpage">7351</span><span class="refDoi"> DOI: 10.1021/jm801252w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801252w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2jsbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7348-7351&author=S.+C.+Mayerauthor=A.+F.+Kreftauthor=B.+Harrisonauthor=M.+Abou-Gharbiaauthor=M.+Antaneauthor=S.+Aschmiesauthor=K.+Atchisonauthor=M.+Chlenovauthor=D.+C.+Coleauthor=T.+Comeryauthor=G.+Diamantidisauthor=J.+Ellingboeauthor=K.+Fanauthor=R.+Galanteauthor=C.+Gonzalesauthor=D.+M.+Hoauthor=M.+E.+Hokeauthor=Y.+Huauthor=D.+Hurynauthor=U.+Jainauthor=M.+Jinauthor=K.+Kremerauthor=D.+Kubrakauthor=M.+Linauthor=P.+Luauthor=R.+Magoldaauthor=R.+Martoneauthor=W.+Mooreauthor=A.+Oganesianauthor=M.+N.+Pangalosauthor=A.+Porteauthor=P.+Reinhartauthor=L.+Resnickauthor=D.+R.+Riddellauthor=J.+Sonnenberg-Reinesauthor=J.+R.+Stockauthor=S.-C.+Sunauthor=E.+Wagnerauthor=T.+Wangauthor=K.+Wollerauthor=Z.+Xuauthor=M.+M.+Zaleskaauthor=J.+Zeldisauthor=M.+Zhangauthor=H.+Zhouauthor=J.+S.+Jacobsen&title=Discovery+of+begacestat%2C+a+Notch-1-sparing+%CE%B3-secretase+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm801252w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Begacestat, a Notch-1-Sparing γ-Secretase Inhibitor for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Mayer, Scott C.; Kreft, Anthony F.; Harrison, Boyd; Abou-Gharbia, Magid; Antane, Madelene; Aschmies, Suzan; Atchison, Kevin; Chlenov, Michael; Cole, Derek C.; Comery, Thomas; Diamantidis, George; Ellingboe, John; Fan, Kristi; Galante, Rocco; Gonzales, Cathleen; Ho, Douglas M.; Hoke, Molly E.; Hu, Yun; Huryn, Donna; Jain, Uday; Jin, Mei; Kremer, Kenneth; Kubrak, Dennis; Lin, Melissa; Lu, Peimin; Magolda, Ron; Martone, Robert; Moore, William; Oganesian, Aram; Pangalos, Menelas N.; Porte, Alex; Reinhart, Peter; Resnick, Lynn; Riddell, David R.; Sonnenberg-Reines, June; Stock, Joseph R.; Sun, Shaiu-Ching; Wagner, Erik; Wang, Ting; Woller, Kevin; Xu, Zheng; Zaleska, Margaret M.; Zeldis, Joseph; Zhang, Minsheng; Zhou, Hua; Jacobsen, J. Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7348-7351</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">SAR on HTS hits 1 and 2 led to the potent, Notch-1-sparing GSI 9, which lowered brain Aβ in Tg2576 mice at 100 mg/kg po.  Converting the metabolically labile Me groups in 9 to trifluoromethyl groups afforded the more stable analog 10, which had improved in vivo potency.  Further side chain modification afforded the potent Notch-1-sparing GSI begacestat (5), which was selected for development for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs3eNPOOjp4rVg90H21EOLACvtfcHk0liUAiYnnW4daA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2jsbjL&md5=c67a1b8bf40825f2d1b1eb707c8d5c25</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm801252w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801252w%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DS.%2BC.%26aulast%3DKreft%26aufirst%3DA.%2BF.%26aulast%3DHarrison%26aufirst%3DB.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DAntane%26aufirst%3DM.%26aulast%3DAschmies%26aufirst%3DS.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DChlenov%26aufirst%3DM.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DComery%26aufirst%3DT.%26aulast%3DDiamantidis%26aufirst%3DG.%26aulast%3DEllingboe%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DGalante%26aufirst%3DR.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DHo%26aufirst%3DD.%2BM.%26aulast%3DHoke%26aufirst%3DM.%2BE.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DHuryn%26aufirst%3DD.%26aulast%3DJain%26aufirst%3DU.%26aulast%3DJin%26aufirst%3DM.%26aulast%3DKremer%26aufirst%3DK.%26aulast%3DKubrak%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DMagolda%26aufirst%3DR.%26aulast%3DMartone%26aufirst%3DR.%26aulast%3DMoore%26aufirst%3DW.%26aulast%3DOganesian%26aufirst%3DA.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26aulast%3DPorte%26aufirst%3DA.%26aulast%3DReinhart%26aufirst%3DP.%26aulast%3DResnick%26aufirst%3DL.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DSonnenberg-Reines%26aufirst%3DJ.%26aulast%3DStock%26aufirst%3DJ.%2BR.%26aulast%3DSun%26aufirst%3DS.-C.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWoller%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DZaleska%26aufirst%3DM.%2BM.%26aulast%3DZeldis%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DJacobsen%26aufirst%3DJ.%2BS.%26atitle%3DDiscovery%2520of%2520begacestat%252C%2520a%2520Notch-1-sparing%2520%25CE%25B3-secretase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7348%26epage%3D7351%26doi%3D10.1021%2Fjm801252w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dockens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slemmon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denton, R. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhyne, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raybon, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barten, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankaranarayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guss, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simutis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillman, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starrett, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sverdlov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaneda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coric, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaczek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, G.</span><span> </span><span class="NLM_article-title">Pharmacodynamics of selective inhibition of γ-secretase by avagacestat</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">686</span><span class="NLM_x">–</span> <span class="NLM_lpage">695</span><span class="refDoi"> DOI: 10.1124/jpet.112.199356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1124%2Fjpet.112.199356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=23275065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVaisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2013&pages=686-695&author=C.+F.+Albrightauthor=R.+C.+Dockensauthor=J.+E.+Meredithauthor=R.+E.+Olsonauthor=R.+Slemmonauthor=K.+A.+Lentzauthor=J.-S.+Wangauthor=R.+X.+Dentonauthor=G.+Pilcherauthor=P.+W.+Rhyneauthor=J.+J.+Raybonauthor=D.+M.+Bartenauthor=C.+Burtonauthor=J.+H.+Toynauthor=S.+Sankaranarayananauthor=C.+Polsonauthor=V.+Gussauthor=R.+Whiteauthor=F.+Simutisauthor=T.+Sandersonauthor=K.+W.+Gillmanauthor=J.+E.+Starrettauthor=J.+Bronsonauthor=O.+Sverdlovauthor=S.-P.+Huangauthor=L.+Castanedaauthor=H.+Feldmanauthor=V.+Coricauthor=R.+Zaczekauthor=J.+E.+Macorauthor=J.+Houstonauthor=R.+M.+Bermanauthor=G.+Tong&title=Pharmacodynamics+of+selective+inhibition+of+%CE%B3-secretase+by+avagacestat&doi=10.1124%2Fjpet.112.199356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacodynamics of selective inhibition of γ-secretase by avagacestat</span></div><div class="casAuthors">Albright, Charles F.; Dockens, Randy C.; Meredith, Jere E., Jr.; Olson, Richard E.; Slemmon, Randy; Lentz, Kimberley A.; Wang, Jun-Sheng; Denton, R. Rex; Pilcher, Gary; Rhyne, Paul W.; Raybon, Joseph J.; Barten, Donna M.; Burton, Catherine; Toyn, Jeremy H.; Sankaranarayanan, Sethu; Polson, Craig; Guss, Valerie; White, Randy; Simutis, Frank; Sanderson, Thomas; Gillman, Kevin W.; Starrett, John E., Jr.; Bronson, Joanne; Sverdlov, Oleksandr; Huang, Shu-Pang; Castaneda, Loma; Feldman, Howard; Coric, Vlad; Zaczek, Robert; Macor, John E.; Houston, John; Berman, Robert M.; Tong, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">686-695</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A hallmark of Alzheimer's disease (AD) pathol. is the accumulation of brain amyloid β-peptide (Aβ), generated by γ-secretase-mediated cleavage of the amyloid precursor protein (APP).  Therefore, γ-secretase inhibitors (GSIs) may lower brain Aβ and offer a potential new approach to treat AD.  As γ-secretase also cleaves Notch proteins, GSIs can have undesirable effects due to interference with Notch signaling.  Avagacestat (BMS-708163) is a GSI developed for selective inhibition of APP over Notch cleavage.  Avagacestat inhibition of APP and Notch cleavage was evaluated in cell culture by measuring levels of Aβ and human Notch proteins.  In rats, dogs, and humans, selectivity was evaluated by measuring plasma blood concns. in relation to effects on cerebrospinal fluid (CSF) Aβ levels and Notch-related toxicities.  Measurements of Notch-related toxicity included goblet cell metaplasia in the gut, marginal-zone depletion in the spleen, redns. in B cells, and changes in expression of the Notch-regulated hairy and enhancer of split homolog-1 from blood cells.  In rats and dogs, acute administration of avagacestat robustly reduced CSF Aβ40 and Aβ42 levels similarly.  Chronic administration in rats and dogs, and 28-day, single- and multiple-ascending-dose administration in healthy human subjects caused similar exposure-dependent redns. in CSF Aβ40.  Consistent with the 137-fold selectivity measured in cell culture, we identified doses of avagacestat that reduce CSF Aβ levels without causing Notch-related toxicities.  Our results demonstrate the selectivity of avagacestat for APP over Notch cleavage, supporting further evaluation of avagacestat for AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5fAxZamNybbVg90H21EOLACvtfcHk0liUAiYnnW4daA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVaisr8%253D&md5=91241c812b36909ea783288520bc6af5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.199356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.199356%26sid%3Dliteratum%253Aachs%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DDockens%26aufirst%3DR.%2BC.%26aulast%3DMeredith%26aufirst%3DJ.%2BE.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26aulast%3DSlemmon%26aufirst%3DR.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DJ.-S.%26aulast%3DDenton%26aufirst%3DR.%2BX.%26aulast%3DPilcher%26aufirst%3DG.%26aulast%3DRhyne%26aufirst%3DP.%2BW.%26aulast%3DRaybon%26aufirst%3DJ.%2BJ.%26aulast%3DBarten%26aufirst%3DD.%2BM.%26aulast%3DBurton%26aufirst%3DC.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DSankaranarayanan%26aufirst%3DS.%26aulast%3DPolson%26aufirst%3DC.%26aulast%3DGuss%26aufirst%3DV.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DSimutis%26aufirst%3DF.%26aulast%3DSanderson%26aufirst%3DT.%26aulast%3DGillman%26aufirst%3DK.%2BW.%26aulast%3DStarrett%26aufirst%3DJ.%2BE.%26aulast%3DBronson%26aufirst%3DJ.%26aulast%3DSverdlov%26aufirst%3DO.%26aulast%3DHuang%26aufirst%3DS.-P.%26aulast%3DCastaneda%26aufirst%3DL.%26aulast%3DFeldman%26aufirst%3DH.%26aulast%3DCoric%26aufirst%3DV.%26aulast%3DZaczek%26aufirst%3DR.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DHouston%26aufirst%3DJ.%26aulast%3DBerman%26aufirst%3DR.%2BM.%26aulast%3DTong%26aufirst%3DG.%26atitle%3DPharmacodynamics%2520of%2520selective%2520inhibition%2520of%2520%25CE%25B3-secretase%2520by%2520avagacestat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D344%26spage%3D686%26epage%3D695%26doi%3D10.1124%2Fjpet.112.199356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Niva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Schaick, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundkvist, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, S. A. G.</span><span> </span><span class="NLM_article-title">Has inhibition of Aβ production adequately been tested as therapeutic approach in mild AD? A model-based meta-analysis of γ-secretase inhibitor data</span> <span class="citation_source-journal">Eur. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1247</span><span class="NLM_x">–</span> <span class="NLM_lpage">1260</span><span class="refDoi"> DOI: 10.1007/s00228-012-1459-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1007%2Fs00228-012-1459-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1247-1260&author=C.+Nivaauthor=J.+Parkinsonauthor=F.+Olssonauthor=E.+van+Schaickauthor=J.+Lundkvistauthor=S.+A.+G.+Visser&title=Has+inhibition+of+A%CE%B2+production+adequately+been+tested+as+therapeutic+approach+in+mild+AD%3F+A+model-based+meta-analysis+of+%CE%B3-secretase+inhibitor+data&doi=10.1007%2Fs00228-012-1459-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2Fs00228-012-1459-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00228-012-1459-3%26sid%3Dliteratum%253Aachs%26aulast%3DNiva%26aufirst%3DC.%26aulast%3DParkinson%26aufirst%3DJ.%26aulast%3DOlsson%26aufirst%3DF.%26aulast%3Dvan%2BSchaick%26aufirst%3DE.%26aulast%3DLundkvist%26aufirst%3DJ.%26aulast%3DVisser%26aufirst%3DS.%2BA.%2BG.%26atitle%3DHas%2520inhibition%2520of%2520A%25CE%25B2%2520production%2520adequately%2520been%2520tested%2520as%2520therapeutic%2520approach%2520in%2520mild%2520AD%253F%2520A%2520model-based%2520meta-analysis%2520of%2520%25CE%25B3-secretase%2520inhibitor%2520data%26jtitle%3DEur.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2013%26volume%3D69%26spage%3D1247%26epage%3D1260%26doi%3D10.1007%2Fs00228-012-1459-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Best, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Donnell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkie, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosahl, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laroque, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boussiquet-Leroux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churcher, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atack, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M. S.</span><span> </span><span class="NLM_article-title">The novel γ secretase inhibitor N-[cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide (MRK-560) reduces amyloid plaque deposition without evidence of Notch-related pathology in the Tg2576 mouse</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">552</span><span class="NLM_x">–</span> <span class="NLM_lpage">558</span><span class="refDoi"> DOI: 10.1124/jpet.106.114330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1124%2Fjpet.106.114330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=17099072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhs1Wktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=552-558&author=J.+D.+Bestauthor=D.+W.+Smithauthor=M.+A.+Reillyauthor=R.+O%27Donnellauthor=H.+D.+Lewisauthor=S.+Ellisauthor=N.+Wilkieauthor=T.+W.+Rosahlauthor=P.+A.+Laroqueauthor=C.+Boussiquet-Lerouxauthor=I.+Churcherauthor=J.+R.+Atackauthor=T.+Harrisonauthor=M.+S.+Shearman&title=The+novel+%CE%B3+secretase+inhibitor+N-%5Bcis-4-%5B%284-chlorophenyl%29sulfonyl%5D-4-%282%2C5-difluorophenyl%29cyclohexyl%5D-1%2C1%2C1-trifluoromethanesulfonamide+%28MRK-560%29+reduces+amyloid+plaque+deposition+without+evidence+of+Notch-related+pathology+in+the+Tg2576+mouse&doi=10.1124%2Fjpet.106.114330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The novel γ secretase inhibitor N-[cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]- 1,1,1-trifluoromethanesulfonamide (MRK-560) reduces amyloid plaque deposition without evidence of notch-related pathology in the Tg2576 mouse</span></div><div class="casAuthors">Best, Jonathan D.; Smith, David W.; Reilly, Michael A.; O'Donnell, Ruth; Lewis, Huw D.; Ellis, Semantha; Wilkie, Neil; Rosahl, Thomas W.; Laroque, Philippe A.; Boussiquet-Leroux, Christine; Churcher, Ian; Atack, John R.; Harrison, Timothy; Shearman, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">552-558</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">There is a substantial body of evidence indicating that β-amyloid peptides (Aβ) are crit. factors in the onset and development of Alzheimer's disease (AD).  One strategy for combating AD is to reduce or eliminate the prodn. of Aβ through inhibition of the γ-secretase enzyme, which cleaves Aβ from the amyloid precursor protein (APP).  We demonstrate here that chronic treatment for 3 mo with 3 mg/kg of the potent, orally bioavailable and brain-penetrant γ-secretase inhibitor N-[cis-4-[(4-chlorophenyl)-sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]- 1,1,1-trifluoromethanesulfonamide (MRK-560) attenuates the appearance of amyloid plaques in the Tg2576 mouse.  These redns. in plaques were also accompanied by a decrease in the level of reactive gliosis.  The morphometric and histol. measures agreed with biochem. anal. of Aβ(40) and Aβ(42) in the cortex.  Interestingly, the vol. of the plaques across treatment groups did not change, indicating that reducing Aβ levels does not significantly alter deposit growth once initiated.  Furthermore, we demonstrate that these beneficial effects can be achieved without causing histopathol. changes in the ileum, spleen, or thymus as a consequence of blockade of the processing of alternative substrates, such as the Notch family of receptors.  This indicates that in vivo a therapeutic window between these substrates seems possible-a key concern in the development of this approach to AD.  An understanding of the mechanisms whereby MRK-560 shows differentiation between the APP and Notch proteolytic pathway of γ-secretase should provide the basis for the next generation of γ-secretase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH9vXalcQ5HbVg90H21EOLACvtfcHk0lgbShSiKow-ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhs1Wktbc%253D&md5=22c7762b019fede18826bd47cb901705</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.114330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.114330%26sid%3Dliteratum%253Aachs%26aulast%3DBest%26aufirst%3DJ.%2BD.%26aulast%3DSmith%26aufirst%3DD.%2BW.%26aulast%3DReilly%26aufirst%3DM.%2BA.%26aulast%3DO%2527Donnell%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DH.%2BD.%26aulast%3DEllis%26aufirst%3DS.%26aulast%3DWilkie%26aufirst%3DN.%26aulast%3DRosahl%26aufirst%3DT.%2BW.%26aulast%3DLaroque%26aufirst%3DP.%2BA.%26aulast%3DBoussiquet-Leroux%26aufirst%3DC.%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DAtack%26aufirst%3DJ.%2BR.%26aulast%3DHarrison%26aufirst%3DT.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26atitle%3DThe%2520novel%2520%25CE%25B3%2520secretase%2520inhibitor%2520N-%255Bcis-4-%255B%25284-chlorophenyl%2529sulfonyl%255D-4-%25282%252C5-difluorophenyl%2529cyclohexyl%255D-1%252C1%252C1-trifluoromethanesulfonamide%2520%2528MRK-560%2529%2520reduces%2520amyloid%2520plaque%2520deposition%2520without%2520evidence%2520of%2520Notch-related%2520pathology%2520in%2520the%2520Tg2576%2520mouse%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D552%26epage%3D558%26doi%3D10.1124%2Fjpet.106.114330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josien, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asberom, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasikumar, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">Identification of presenilin 1-selective γ-secretase inhibitors with reconstituted γ-secretase complexes</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4973</span><span class="NLM_x">–</span> <span class="NLM_lpage">4980</span><span class="refDoi"> DOI: 10.1021/bi200026m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi200026m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=4973-4980&author=J.+Leeauthor=L.+Songauthor=G.+Terracinaauthor=T.+Baraauthor=H.+Josienauthor=T.+Asberomauthor=T.+K.+Sasikumarauthor=D.+A.+Burnettauthor=J.+Claderauthor=E.+M.+Parkerauthor=L.+Zhang&title=Identification+of+presenilin+1-selective+%CE%B3-secretase+inhibitors+with+reconstituted+%CE%B3-secretase+complexes&doi=10.1021%2Fbi200026m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fbi200026m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi200026m%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DAsberom%26aufirst%3DT.%26aulast%3DSasikumar%26aufirst%3DT.%2BK.%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DIdentification%2520of%2520presenilin%25201-selective%2520%25CE%25B3-secretase%2520inhibitors%2520with%2520reconstituted%2520%25CE%25B3-secretase%2520complexes%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D4973%26epage%3D4980%26doi%3D10.1021%2Fbi200026m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Xu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asberom, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domalski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josien, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBriar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhail, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pissarnitski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasikumar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span> </span><span class="NLM_article-title">Design and synthesis of tricyclic sulfones as γ-secretase inhibitors with greatly reduced Notch toxicity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2591</span><span class="NLM_x">–</span> <span class="NLM_lpage">2596</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.02.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1016%2Fj.bmcl.2010.02.080" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2591-2596&author=R.+Xuauthor=D.+Coleauthor=T.+Asberomauthor=T.+Baraauthor=C.+Bennettauthor=D.+A.+Burnettauthor=J.+Claderauthor=M.+Domalskiauthor=W.+Greenleeauthor=L.+Hydeauthor=H.+Josienauthor=H.+Liauthor=M.+McBriarauthor=B.+McKittrickauthor=A.+T.+McPhailauthor=D.+Pissarnitskiauthor=L.+Qiangauthor=M.+Rajagopalanauthor=T.+Sasikumarauthor=J.+Suauthor=H.+Tangauthor=W.-L.+Wuauthor=L.+Zhangauthor=Z.+Zhao&title=Design+and+synthesis+of+tricyclic+sulfones+as+%CE%B3-secretase+inhibitors+with+greatly+reduced+Notch+toxicity&doi=10.1016%2Fj.bmcl.2010.02.080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.02.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.02.080%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DR.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DAsberom%26aufirst%3DT.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DBennett%26aufirst%3DC.%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DDomalski%26aufirst%3DM.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMcBriar%26aufirst%3DM.%26aulast%3DMcKittrick%26aufirst%3DB.%26aulast%3DMcPhail%26aufirst%3DA.%2BT.%26aulast%3DPissarnitski%26aufirst%3DD.%26aulast%3DQiang%26aufirst%3DL.%26aulast%3DRajagopalan%26aufirst%3DM.%26aulast%3DSasikumar%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DW.-L.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DZ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520tricyclic%2520sulfones%2520as%2520%25CE%25B3-secretase%2520inhibitors%2520with%2520greatly%2520reduced%2520Notch%2520toxicity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2591%26epage%3D2596%26doi%3D10.1016%2Fj.bmcl.2010.02.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Sasikumar, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span> </span><span class="NLM_article-title">Tricyclic sulfones as orally active γ-secretase inhibitors: synthesis and structure-activity relationship studies</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3632</span><span class="NLM_x">–</span> <span class="NLM_lpage">3635</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.04.104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1016%2Fj.bmcl.2010.04.104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3632-3635&author=T.+K.+Sasikumarauthor=L.+Qiangauthor=D.+A.+Burnettauthor=D.+Coleauthor=R.+Xuauthor=H.+Liauthor=W.+J.+Greenleeauthor=J.+Claderauthor=L.+Zhangauthor=L.+Hyde&title=Tricyclic+sulfones+as+orally+active+%CE%B3-secretase+inhibitors%3A+synthesis+and+structure-activity+relationship+studies&doi=10.1016%2Fj.bmcl.2010.04.104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.04.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.04.104%26sid%3Dliteratum%253Aachs%26aulast%3DSasikumar%26aufirst%3DT.%2BK.%26aulast%3DQiang%26aufirst%3DL.%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHyde%26aufirst%3DL.%26atitle%3DTricyclic%2520sulfones%2520as%2520orally%2520active%2520%25CE%25B3-secretase%2520inhibitors%253A%2520synthesis%2520and%2520structure-activity%2520relationship%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3632%26epage%3D3635%26doi%3D10.1016%2Fj.bmcl.2010.04.104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Pissarnitski, D.; Zhao, Z.</span><span> </span><span class="NLM_article-title">Spirocyclic sulfones as gamma secretase inhibitors</span>. PCT Int. Appl. WO 2014085211 A2 20140605,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+Pissarnitski&author=Z.+Zhao&title=Spirocyclic+sulfones+as+gamma+secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPissarnitski%26aufirst%3DD.%26atitle%3DSpirocyclic%2520sulfones%2520as%2520gamma%2520secretase%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Kabalka, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gooch, E. E.,  III.</span><span> </span><span class="NLM_article-title">A mild and convenient procedure for conversion of alkenes into alkyl iodides via reaction of iodine monochloride with organoboranes</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3578</span><span class="NLM_x">–</span> <span class="NLM_lpage">3580</span><span class="refDoi"> DOI: 10.1021/jo01306a007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01306a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1980&pages=3578-3580&author=G.+W.+Kabalkaauthor=E.+E.+Gooch&title=A+mild+and+convenient+procedure+for+conversion+of+alkenes+into+alkyl+iodides+via+reaction+of+iodine+monochloride+with+organoboranes&doi=10.1021%2Fjo01306a007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjo01306a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01306a007%26sid%3Dliteratum%253Aachs%26aulast%3DKabalka%26aufirst%3DG.%2BW.%26aulast%3DGooch%26aufirst%3DE.%2BE.%26atitle%3DA%2520mild%2520and%2520convenient%2520procedure%2520for%2520conversion%2520of%2520alkenes%2520into%2520alkyl%2520iodides%2520via%2520reaction%2520of%2520iodine%2520monochloride%2520with%2520organoboranes%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1980%26volume%3D45%26spage%3D3578%26epage%3D3580%26doi%3D10.1021%2Fjo01306a007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Teall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhard, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, N. N.</span><span> </span><span class="NLM_article-title">Aryl sulfones: a new class of γ-secretase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2685</span><span class="NLM_x">–</span> <span class="NLM_lpage">2688</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2004.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1016%2Fj.bmcl.2004.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=15863342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslyqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2685-2688&author=M.+Teallauthor=P.+Oakleyauthor=T.+Harrisonauthor=D.+Shawauthor=E.+Kayauthor=J.+Elliottauthor=U.+Gerhardauthor=J.+L.+Castroauthor=M.+Shearmanauthor=R.+G.+Ballauthor=N.+N.+Tsou&title=Aryl+sulfones%3A+a+new+class+of+%CE%B3-secretase+inhibitors&doi=10.1016%2Fj.bmcl.2004.12.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Aryl sulfones: a new class of γ-secretase inhibitors</span></div><div class="casAuthors">Teall, Martin; Oakley, Paul; Harrison, Timothy; Shaw, Duncan; Kay, Euan; Elliott, Jason; Gerhard, Ute; Castro, Jose L.; Shearman, Mark; Ball, Richard G.; Tsou, Nancy N.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2685-2688</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The development of a novel series of 4-aryl, 4-phenylsulfonyl cyclohexananone-derived γ-secretase inhibitors for the potential treatment of Alzheimer's disease is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomTv1qLIbi97Vg90H21EOLACvtfcHk0lgAPqbXJM041A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslyqs7w%253D&md5=bf29cf1204c347cc983b51e6b1883a7d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DTeall%26aufirst%3DM.%26aulast%3DOakley%26aufirst%3DP.%26aulast%3DHarrison%26aufirst%3DT.%26aulast%3DShaw%26aufirst%3DD.%26aulast%3DKay%26aufirst%3DE.%26aulast%3DElliott%26aufirst%3DJ.%26aulast%3DGerhard%26aufirst%3DU.%26aulast%3DCastro%26aufirst%3DJ.%2BL.%26aulast%3DShearman%26aufirst%3DM.%26aulast%3DBall%26aufirst%3DR.%2BG.%26aulast%3DTsou%26aufirst%3DN.%2BN.%26atitle%3DAryl%2520sulfones%253A%2520a%2520new%2520class%2520of%2520%25CE%25B3-secretase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2685%26epage%3D2688%26doi%3D10.1016%2Fj.bmcl.2004.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Churcher, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Best, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitzel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerrad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morentin-Gutierrez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortishire-Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakley, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teall, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrigley, J. D. J.</span><span> </span><span class="NLM_article-title">4-Substituted cyclohexyl sulfones as potent, orally active γ-secretase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">280</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2005.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1016%2Fj.bmcl.2005.10.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=280-284&author=I.+Churcherauthor=D.+Beherauthor=J.+D.+Bestauthor=J.+L.+Castroauthor=E.+E.+Clarkeauthor=A.+Gentryauthor=T.+Harrisonauthor=L.+Hitzelauthor=E.+Kayauthor=S.+Kerradauthor=H.+D.+Lewisauthor=P.+Morentin-Gutierrezauthor=R.+Mortishire-Smithauthor=P.+J.+Oakleyauthor=M.+Reillyauthor=D.+E.+Shawauthor=M.+S.+Shearmanauthor=M.+R.+Teallauthor=S.+Williamsauthor=J.+D.+J.+Wrigley&title=4-Substituted+cyclohexyl+sulfones+as+potent%2C+orally+active+%CE%B3-secretase+inhibitors&doi=10.1016%2Fj.bmcl.2005.10.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DBeher%26aufirst%3DD.%26aulast%3DBest%26aufirst%3DJ.%2BD.%26aulast%3DCastro%26aufirst%3DJ.%2BL.%26aulast%3DClarke%26aufirst%3DE.%2BE.%26aulast%3DGentry%26aufirst%3DA.%26aulast%3DHarrison%26aufirst%3DT.%26aulast%3DHitzel%26aufirst%3DL.%26aulast%3DKay%26aufirst%3DE.%26aulast%3DKerrad%26aufirst%3DS.%26aulast%3DLewis%26aufirst%3DH.%2BD.%26aulast%3DMorentin-Gutierrez%26aufirst%3DP.%26aulast%3DMortishire-Smith%26aufirst%3DR.%26aulast%3DOakley%26aufirst%3DP.%2BJ.%26aulast%3DReilly%26aufirst%3DM.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26aulast%3DTeall%26aufirst%3DM.%2BR.%26aulast%3DWilliams%26aufirst%3DS.%26aulast%3DWrigley%26aufirst%3DJ.%2BD.%2BJ.%26atitle%3D4-Substituted%2520cyclohexyl%2520sulfones%2520as%2520potent%252C%2520orally%2520active%2520%25CE%25B3-secretase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D280%26epage%3D284%26doi%3D10.1016%2Fj.bmcl.2005.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Jelley, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrigley, J. D. J.</span><span> </span><span class="NLM_article-title">3-Substituted gem-cyclohexane sulfone based γ-secretase inhibitors for Alzheimer’s disease: Conformational analysis and biological activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3839</span><span class="NLM_x">–</span> <span class="NLM_lpage">3842</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.04.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;key=10.1016%2Fj.bmcl.2006.04.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3839-3842&author=R.+A.+Jelleyauthor=J.+Elliottauthor=K.+R.+Gibsonauthor=T.+Harrisonauthor=D.+Beherauthor=E.+E.+Clarkeauthor=H.+D.+Lewisauthor=M.+Shearmanauthor=J.+D.+J.+Wrigley&title=3-Substituted+gem-cyclohexane+sulfone+based+%CE%B3-secretase+inhibitors+for+Alzheimer%E2%80%99s+disease%3A+Conformational+analysis+and+biological+activity&doi=10.1016%2Fj.bmcl.2006.04.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DJelley%26aufirst%3DR.%2BA.%26aulast%3DElliott%26aufirst%3DJ.%26aulast%3DGibson%26aufirst%3DK.%2BR.%26aulast%3DHarrison%26aufirst%3DT.%26aulast%3DBeher%26aufirst%3DD.%26aulast%3DClarke%26aufirst%3DE.%2BE.%26aulast%3DLewis%26aufirst%3DH.%2BD.%26aulast%3DShearman%26aufirst%3DM.%26aulast%3DWrigley%26aufirst%3DJ.%2BD.%2BJ.%26atitle%3D3-Substituted%2520gem-cyclohexane%2520sulfone%2520based%2520%25CE%25B3-secretase%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Conformational%2520analysis%2520and%2520biological%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3839%26epage%3D3842%26doi%3D10.1016%2Fj.bmcl.2006.04.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span> </span><span class="NLM_article-title">Characterization of the reconstituted γ-secretase complex from Sf9 cells co-expressing presenilin 1, nicastrin, aph-1a, and pen-2</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">4450</span><span class="NLM_x">–</span> <span class="NLM_lpage">4457</span><span class="refDoi"> DOI: 10.1021/bi0481500</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0481500" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=4450-4457&author=L.+Zhangauthor=J.+Leeauthor=L.+Songauthor=X.+Sunauthor=J.+Shenauthor=G.+Terracinaauthor=E.+M.+Parker&title=Characterization+of+the+reconstituted+%CE%B3-secretase+complex+from+Sf9+cells+co-expressing+presenilin+1%2C+nicastrin%2C+aph-1a%2C+and+pen-2&doi=10.1021%2Fbi0481500"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fbi0481500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0481500%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DParker%26aufirst%3DE.%2BM.%26atitle%3DCharacterization%2520of%2520the%2520reconstituted%2520%25CE%25B3-secretase%2520complex%2520from%2520Sf9%2520cells%2520co-expressing%2520presenilin%25201%252C%2520nicastrin%252C%2520aph-1a%252C%2520and%2520pen-2%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D4450%26epage%3D4457%26doi%3D10.1021%2Fbi0481500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i30"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00774">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_68730"></div></div></div></div></div><hr /></hr><p class="last">. The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b00774">10.1021/acs.jmedchem.5b00774</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Protocols for in vitro studies: membrane-based and cell-based γ-secretase assays, determination of PS-1 vs PS-2 selectivity; protocols for the in vivo studies (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b00774/suppl_file/jm5b00774_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b00774/suppl_file/jm5b00774_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00774/suppl_file/jm5b00774_si_001.pdf">jm5b00774_si_001.pdf (183.72 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00774/suppl_file/jm5b00774_si_002.csv">jm5b00774_si_002.csv (2.58 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00774&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00774%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-22%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00774" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                959KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67995faf8ac0234a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
